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ABSTRACT 
Campylobacter is currently the most frequently isolated food-borne bacterial 
pathogen worldwide. Infections caused by C. jejuni may be self-limiting enteritis or 
chronic conditions such as Guillain-Barre' syndrome (GBS). Although the 
mechanisms by which C. jejuni causes disease are not clearly understood, the 
activation of the transcription factor NF-KB, which controls pro-inflammatory 
responses, is thought to be an important contributing mechanism for initiating the 
host's immune responses to C. jejuni infection. Signaling pathways leading to NF-KB 
by pathogens and/or their products include transmembrane Toll-like receptors 
(TLRs) and intracellular receptors nucleotide-binding oligomerization domain 
proteins (NODs). This study was carried out to: 1) investigate NF-KB activation by 
C. jejuni, 2) provide structural details regarding the NF-KB activating component(s) 
in C. jejuni boiled cell extract (BeE) and 3) investigate the role of TLRs (TLR2 and 
TLR4) and NODs (NODI and NOD2) in mediating NF-KB activation by C. jejuni. 
By means of measuring reporter gene activity, NF-KB activation and subsequent 
cytokine production by live or heat-killed C. jejuni, or BeE were observed in a range 
of tissue cultures cell lines. Structural characterisation of the NF-KB activating 
component in BeE indicated that the bioactive structure is an alpha-linked linear 
oligosaccharide composed of glucose where the activation by the oligosaccharide is 
suppressed upon pre-treatment of BeE with amyloglucosidase. NF- KB activation 
was observed to be augmented in cell lines transfected with TLR2 but not with 
TLR4. This activation is reduced upon transfection of cells with the dominant-
negative versions (DNV) of TLR-adaptor molecules MYD88 or lRAKl. 
Additionally, NF-KB activation by C. jejuni was observed to be independent of 
NOD 1 and NOD2 in cells transfected with DNV of these receptors. 
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CHAPTER 1 Literature revie\v 
CHAPTER 1 
1.1 Introduction 
Campylobacter infections are now recognised as a worldwide health problem 
(Brown et al., 2004). The infection's prognosis is usually self-limiting diarrhoea 
(Blaser et al., 1983) but occasionally chronic complications such as Guillain-Barre 
Syndrome (GBS) can occur (Smith, 1995). Although several virulence 
factors/mechanisms have been identified in Campylobacter (Ketley, 1997), how the 
bacterium elicits the host immune responses is yet to be understood. The 
transcription factor NF-KB is one of the central regulators of host-inflammatory 
genes. Campylobacter jejuni has been reported to activate NF-KB and produce 
various cytokines and chemokines (Mellits et al., 2002; Jin et aI, 2003; Jones et al., 
2003; Hu and Hickey, 2005; Hu and Hickey, 2006; Johanesen et al., 2006). Trans-
membrane receptors (TLRs) and the cytoplasmic receptors (NODs) have been shown 
to mediate the signaling pathways leading to NF-KB activation (Takada and Akira, 
2004; Strober et al., 2005). The roles of these receptors in Campylobacter 
pathogenesis, and the NF-KB-activating Campylobacter component or components 
are not known. The aims of the research are to; 
1- Investigate the receptor-mediated signalling pathways involved in NF-KB 
activation by C. jejuni. 
2- Characterise the bioactive component or components of C. jejuni that activate NF-
KB. 
1.2 History 
In 1963, Sebald and Veron proposed the genus Campylobacter after finding by 
means of fermentative metabolism and DNA base composition comparisons, that the 
vibrio-like bacterium was different from Vibrio fetus. Ten years later, the mis-placed 
1 
members of Vibrio species (V. jejuni, V. sputorum, V. fa ecalis, and V. coli) were 
transferred to the genus Campylobacter (Veron and Chatelain, 1973). The 
recognition of C. fetus as the. cause of abortion in some farm animals and diarrhoea 
in others drew more scientific interest to the Campylobacter genus (Butzler et al., 
1973). This attention led to the discovery of 12 new Campylobacter species by the 
1990s (Vandamme and Goossens, 1992). Currently, there are 16 species and 6 
subspecies in the genus Campylobacter. The genetically related Campylobacter 
species C. jejuni, C. doylei, C. coli, C. lari, C. upsaliensis and C. helveticus are those 
most frequently associated with human and animal diarrhoea (On et ai., 1998; 
Vandamme et al., 1997). 
1.3 Microbiology 
Campylobacters are Gram-negative spirally curved small rods, 5-8 !lm in length and 
0.2-0.8 !lm in width. They exhibit cork-screw motility by a polar flagellum at one or 
both ends of the cell. 
Figure 1.1: Scanning electron· microscope image of Campylobacter jejltlli, illustrating its 
corkscrew appearance and bipolar flagella (Altekruse et ai., 1999). 
Campylobacters are microaerophilic, requmng 3-15% O2, and 3-5% CO2 
concentrations depending on the species. Some species are thermophilic with an 
optimal growth temperature of 42°C. Campylobacters are catalase and oxidase 
positive, and most are urease negative. All the species have small genome sizes of 
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approximately 1700 kilobases. The human related pathogens C. jejuni and C. coli 
have a similar G+C DNA content of30-35% (Ketley, 1997; van Vliet et al., 2001). 
1.4 Sources of campylobacters 
The gut environment of many aVIan speCIes, including those grown 
commercially, provides optimum conditions for Campylobacter (Newell and 
Wagenaar 2000). Colonisation of most broiler chicken flocks by Campylobacter is 
not detectable until 10 days following hatching but then persists for many weeks. 
The introduction of infected birds to hatching chicks will increase the risk of 
spreading Campylobacter in the population (Shanker et al., 1990). Once one bird in 
a flock is colonised, the infection spreads very quickly through horizontal transfer 
(Beery et al., 1988). Complete colonisation within a flock has been reported by the 
49th day, which is the end of the growing period (Gregory et al., 1997). The change 
of colonisation rate from 0 at hatching to 100% at slaughter has been suggested to be 
due to the fact that campylobacters can be spread from chick to chick via the 
communal source of drinking water (Montrose et al., 1985). However, once one bird 
is infected the spread will be rapid because chickens are coprophagic. Litter, 
contaminated water, birds, insects, rodents, and farm workers are reported sources 
for horizontal transmission of campylobacters in poultry (Aarts et al., 1995; Evans 
and Sayers, 2000; Line, 2000). On entering the slaughterhouse, poultry have large 
numbers of Campylobacter spp. on their skin, feathers and in their intestinal counts 
of up to logto 9 CFU/g of caecal content have been reported from birds slaughtered 
and sampled at the farm. The levels of Campylobacter spp. on birds transported from 
the farm were found to increase from 10gIO 3 CFU/carcass to logto 7 CFU/carcass 
after transport to the processing plant (Stem et al., 1995). In broiler flocks, a survey 
of faeces found 94% of samples were positive for Campylobacter with an average 
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count of 10glO 5.17 CFU/g (Stern and Robach, 2003). Approximately 80% of raw 
chickens sold in the UK are contaminated with thermophilic campylobacters at levels 
as high as several thousand per cm2 of skin (Corry and Atabay, 2001). It has been 
estimated that the frequency of human campylobacteriosis can be reduced (up to 30-
fold) if a 10glO 2.0 reduction in Campylobacter numbers on retail chicken carcasses is 
achieved. Bacteriophage therapy is thought to be an effective means by which this 
colonisation could be controlled, thus limiting the entry of campylobacters into the 
human food chain (Loc-Carrillo et al., 2005). 
In cattle, experimental infection of ruminating and milk-fed calves with C. 
jejuni and C. fetus subsp. fetus caused febrile enteritis, and the intestinal lesions were 
similar to those found in humans (AI-Mashat et al., 1983). Unpasteurised milk 
consumption was the suspected cause of the largest outbreak of campylobacteriosis 
that affected 2500 school children in the UK (Jones et al., 1981). Campylobacter has 
been reported to be rarely present in bulk milk tanks (Doyle and Roman, 1982), but a 
study recorded the presence of 16 organisms per 100 ml in sampled bulk milk tanks 
(Humphrey and Beckett, 1987). The source of Campylobacter in bulk milk was 
thought to originate from subclinical mastitis of cows. Contamination of milk at the 
collection point with faecal matter could be another source (Orr et al., 1995). In beef 
cattle, carriage rates have been reported to be as high as 89% of 306 animals 
surveyed with an average of 610 organisms/g of faecal matter (Stanley et al., 1998). 
During the pig fattening period at farms, it was found that pigs could harbour up to 
eight spccies of Campylobacter where C. coli was the most frequently isolated 
species (Munroe et al., 1983). A study on the prevalence of thermo-tolerant 
Campylobacter spp. in lamb carcasses found that 92% of 360 small intestine samples 
were positive with an average concentration of 10glO 4 CFU/g of intestinal content 
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(Stanley et al., 1998). In another study on cases of sheep abortion, C. fetus subsp. 
fetus caused most abortions while C. jejuni was reported as the putative cause of 22% 
of the cases (Varga et aI., 1990). 
Campylobacter jejuni can cause disease in rabbits and domestic ferrets. The 
carriage rates of C. jejuni in rats, mice, guinea-pigs, and rabbits are generally low. 
Healthy puppies experimentally infected with C. jejuni were colonised without 
illness or only mild enteric infection (Varga et al., 1990; Skirrow, 1994). The 
carriage rates in dogs and cats were found to be 25% and 18%, respectively 
(Sandberg et al., 2002). 
Sources of water contamination with Campylobacter spp. include wild birds 
(Sacks et al., 1986), sewage effluent (Jones, 2001), and domestic animals (Blaser et 
al., 1983). Water contaminated by faecal matter from farm animals has been 
considered to be the source of some campylobacteriosis outbreaks (Clark et al., 
2003). Raw mussels, raw clams, and oysters contaminated with Campylobacter were 
reported to cause disease in humans. Contaminated water may have been the source 
of shellfish-borne infection (Trezeiva et al., 1991; Stlezer et al., 1989; Blaser et al., 
1986). 
1.5 Environmental survival mechanisms 
Bacteria are considered to enter a viable-but-nonculturable (VBNC) state when 
subjected to environmental stress. In the VBNC state, bacteria do not grow on 
laboratory media, but are alive and demonstrate very low levels of metabolic activity 
(Oliver, 2000). Upon entry into stationary phase or limiting nutrients, 
Campylobacter spp were shown to enter the VBNC state transforming from a motile 
spiral form to a coccoid form (Rollins and Colwell, 1986). Although resuscitation of 
VBNC Campylobacter cells has been reported in laboratory animals, isolation of 
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Campylabaeter from chicks and detection of specific antibodies from humans were 
not reported when subjects of these experiments were infected with VBNC 
Campylabaeter (Beumer et al., 1992). VBNC remains a source of conjecture with 
respect to Campylabaeter research. 
Campylabaeter spp are generally heat-sensitive bacteria, with a decimal 
reduction time of 1 minute at 55°C. Foods receiving mild heat treatment may 
represent a health risk of Campylabaeter infections. This is supported by the finding 
that C. cali isolated from pork livers subjected to heat treatment in PBS solution at 
48-63 °C in water-bath showed a non-logarithmic reduction resulting in a tailing 
effect at temperatures above 56°C (Moore and Madden, 2000). Of heat-shock 
proteins expressed by Campylabaeter, DnaJ was reported to play a role in viva. A 
Campylabaeter jejuni mutation deficient in the DnaJ gene was unable to colonise 
chickens (Konkel et al., 1998). The major cold-shock protein CspA present in many 
enteric bacteria is not present in the genome sequence of C. jejuni 11168 (Parkhill et 
at., 2000). A sudden decrease in growth rate was observed when C. jejuni was 
subjected to temperatures a few degrees below the minimum-growth temperature. 
However, motility, oxygen consumption, protein synthesis and survival of C. jejuni 
at 4°C have been reported (Wilma et al., 1998). C. jejuni grow optimally at pH of 
6.5-7.5. No surviving C. jejuni were detected after one day or 3 days at a pH 5 and 
9, respectively (Christopher et al., 1982). The mechanisms of oxygen tolerance and 
oxygen metabolism that remove reactive oxygen species (ROS) are not clearly 
understood in Campylabaeter spp. (van Vliet et al. 2001). However, the iron-
containing SodB, katA-encoded catalase, and alkyl hydroxide reductase are thought 
to protect Campylabaeter against oxidative stress (Purdy et al., 1999; Grant and 
Park, 1995; Baillon et at., 1999). Campylabaeter jejuni is very sensitive to dry 
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conditions and storage at room temperature where it will survive less well than in the 
cold and humid conditions of a refrigerator (Doyle and Roman, 1982). 
1.6 Epidemiology 
Between 1991 and 2001, the number of reported cases of Campylobacter infections 
in the UK per year rose from 32,000 to approximately 56,500 (Brown et al., 2004). 
It is now estimated that there are about 500,000 cases of Campylobacter infections 
every year in England and Wales (Food Standards Agency, UK, 2000). 
Campylobacter jejuni infections account for 90% of the reported cases (Gillespie et 
al., 2002). At a cost of four million pounds, and an estimated 25,000 cases of 
infections per year, C. coli are also increasingly becoming recognised as an 
important pathogen (Tam et al., 2003). Table 1.1 shows the reported incidences of 
Campylobacter enteritis in selected countries. 
In the early 1980s, Campylobacter infections became reportable illnesses in 
the United States. However, the impact of Campylobacter infections was 
underestimated because the reporting systems did not culture stool samples for 
Campylobacter when attempting to diagnose other enteric pathogens. 
Campylobacter was identified 2-7 times more frequently than Salmonella or Shigella 
when stool samples were cultured for Campylobacter. Currently, it is estimated that 
only 1 in 38 Campylobacter cases are reported in the USA. In the United States, the 
Center for Disease Control estimates the yearly number of Campylobacter cases to 
be around 2.4 million (Mead et al., 1999). For unknown reasons, Campylobacter 
infections have age and sex distributions unique among bacterial pathogens. Two 
age-peaks of infection occur: The first is at 1 year of age, and the second is at 15-44 
years of age. The majority of infections occur among male patients. The seasonal 
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distribution shows a surge of infections in May and peaks in August (Friedman et al., 
2000) 
Table 1.1. Incidences of Campylobacter enteritis in selected countries. 
Country 
England and Wales 
Finland 
Denmark 
Scotland 
Sweden 
USA 
Algeria 
Tanzania 
Egypt 
Nigeria 
Cameron 
Brazil 
Guatemala 
Thailand 
Bangladesh 
Increasing reported incidence* 
(Cases per 100,000) 
1986 1992 1998 
34 61 94 
10 23 37 
\3 14 42 
34 86 118 
24 41 58 
Decreasing reported 
incidence" 
(Cases per 100,000) 
1997 2000 2003 
25 16 12 
Isolation rate (%) 
*** 
«5-yr old) 
17.7 
18 
9 
16.5 
7.7 
9.9 
12.1 
13 
17.4 
*: Advances in identification methods facilitated better epidemiological reporting (Schlundt et. al., 
2004). **: Decrease is due to better prevention measures (CDC, 2005). ***: Rates from laboratory-
based statistics since popUlation surveys are not conducted in developing countries (Coker et al., 
2002). 
In industrialised nations, the single most important route of Campylobacter 
infections is thought to be the consumption of chicken. Studies have reported that 
50%-70% of all Campylobacter infections investigated were linked to the 
consumption of chicken (Harris et al., 1986; Adak et al., 1995). Although most 
Campylobacter infections are sporadic, consumption of unpasteurised milk is the 
most frequent cause of infection outbreaks (Friedman et al., 2000). Consumption of 
sausages or red meat, contaminated water and contact with pets, are other possible 
sources of sporadic infections (Kapperud et al., 1992; Nielsen et al., 1998). 
Direct transmission is mainly occupational among farmers, butchers, abattoir 
workers and poultry processors. Human-to-human transmission has been described 
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infrequently in young children (AlIos, 2001). The presence of an underlying disease 
predisposes patients for acquiring Campyiobacter and increases the severity of the 
infection (Pigrau et aI., 1997). In one study on patients having bacteraemia caused 
by Campyiobacter, most patients also had liver cirrhosis, vascular diseases, or AIDS 
(Tee and Mijch, 1998). Raising the gastric pH by an antacid medicine or using 
antibiotics are considered as risks for acquiring infection (Neal et ai., 1996). 
Another risk factor is international travel. Travelling to Mediterranean countries and 
Asia is a common campylobacteriosis risk factor for European citizens (Kapperaud, 
1994; Neimann et at., 2003). 
In developing countries, Campyiobacter infections are hyper-endemic among 
young children. Unlike infections in industrialised countries, asymptomatic 
infections occur commonly in both children and adults in tropical developing 
countries. Additionally, no seasonal peaks are observed and infection outbreaks are 
uncommon (AlIos, 2000). 
1.7 Prevention 
On the farm Campyiobacter infection control may assist in reducing 
contamination of the retail carcasses, poultry and red meat products (Kapperud et ai., 
1992). Strict hygiene reduces intestinal carriage in food animals (Kazwalla et ai., 
1990). This is supported by the finding that chlorinating poultry flock drinking water 
reduces intestinal colonisation rates (Pearson et ai., 1993). Other reported ways of 
reducing colonisation are treatment of chicks with commensal bacteria, 
bacteriophage and by immunization of older birds (Stem, 1994; Loc-Carrillo et al., 
2005 Widder et al., 1996). Reducing C. jejuni counts on food animal carcasses at the 
slaughter and processing facilities is also important for effective control of 
Campylobacter infections (Izat et aI., 1988). Campylobacter jejuni counts on chicken 
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and turkeys at slaughter increased by up to 100-fold during the defeathering and 
eviscerating stages but the bacterial count decreased during subsequent processing 
steps (Oosterom et aI., 1983). Scalding of turkey carcasses reduced the counts to 
near undetectable levels. Campyiobacter jejuni contamination of the chiller water can 
be reduced by the addition of sodium chloride or trisodium phosphate to the chiller 
water in the presence of an electrical current (Acuff et al., 1986). Up to a 100-fold 
decrease of carcasse contamination can be achieved by the use of chlorinated water 
and clean working surfaces at the slaughter house (Mead et al., 1995). The use of 
lactic acid on swine carcasses reduced C. jejuni counts to undetectable levels (Epling 
et ai., 1993). A dose of 0.25 kGy radiation levels has been reported to be sufficient 
for eliminating Campylobacter from poultry carcasses although there is little 
enthusiasm from consumers for this practice (Patterson 1995). 
Natural or artificial Campylobacter contamination can be reduced during 
different processing steps (Table 1.2). However, Campyiobacter can still be detected 
in retail foods and in experimental test foods that have been subjected to different 
storage conditions (Table 1.2). In order to minimise the incidence of 
campylobacteriosis incidences, safe food preparation and handling procedures need 
to be followed (CDC, 2005). In most countries, not following safe-food handling 
procedures (Table 1.3) in kitchens is considered to be the risk factor associated with 
most cases of food-borne disease (Zhao et ai., 1998). In the UK it is estimated that 
insufficient heat treatment and the cross-contamination of foods account for 35 and 
28 %, respectively, of food-borne disease outbreaks investigated (Ryan et ai., 1996). 
In the USA, over a 14 year period, 21 % of the reported cases of food-borne diseases 
were related to private households (Williamson et al., 1992). After handling poultry 
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and raw meat, careful hand washing is very important to reduce the risk of cross-
contamination (Brown et al., 1988). 
Table 1.2. Incidence of Campylobacter in tested items. 
Item Prevalence (%) Population Total decrease Reference (CFU/g) (CFU/day) 
Poultry at farm 96.4 Stem and Robach, 200 I 
Pre-scald skin 52.5 6.61og lO Kotula and Pandya, 1995 
Poultry carcass pre-wash 87 4.781og lO Bashors el al., 2004 
Poultry carcass post-wash 80 4.31oglO Bashors el al., 2004 
Poultry carcass pre-chill 99 4.751oglO Northcutt el al., 2003 
Poultry carcass post-chill 83 31og lo Northcutt el al., 2003 
Retail-packaged broiler 98 Stem and Line, 1992 
Raw broiler 69 Willis and Murray, 1997 
Chicken carcass at retail 63 Bongkot, 1997 
Chicken, lamb, pig, and ox liver 83,72.9,71.7, Kramer el al., 2000 
at retail and 54.2, 
respectively. 
Chicken, duck, turkey, beef, 49.9,45.8,37.5, Whyte el al., 200 
pork, lamb, bulk milk, and 3.2,5.1,11.8,1.6, 
shellfish and 2.3, 
respectively. 
Chicken carcass stored at -20°C 1.4 loglO/64 Oosterom el al., 1983 
Ground beef stored at -15°C 31oguyl4 Stem and Kotula, 1982 
Red meat stored at -18°C I. 7 loglO/40 Gill and Linda, 1982 
Chicken meat stored at 4°C 1.1 loglO/18 Blankenship and Craven, 
1982 
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Table 1.3. Consumer's responses to food safety-procedures surveys. 
Safe food handling/ Hygienic procedures 
Washing hands not important in relation to 
food hygiene 
Washing hands not performed after 
handling raw meat and poultry 
Cutting board not washed after handling 
raw meat and poultry 
Food items handled in a way that could 
lead to cross-contamination 
Sufficient heat treatment not recognised as 
a preventive option to food borne disease 
Meals not heated to a core-temperature of 
74°C 
Percentage of surveyed people 
who did agree with statement 
18.5% 
34% 
33% 
76% 
33% 
24% 
Reference 
Jay et ai., 1999 
Altekruse et al., 1995 
Altekruse et ai., 1995 
Daniels, 1998 
AItekruse et ai., 1995 
Griffith et ai., 1998 
The isolation of Campylobacter from hands that handled raw poultry was 
reported in 42 of 58 trials (de Boer et al., 1990). When contaminated hands were 
washed and dried, Campylobacter could not be detected. Drying hands after washing 
is important for elimination of the bacteria from the fingers (Coates et al., 1987). 
Campylobacter was detected on kitchen utensils exposed to raw poultry and on 
vegetables (handled with these utensils), in 46 and 9 % of the tested samples, 
respectively (de Boer et al., 1990). Enforcing stricter food safety measures by 
government agencies would probably minimize the risk for food-borne diseases. At 
places where foods are prepared or consumed in large quantities, this enforcement 
would be more effective. In the USA, there was a decline in the incidence of 
Campylobacter in the period from 1996 to 2003. This decline is considered to be as 
a result of safe food-control measures and educational campaigns carried out by the 
specialising government agencies (CDC, 2005). 
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1.8 Identification 
Direct microscopic examination of fresh liquid faeces with Gram's stain or a 
phase-contrast optical system can be used for quick Campylobaeter enteritis 
diagnosis. The spiral morphology and rapid spinning motion can aid in 
distinguishing Campylobaeter spp. from other bacteria. Latex agglutination antigen-
based commercial kits can be used for direct detection of C. jejuni and C. eoli in 
faecal samples (Bolton, 2001). Primary plating on selective blood-based or blood 
free charcoal-based plates in a micro aerobic atmosphere at 42 °e for 48-72 h is used 
for C. jejuni and C. eali isolation (Karmali et al., 1986; Endtz et al., 1991). The 
selective agent that is used to inhibit most stool flora other than Campylabaeter 
species is cephalothin. An antibiotic-free media for culturing stool samples filtered 
through <0.65 Jlm filters can be used if the initial results of culture are negative and 
Campylabaeter is suspected to be present. This is because some non-jejuni 
campylobacters are susceptible to cephalothin (Bolton, 2001). To isolate 
Campylabaeter from food samples, where its presence can be in low numbers 
compared to other competing bacteria, it may be necessary to use enrichment culture 
in a broth medium. This allows the recovery of small numbers of cells prior to 
plating on selective media. This process may take up to five days to achieve 
definitive results (Sails et a!., 2003). A rapid peR assay for direct detection of 
Campylabaeter from chicken faeces has been developed (Bang et al., 2001). 
Drawbacks of peR assays include; presence of inhibitors and the sample volumes 
needed for mass screening. The development of a DNA microarray method, which 
overcomes the limitations of peR, that can be used for the direct detection of 
Campylabaeter from chicken faecal swabs in 3 h has been reported. Specific 
sequences targeting the 16S rRNA and, the 16S-23S rRNA intergenic region were 
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amplified and fluorescently labelled usmg PCR. The PCR products were then 
hybridized to immobilised capture probes on the microarray. Using this method C. 
jejuni and C. coli can be detected and differentiated directly from chicken faeces 
(Keramas et al., 2003). 
Because of the similarity of the symptoms and the disease prognosis caused by 
Campylobacter species, no further identification is usually performed in routine 
laboratory settings. In most laboratories, biochemical testing is limited by cost and 
duration of the tests. To trace the routes of Campylobacter transmission, incidence 
and patterns, an epidemiologist needs the means for species differentiation (Frost, 
2001). Given that the incorrect results of some biochemical tests such as antibiotic 
resistance and the hippurase test can confound the epidemiological investigation, 
differentiation among campylobacters should not rely on just biochemical testing 
(Bolton et al., 1984). The biochemical tests used to aid Campylobacter spp 
differentiation include; hippurate hydrolysis, catalase, alpha-haemolysis, urease, 
nitrate reduction, selenite reduction, hydrogen sulphide production, indoxyl acetate 
hydolysis, and growth (at 25/42 °C; on minimal medium and on MacConkey; in the 
presence of glycine, NaCl, cefoperazone, cephalothin, or nalidixic acid) profiles 
(Vandamme, 2000). 
1.8.1 Serotyping 
The serotyping for C. jejuni was described by Penner and Hennessy on the basis of 
using soluble heat-stable antigens in a haemagglutination test. This test comprises of 
47 antisera for C.jejuni and 18 for C. coli (Penner and Hennessy, 1980; Penner et al., 
1983). In 1982, a serotyping method that detects variation in heat-labile antigens was 
proposed (Lior et aI., 1982). This method, which is a slide-agglutination based test, 
recognises 130 serotypes of C. jejuni, C. coli, and C. lari . . The need for high quality 
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antisera, and the non-typeability (up to 20% of isolates) are the main disadvantages 
ofserotyping (Lior et ai., 1982; Nielsen et ai., 1997). 
1.8.2 Phage typing 
In 1985, Grajewski and others developed a phage-typing system for differentiating 
between strains of C. jejuni and C. coli (Grajewski et ai., 1985). The system has an 
epidemiological potential, and can be used as adjunct or an alternative to serotyping. 
In the UK, the isolation of Campylobacter-specific bacteriophages from broiler 
chicken (Connerton et ai., 2004) and retail poultry (Atterbury et ai., 2003) has been 
reported. Approximately 80.6% of 754 Campyiobacter isolates from 17 different 
countries were typable using this method (Khakhria and Lior, 1992). 
1.8.3 Genotyping 
1.8.3.1 Fia typing 
Campylobacters have two flagellin genes,flaA andflaB. In C. jejuni, the two genes 
are in tandem, separated by approximately 0.2 kilobases. The genes are conserved, 
with 92% identity between the flaA and flaB DNA sequences from individual 
isolates (Meinnersmann et ai., 1997). However, the intragenic region of the fla genes 
differs between isolates, thereby providing the basis of a typing scheme. Indeed, fla 
typing has proved to be valuable for the majority of C. coli strains and some strains 
of C. iari, C. helveticus (Owen et al., 1993) and C.jejuni subsp. doylei (Wassenaar et 
al., 2000). Although fla typing has proven to be a useful, reliable and relatively 
simple subtyping technique, the variations in the procedure that have been described 
do not allow results obtained in different laboratories to be compared directly 
(Wassenaar et al., 2000). 
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1.8.3.2 Ribotyping 
In 1992, ribotyping based on the detection of RFLP-containing ribosomal RNA 
genes was introduced. Utilising the 16S gene of the heat-stable serotypes of C. jejuni 
100% typeability was obtained (Fitzgerald et aI., 1996). This time-consuming typing 
method can not distinguish between C. fetus subsp. fetus and C. fetus subsp. 
venerealis since these subspecies contain only three ribosomal copies (Denes et al., 
1997). However, ribotyping is most useful for distinguishing between 
Campylobacter species that are difficult to analyse by phenotypic tests (Kiehlbauch 
eta!.,1991). 
1.8.3.3 Random Amplification of Polymorphic DNA (RAPD) 
In the RAPD typing method, the result of an amplified random primer shows 
banding patterns of peR products when run on agarose gels that are suitable for 
comparison of isolates within bacterial species. The discrimination level obtained by 
RAPD for Campylobacter was reported to be as good as that of pulsed field gel 
electrophoresis (Nielsen et al., 2000). However, the reproducibility of RAPD typing 
may vary in different laboratories (Hernandez et al., 1991). Up to 14% of strains 
examined were untypeable due to DNase activity (Hernandez et al., 1991; Fitzgerald 
et al., 1996). 
1.10.3.4 Amplified Fragment Length Polymorphism (AFLP) 
The AFLP method has been used to subtype C. jejuni (Duim et al., 1999) but is a 
complex and expensive typing method to set up. In this method, the genome is 
digested with two restriction endonucleases, oligonucleotides are ligated to the 
fragments, and then amplified. This produces fragments of different size which 
produces a unique fingerprint when separated by electrophoresis (Lindstedst et al., 
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2000). The possibility of sampling the whole genome randomly is a major advantage 
of this method (Wassenaar et al., 2000). 
1.8.3.5 Multi-locus Sequence Typing (MLST) 
Multi-locus sequence typing uses comparative DNA sequencing of 
conserved housekeeping genes to characterise bacteria. The level of diversity across 
the MLST loci is important for the potential identification of alleles or sequence 
types that may correlate with animal host, geographical location, or other factors 
related to the source of the strain (Miller et al., 2006). MLST was able to discriminate 
among C.jejuni isolates effectively, and is thought to provide a means for the 
investigation of disease outbreaks (Dingle et al., 2001). As MLST provides 
unambiguous profiling and data can be compared on internet databases, MLST is 
thought to be the choice method for genotyping C. jejuni during outbreak 
investigation (Wassenaar et al., 2000). 
1.8.3.6 Pulsed-Field Gel Electrophoresis (PFGE) 
PFGE is a technique used to separate long strands of DNA by length in order 
to compare differences among samples. Plasmids which may occur in 
Campylobacter spp. may potentially be detected by PFGE together with the 
chromosomal DNA (Fayos et al., 1993). DNA fragments obtained by digestion with 
random cutting restriction endonucleases are generally very large (up to 200 kb). 
These can be separated on the basis of size by using special electrophoretic 
conditions. Variations in the presence of relevant restriction sites result in genotypic 
profiles. PFGE has been used to type C. jejuni, C. coli, C. fetus and C. upsiLiiensis 
(Yan et al., 1991). However, because of the variations in the restriction enzymes and 
electrophoretic conditions used, comparisons of the PFGE profiles obtained in 
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different laboratories require careful consideration (Gibson et al., 1994; Bourke et 
al., 1996). 
1.9 Symptoms and complications 
The infectious dose of Campylabaeter and susceptibility of exposed humans to 
develop the illness were reported to be variable. It is reported that as few as 500 
organisms can cause the disease (Walker et al., 1986). The acute self-limited 
gastroenteritis caused by Campylabaeter is characterised by watery or bloody 
diarrhoea, fever, and abdominal cramps. However, because these symptoms can be 
associated with other bacterial enteric infections, it is not possible to diagnose 
Campylabaeter infection based on the symptoms (Blaser et al., 1983). The 
incubation period can extend to 10 days but it is commonly between 2 and 5 days. 
Vomiting is rare and abdominal pain may persist after diarrhoea stops (Butzler, 
2004). Stool sample examination shows the presence of leukocytes, fresh blood and 
mucus. Other complications may include mucosal oedema with or without 
haemorrhage, jejunum mesenteric adenitis and immunoproliferative small intestinal 
disease. Bacteraemia may occur in immune compromised patients (Skirrow et al., 
1993). Patients may rarely develop extraintestinal infections, including meningitis 
(Goossens et al., 1986), osteomyelitis and neonatal sepsis (Vandenberg et al., 2003). 
With an incidence of 111000 infections, the paralytic condition, Guillain-Barre' 
syndrome (GBS), is the most serious complication of Campylobaeter infection 
(Smith, 1995). Campylobaeter jejuni is the most frequently observed pathogen as 
the antecedent infection in patients with GBS (Leonard et al., 2004). This peripheral 
neuron demyelinating acute syndrome is characterised by an ascending paralysis. 
Oligosaccharides from C. jejuni, have a structure that mimics the GMI ganglioside 
of the peripheral neuron membrane, which may play a role in GBS pathogenesis 
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(Yuki et ai., 1997). Major neurological sequelae occur in 20% of cases, and the 
mortality rate ofGBS is 2-3% (Brescoe et ai., 1987). 
1.10 Treatment and antibiotic resistance 
Preventing dehydration in patients with Campyiobaeter enteritis is necessary 
for a good prognosis. In severe and prolonged cases of infection, antibiotics such as 
erythromycin may be used for treatment (Altekruse et al., 1999). The resistance of 
Campylobaeter to fluoroquinolones has been reported (Smith et al., 1999). Co-
incidentally, the existence of fluroquiolone resistance in Campylabaeter was dated to 
the introduction of these agents for use in veterinary medicine (Endtz et al., 1991). 
Mutations affecting efflux pumps as well as mutations in the genes encoding DNA 
gyrase and topoisomerase have been reported as the resistance mechanisms toward 
fluoroquinolones. Although efflux-mediated resistance has been demonstrated in the 
laboratory, the existence of clinical resistant isolates has not been reported. Wildtype 
C. jejuni gyrase is more susceptible to inhibition by quinolones than that of purified 
gyrase from fluoroquinolone resistant C. jejuni (Gootz and Martin, 1991; Charvalos 
et aI., 1995). Macrolides such as erythromycin bind to the ribosome and cause 
inhibition of the association of the peptidyl-tRNA. The resistance of C. jejuni and C. 
eoli to erythromycin is not mediated by efflux, modification of the antibiotic, or the 
presence of rRNA methylase. The screening of the 23S rRNA genes from 
erythromycin- resistant campylobacter identified mutations at the same locations in 
each genome. Alteration of the ribosome may therefore be the mechanism of 
resistance to macrolides (Yan and Taylor, 1991; Taylor et aI., 1997). 
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1.11 Campy[obacter Pathogenesis 
1.11.1 Motility 
The corkscrew-like motion of Campylobacter is facilitated by the polar 
flagella (Newell et al., 1985). In C. jejuni, the flagellum consists of a basal body, 
hook and filament. Two proteins (FlaA and FlaB) make up the flagellar filament. 
The FlaA protein (regulated by 0'28) is more highly expressed than than FlaB protein 
which is regulated by 0' 54 (Nuijten et al., 1991; Henderixon et al., 2001). Mutants 
of FlaA but not FlaB produced truncated filaments (Guerry et al., 1991; Wassenaar et 
al., 1991). Although the motility of Campylobacter correlates with the FlaA protein 
synthesis, fully flagellated and motile campylobacters have been reported in a FlaA 
mutant (Wassenaar et al., 1994). Chemically induced mutations resulted in C.jejuni 
singularly-flagellated and non-flagellated cells. These mutants were non-motile, and 
were unable to colonise mice. Bipolar flagella may be necessary for Campylobacter 
to move through the intestinal mucus (Morooka et al., 1985). A hypo-motile isolate 
of C. jejuni was able to colonize the mouce intestine as efficiently as the wild-type 
strain (Newell, 1986). In day-old chicks, the expression of flagellin was more 
important than motility for optimal colonisation (Wassenaar et al., 1993). However, 
C. jejuni having FlaA but not FlaB resulted in strains that colonised the chicks at 
higher levels than the wild-type bacteria (Wassenaar et al., 1993). 
In epithelial cells cultured with C. jejuni, the expression of FlaA was found necessary 
for maximal invasion and translocation across polarised cell monolayers (Wassenaar 
et al., 1991; Yao et al., 1994). Interestingly, C.jejuni expressing FlaB but not FlaA 
exhibited higher invasion ability. The flagellar structure may be more important for 
t.jejuni intemalisation than motility (Wassenaar et al., 1991; Grant et al., 1993). 
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1.11.2 Chemotaxis 
Chemotaxis, which is the movement of an organism towards or away from 
chemical substances, of Campylobacter has been studied (Hugdahl et al., 1988; 
Takata et al., 1992). In agar plates containing a variety of different chemicals, C. 
jejuni exhibited a chemotactic resp?nse to some amino and organic acids, and L-
fucose. A zone of turbidity in the plates indicated that the terminal sugar L-fucose, a 
component of mucin, acts as chemoattractant for C. jejuni (Hugdahl et al., 1988). As 
with other enteric pathogenic bacteria (Freter et al., 1981), chemotaxis has been 
reported to be a virulence factor for C. jejuni (Takata et al., 1992). Non-chemotactic 
mutants of C. jejuni were not able to colonise mice even at high doses. The flagella 
of these mutants were similar to those from the wild-type (Takata et al., 1992). A 
motile non-chemotactic cheY C. jejuni mutant was capable of adherence and 
invasion of cultured cells. However, this mutant was not able to colonise mice or 
cause symptoms in ferrets (a model of infection sometimes used to mimic human 
infection). Motility without chemotaxis ability may have led to the removal of C. 
jejuni from the host by fluid flow (Yao et al., 1997). 
1.11.3 Adhesion, invasion, and translocation 
Heat-killed or treatment of C. jejuni with either sodium azide or 
chloramphenicol did not affect the ability of the cells to adhere to mammalian tissue 
culture cell lines. This observation suggests that C. jejuni constitutively expresses 
surface adhesins (Konkel and Ceiplak, 1992). In a non- polarised cell line treated 
with a chemical mimicking the mucus layer, C. jejuni showed increased binding and 
entry into the cells. The mucus-mimicking chemical treatment prolongs the contact 
of C. jejuni with the cell line resulting in increased adherence and invasion 
(Szymanski et al., 1995). A protein termed PEB 1 has been reported to mediate the 
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binding of C. jejuni to epithelial cells (Pei et al., 1998). Three other outer membrane 
proteins (OMP) have been proposed to playa role in C. jejuni binding to host cells 
(de Melo and Pechere, 1990). CadF is another OMP that has been identified in the 
mediation of binding of C. jejuni to fibronectin (Konkel et al., 1997). The major 
outer membrane protein (OmpE) was also reported to act as adhesin (Moser et al., 
1997). 
The lipoprotein, JlpA was reported to have a role in C. jejuni adherence. A 
JlpA mutant showed reduced ability to bind a HEp-2 cell line (Jin et al., 2001). The 
flagella contact with host cell, as observed by electron microscopy may indicate that 
flagella act as adhesins (Konkel et al., 1992). Another deduced role for LPS is 
supported by the observation that pre-treatment of cell lines with LPS reduced the 
binding of C. jejuni to the cells (McSweegan and Walker, 1986). 
Using an antibiotic protection assay, several studies investigated C. jejuni 
entry, survival and replication in tissue culture cell lines (Newell et al., 1985; Konkel 
et al., 1990; Everest et al., 1992; Doig et al., 1996; Konkel et al., 1999). During 
incubation with eukaryotic cells, C. jejuni secretes invasion antigens, the Cia 
proteins. A C. jejuni mutant in CiaB exhibited reduced invasion but its ability to bind 
to a eukaryotic cell line was not altered (Konkel et al., 1999). The infection of 
piglets with a C. jejuni CiaB mutant resulted in delayed development of diarrhoea 
and less severity of histological damage compared to controls. These observations 
indicate that at least the CiaB protein promotes C. jejuni invasion and its uptake by 
host cells (Konkel et al., 1999). The invasion ability was reported to be strain-
dependent (Newell et al., 1985; Konkel and Joens, 1989) with the clinical isolates 
showing higher invasion level than the environmental isolates (Newell et al., 1985). 
Clinical isolates from individuals with colitis had higher levels of invasion than those 
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from asymptomatic individuals (Everest et at., 1992). Invasion has been reported 
with low (Hu and Kopecko, 1999) and high (Biswas et at., 2000) multiplicities of 
infection. Campylobacter jejuni survives in the invaded cells and induces a cytotoxic 
response (Konkel et aI., 1992). Metabolic inactivation has been reported to prevent 
endocytosis-mediated internalization of C. jejuni, where synthesis of internalization 
promoting proteins (IPP) is thought to be required to mediate invasion. 
Campytobacter jejuni invasion ability was inhibited by the suppression of IPP 
synthesis by chemical or heat treatment (Konkel and Ceiplak, 1992). The entry-
promoting proteins are reported to be only synthesised by C. jejuni when incubated 
with epithelial cells (Konkel et at., 1993). Animal models of infection revealed that 
colonic biopsy from C. jejuni infected monkeys showed penetration of the epithelial 
cells by the bacteria (Russell et at., 1993). Other animal model studies on newborn 
pigs (Babakhani et at., 1993), mice (Sosula et at., 1988), and chicken embryos 
(Welkos, 1984) reported similar observations indicating that C. jejuni is able to 
invade epithelial cells. 
The ability of a bacterial pathogen to translocate across a cell barrier is 
considered a virulence mechanism. Where a pathogen translocates across a 
monolayer of polarised cells it causes more cellular damage than a pathogen that 
minimally translocates (Kops et al., 1996). Campytobacter isolates from patients 
with enteritis were twice as able to translocate across polarised cell lines than non-
clinical isolates (Everest et at., 1992). However, non-invasive C. jejuni isolates were 
also reported to translocate across polarized monolayers (Everest et at., 1992). In 
another experiment, the ability of clinical isolates of C. jejuni to translocate across 
polarised cells and invade polarised and non-polarised cells was investigated. No 
correlation between invasiveness and the ability of the isolates to translocate was 
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reported (Harvey et ai., 1999). The monolayer integrity was maintained over a 6 h 
period as measured by trans-epithelial electrical resistance (TEER). However, a loss 
of TEER was reported after 24 hours of incubating cell mono layers with C. jejuni 
indicating the disruption of the tight junctions (Harvey et ai., 1999; Bras and Ketley, 
1999). Bacterial translocation, invasion, or toxin production may have led to tight 
junction disruption (Bras and Ketley, 1999). Campylobacter jejuni translocation 
may be via transcellular or paracellular routes. Internalised bacteria and reducing the 
host endocytic process by lowering the temperature support the transcellular route 
(Konkel et al. 1992). The use of the paracellular route is supported by the 
observation that the invasiveness of C. jejuni does not correlate quantitatively with 
translocation efficiency (Harvey et al., 1999). 
1.11.4 Cytolethal distending toxin (CDT) 
In 1988, Johnson and Lior reported that different Campylobacter strains 
produced CDT. The addition of diluted celllysates of the whole bacteria to different 
cell lines caused cell nuclei distension and eventual cell death (Johnson and Lior, 
1988). CDT causes eukaryotic cells to arrest in the G21M transition phase of the cell 
cycle. Although cell division stops, the cytoplasm continues to grow and distend 
resulting in morphological changes and cell death (Lara et al., 2000). The 
production of heat-labile and trypsin-sensitive CDT is dependent on three genes 
(cdtA, cdtB, and cdtC) , the expression of which is not affected by alterations in 
environmental conditions (Picket et al. 1996; Picket, 2000). Three protein subunits 
(outer-membrane associated) of CDT are necessary for the toxin delivery and activity 
(Hickey et al., 2000). A role for CDT in C. jejuni invasion has been proposed 
(Purdey et ai. 2000). In mice challenged with the C. jejuni wild-type or a cdtB 
mutant it was shown that there were differences in the presence of the organism in 
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the various organs examined. At an early time point, the cdtB mutant colonisation 
rate of mice was less than that of wild-type e. jejuni. It has been reported that the 
pathologic effects of eDT are caused by it DNAse-like activity. Incubation of 
human fibroblasts with e. jejuni eDT resulted in formation of Rad50 foci (a DNA 
repair factor) around dsDNA breaks (Hassene et at., 2003). The presence of another 
toxin was suggested because the cdtB mutant lysates caused cytotoxic effects in a 
HeLa cell line (Purdey et at. 2000). 
1.11.5 Iron Acquisition 
Pathogenic bacteria have developed mechanisms that allow them to overcome 
the growth-limiting effects of transferrin and lactoferrin bonded iron (Andrews et at., 
2003). Iron uptake by bacteria from outer-membrane receptors into the cytosol is 
mediated by siderophores (Greek for iron carrier). Genes encoding enterochelin and 
ferrichrome, which are types of siderophores, have been characterised in 
Campytobacter isolates (Richarson and Park, 1995; Galindo et at., 2001). Purified 
siderophores were utilised by e. jejuni grown in iron-depleted media (Field et at., 
1986). The analysis of the e. jejuni genome revealed the presence of a periplasmic 
binding protein dependent system (a siderophore receptor), a hemin uptake operon, a 
ferrous uptake protein, and genes similar to the tonB system. The latter mediates the 
movement of iron from the siderophore into the periplasm (Parkhill et at., 2000; Van 
Vliet and Ketley, 2001). 
1.11.6 Intracellular survival 
The host and bacterial factors that determine the fate of internalised 
Campylobacter are not understood (Ketley, 1997). In HEP-2 cells, the viability ofe. 
jejuni declined 6 hours after internalisation. The invaded cells showed a strong 
lysosomal response that may have caused the bacterial cell to change to a coccoid 
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form (de Melo et al., 1989). The bacterial oxidative stress defence system can 
increase the invasion ability and improve their intracellular survival. A C. jejuni 
mutant in sodB (superoxide dismutase gene) exhibited shortened survival times in 
INT407 cells (Pesci et al., 1994). Catalase has also been reported to be important for 
C. jejuni survival in macrophages. Mutation in katA (the gene encoding catalase) 
made C. jejuni more susceptible to killing by the phagocytes. Inhibition of 
macrophage nitric oxide synthase permitted the recovery of the mutant (Day et al., 
2000). 
1.11.7 Cell wall components 
1.11.7.1 Lipopolysaccharride (LPS), Capsular Polysaccharide (CPS) and Flagella. 
The synthesis of a high molecular weight glycolipid structure (termed 
lipopolysaccharide), low molecular glycolipid structure (termed lipooligosaccharide; 
LOS) and capsular polysaccharide (CPS) have been reported in C. jejuni (Karlyshev 
et al., 2005) (Figure 1.2). The lipid A component of C. jejuni LOS has been reported 
to have endotoxic activity. C. jejuni LOS may playa role in pathogenesis through 
molecular structural mimicry that result in GBS (Moran, 1996). Additionally 
flagella, LOS and CPS play roles in C. jejuni adhesion, invasion, host colonisation, 
maintenance of cell surface charge and serum resistance (Bacon et ai., 2001; Guerry 
et ai., 2002). The part of LOS composed of beta 1-6-linked disaccharides (attached 
to 10-28 carbon-length fatty acids) linked to sugar residues (by ester or amide 
linkages) is termed Lipid A. This part, which contains glycosidic and nonglycosidic 
phosphoryl groups, varies in bacteria with regard to the number and nature of sugars, 
chain length and location of acyl residues, and the nature of the phosphate group 
substitution (Henderson et ai., 1996). 
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Figure 1.2 . Outer membrane components of C. j ejulli (Karlyshev et al. , 2005). LOS is mostly 
expressed by C. j ejuni studied strains than LPS . LOS core oligosaccharide is composed of variably-
linked glucose, galactose, N-acetyl-D-galactosamine, N-acetylneuraminic acid and L-glycero-D-
mannoheptose res idues attached to 3-deoxy-a-D-manno-oct-2-ulopyranosonic acid which is linked to 
lipid-A. CPS is composed of {3-d-Ribp, {3-d-GalfNAc, a-d-GlcpA6, a uronic acid amidated with 2-
amino-2-deoxyglycerol at, and 6-0-methyl-d-glycero-a-I-gluco-heptopyranose (Michael et al ., 2002) . 
The structure of the glycan in the N-linked glycoproteins is GaINAc-tt l ,4-GaINAc-:t1,4-[Glc{3l ,3-
]GaINAc-u. l ,4-GaINAc-u. l ,4-GaINAc-:d ,3-Bac-{3l ,N-Asn-Xaa, where Bac is baciJlosamine, 2,4-
diacetamido-2,4,6-trideoxyglucopyranose (Young et aZ., 2002). The glycosilated flagellum mediates 
motility and is thought to be an export apparatus (Konkel et aZ., 2004) . 
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To induce immune responses, lipid-A must have the disaccharide, 2 
phosphoryl groups and six fatty acids. The core region of LOS has an inner core 
(heptose and 2-keto-3-deoxyoctonic acid; KDO), and is reported to exert the lipid-A 
activity. The biological activities of S. minnesota LPS without side-chain 
polysaccharides were reported to be more potent than that of with side chain 
polysaccharide (Henderson et ai. , 1996). 
LOS from C. j ejuni has been reported to be of low molecular weight without 
detectable 0 polysaccharide chains (Logan and Trust, 1984). However, the 
, 
production of high molecular weight LPS by 33% of studied C. j ejuni isolates was 
also reported (Preston and Penner, 1987). The high molecular weight 
polysaccharides were later found to be biochemically similar to group II capsular 
polysaccharide not O-antigen. Mutation in kps genes (similar to capsular 
polysaccharide genes in E. coli) resulted in C. jejuni without high molecular weight 
polysaccharide (Karlyshev et ai. , 2000). The structural components of C. j ejuni lipid 
A are acylated and phosphorylated in a similar fashion to other bacterial species' 
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Lipid A. The disaccharide backbone of lipid A is composed of diaminoglucose and 
D-glucosamine of varying molar ratios between strains (Moran, 1997; Moran and 
Penner, 1999). The inner core of oligosaccharide consists of a trisaccharide (KDO, 
and two heptoses) in which the heptose is substituted by a beta 1-4 linked D-glucose 
(Aspinall et al., 1993). The heptose adjacent to KDO can be substituted by 
phosphate or phosphoethanolamine. The outer core sugars are two or three hexoses 
substituted with sialic acid or quinovosamine residues (Moran and Penner, 1999). 
The structure of CPS (Karlyshev et al., 2000; Karlyshev et al., 2005) and LOS 
(Michael et al., 2002; Godschalk et al., 2007) from C. jejuni strain 11168 has been 
reported. 
1.11.8 Peptidoglycan 
The polymer of peptidoglycan consists of glycan strands of two alternating 
sugar derivatives, N-acetylglucosamine and N-acetylmuramic acid, which form a 
dissacharide subunit. A peptide subunit of an alternating four or five amino acids, is 
linked to the carboxy group of N-acetylmuramic acid. In most Gram-negative 
bacteria, diaminopimelic acid is usually the third amino acid of the peptide, whereas 
it is a lysine in Gram-positive bacteria (Fournier and Philpott, 2005). In 
Campylobacter peptidoglycan is presented as GLcNAc-MurNAc-L-Ala-D-Glu-
meso-Dpm-D-Ala (Simbert, 1978) and it has been suggested that its degradation 
causes the bacterial cell morphology to change to the coccoid form (Amano and 
Shibata, 1992). 
1.12 Innate immunity responses to Campylohacter infection 
The human intestine represents a huge surface area of more than 300 square 
meters that is inhabited by more than 400 bacterial species oftotalloglO14 microbial 
cells. This requires the host defence systems to tolerate commensal bacteria while 
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being able to discriminate and deal with invading pathogens (Hao and Lee, 2004). 
The intestinal lumen is mainly occupied by the commensal bacteria, while the mucus 
covered muscosal surface and the crypts containing intestinal stem cells are not 
colonised. In non-inflamed mucosa, direct binding to epithelial cells is inhibited 
(Gusils et al., 2004). Paneth cells (Porter et al., 2002) residing at the base of the 
crypts play an important role in the innate immune defence in the intestine by 
producing several types of antimicrobial peptides for example, the pore-forming u-
defensins HD-5, HD-6 (Ouellete, 1999) and enzymes that include bacterial lipid 
degrading Group IIA phospholipase A2 and peptidoglycan degrading lysozyme 
(Ouellete, 1999). Intestinal epithelial cells produce pore-forming ~ - d e f e n s i n s s HBD1, 
HBD2, HBD3, HBD4, and cathelicidin LL-37lhCAP-18 (Ganz, 2003). Additionally, 
they produce permeability-increasing protein (BPI) which disrupts the outer and 
inner membranes of Gram-negative bacteria, and serves as aLPS neutral ising agent 
(Ganz,2003). 
Intestinal epithelial innate defence against C. jejuni results in the production 
of the bactericidal ~ - d e f e n s i n s . . The sensitivity of C. jejuni to this bactericidal agent 
may explain why most of Campylobacter cases are self-limited (Zilbauer et al., 
2005). The resistance of bacteria to de fens ins can be mediated by lipid-A increased 
acylation (Guo et al., 1998), or they can be modified with a sugar residue (Gunn et 
. al., 1998), degraded with outer-membrane protease (Guina et al., 2000), or removed 
with an efflux pump mechanism (Shafer et al., 1998). The successful avoidance of 
the first innate defences results in invasion of intestinal epithelial cells (lEe) and the 
subsequent activation of the nuclear transcription factor NF-KB. Invasion of IEC is 
not a requisite for NF-KB activation as microbial components are reported to induce 
activation in IEC (Takeda and Akira, 2004). 
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1.12.1 NF-KB activation 
In 1986, NF -KB was identified as a regulator for expressing the kappa light-
chain gene in murine B-Iymphoctyes, but has been subsequently found in many 
different cells (Birbach et al., 2002). Collectively named NF-KB, the inducible 
dimeric transcription factors are made up of members of the ReI family of DNA 
binding proteins that recognise a common sequence motif (May and Ghosh, 1998). 
This group of structurally conserved proteins are regulated via shuttling from the 
cytoplasm to the nucleus in response to a wide range of stimuli such as inflammatory 
cytokines (TNF -a. or interleukin-l), microbial pathogens, pathogen-derived products, 
growth factors, and stress inducers (Chen et al., 1999; Baldwin, 2001). Although 
NF-KB is a ubiquitous transcription factor, most studies of its properties have been 
performed on cells of the immune system (Birbach et al., 2002). NF-KB plays a 
central role in immune system responses through the regulation of genes encoding 
pro-inflammatory cytokines, adhesion molecules, chemokines, growth factors, and 
the inducible enzymes cyclo-oxygenase and nitric oxide synthase (Karin and Ben-
Neriah, 2000). 
There are five mammalian NF-KB proteins that are assigned to two different 
groups. Rel-A (p65), c-Rel and Rel-B proteins (C-terminal transactivation domains) 
constitute the first group. These are synthesised as mature proteins not requiring 
proteolytic modification. The second group includes the precursor proteins, pi 05 
and plOO (encoded by the NF-KBI and NF-KB2 genes respectively), that require 
proteolytic processing to give mature p50 and p52 NF-KB proteins (Ghosh et al., 
1998). The IKBs, (the NF-KB cellular inhibitors), hold NF-KB dimers (Rel-A or c-
ReI) in the cytoplasm in the absence of activating stimuli. The IKB family include 
IKBa., I K B ~ , , IKBE and IKBy. Also, the precursor protein pl00 may act as an IKB or as 
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a specific heterodimeric partner for Rel-B with a subsequent release of p50:Rel-B 
heterodimers. IKBs have multiple ankyrin repeats that interact with NF-KB via a Rel 
homology domain (RHD). This N-terminal domain mediates DNA binding, 
dimerization, nuclear translocation and interaction with the inhibitory IKB proteins 
(Ghosh et at., 1998; Jacobs and Harrison, 1998). In addition to B cells it is now 
known that NF-KB is required for the development and function ofT cells, dendritic 
cells, fibroblasts and macrophages (Baeulle and Henkel, 1994; Li and Verma, 2002). 
In mice, the disruption of the NF-KB p65 subunit was lethal due to developmental 
defects, whereas the lack of the NF-KB p50 subunit resulted in increased 
susceptibility to infection (Weih et at., 1997). Mice with transgenic mutated forms 
of IKBa in T cells were observed to have reduced numbers of CD8+ T cells and 
increased apoptosis (Lavon et. aI, 2000). Additionally, deficiency in B cells and a 
blocked maturation process were reported in mice with disruption in NF-KB1, NF-
KB2 and c-Rel genes (Snapper et at., 1996). In RelB-/- and NF-KB2-/- mice, lack of 
thymic dendritic cells (Arron et at., 2001) and follicular dendritic cells (Burkly et at., 
1995) were demonstrated. Macrophages from RelB-/- mice were deficient in 
response to TNF-a, whereas those from c-Rel-/- were less responsive to TNF-a 
(Weih et at., 1997). 
1.12.1.1 IKB-dependent NF-KB activation 
The activation of the IKB kinase (IKK) complex regulates IKB-mediated NF-
KB activation by ultimately phosphorylating IKBa at the serine 32 and 36. Upon 
phosphorylation, ubiquitin ligase ubiquitin-marks the IKB making them recognised 
by beta-transducing repeat-containing protein (b-TrCP) such that they are rapidly 
degraded by the proteasome (Thompson, 1995). The degradation of the inhibitory 
proteins allows NF-KB to translocate to the nucleus, bind to DNA, and initiate the 
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transcriptional activities (Thompson, 1995). Although the signalling pathways vary, 
where Toll-receptors, TNF-receptors and T cell-receptors utilise different mediator 
molecules, they eventually lead to the activation of the IKK complex and the 
subsequent degradation of IKB proteins (Hu et al., 1999). The IKK complex has 
three-core subunits (lKKa kinase, IKKP kinase and the regulatory protein, NEMO). 
The kinases share an N-terminal catalytic domain, a central leucine zipper and a C-
terminal motif. The exact mechanism of IKK activation is not understood but gene-
distruption experiments have shown that the IKB-dependent NF-KB activation 
depends on the presence of IKKp or NEMO (Barnes and Karin, 1997). Stimulation 
of gene expression is upregulated when IKKa is recruited from the nucleus to the 
promoter regions of NF-KB regulated genes where it phosphorylates histone H3 on 
serine 10 (Hu et al., 1999). IKKP plays a major role in the cytoplasm through 
phosphorylating IKB. In knock-out mice, selective suppression of IKKP inhibited 
NF-KB activation stimulated by TNF-a, LPS and IL-l (Barkit and Gilmore, 1999; 
Wang et aI., 1998). These defective signalling pathways were not observed in IKKa 
knock-out mice (Li et al., 1999; Senftleben et al., 2001). Phosphorylation, which can 
be by the proposed IKK-activating kinases (NIK, MEKK1, MEKK2, MEKK3, and 
CotlTpl-2), is important for the IKK complex activation (Hu et al., 1999). Out of 
these kinases, only MEKK3 has been reported as essential for TNF-a induced IKK 
activation in fibroblasts (van Antwerp et al., 1996). The delayed pro-inflammatory 
induced biphasic NF-KB activation follows MEKK2 complex formation with IKK-
IKB-p65 (Beg and Baltimore, 1996). In response to IL-l stimulation, the 
conformational change triggered IKK activation may be mediated by the 
ubiquitination of TRAF6. This is aided by TAB2 or TAB3 which brings TAKI in 
proximity with TRAF6 (Wallach et al., 1999, Ishitani et al., 2003). In embryonic 
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fibroblasts lacking TAKl, TABl, or TAB2, it has been reported that TNFRl, IL-IR, 
TLR3, and TLR4-mediated NF-KB and AP-l activation are severely impaired only in 
TAKllacking cells (Shim et al., 2005). 
1.12.1.2 IKB-independent NF-KB activation. 
In B cells, IKB-independent NF-KB activation results in the release of p52-
RelB, and pSO-RelB dimers in the absence o f l K K ~ ~ or NEMO (Li and Verma, 2002). 
This pathway leads to NIK and IKKa mediated processing of pI 00, and the 
subsequent release of pS2. Bacterial LPS, lymphotoxin B and Epstein-Barr virus are 
reported activators of NF-KB independent of IKB (Weih et al., 1997; Arron et al., 
2001). 
1.12.1.3 NF-KB and intestinal epithelial cells 
The heterodimer composed of the RelA (P65) and NF-KB 1 (pSO) subunits is 
the major NF-KB protein found in the nucleus of stimulated IECs (Jobin et al., 1997; 
Jobin et al., 1999). IKB-dependent NF-KB activation is important for the innate 
immune responses in IECs. The genes of immune responders are stimulated in IEC 
by NF-KB, and their induction proceeds immediately after stimulation without new 
protein synthesis. 
Genes regulated by NF-KB in IEC include I L - l ~ , , IL-2, IL-6, IL-8, 11-12, 
TNF-a, iNOS, COX-2, ICAM-l, VCAM-l, TCR-n, MHC-I and II molecules, GRO-
n and G R O - ~ , , RANTES and MIP-2 (Baeuerel and Henkel, 1994; Barnes and Karin, 
1997; Neurath et al., 1998). Suitably positioned to sample the intestinal antigenic 
nature and to contact with near by lymphocytes, IECs act as non-professional 
antigen-presenting cells constitutively expressing MHC-I and II on their surfaces 
(Shao et aI., 200S). Cytokines are important mediators in regulating immune and 
inflammatory responses. In addition to the immune cells (dendritic, lymphocyte, and 
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macrophage cells), the IEC can also produce cytokines and chemokines. The 
cytokines IL-l, IL-IO, IL-15, IL-18, and TGF are constitutively expressed by IECs 
and have roles in epithelial cell growth, homeostasis and regulating the influx of 
immune cells into the mucosa. Normal epithelial cells also express I L - l ~ , , IL-6, IL-8, 
TNF-a, MCP-l, CCL20 and GM-CSF. The production of these cytokines is highly 
upregulated in response to pathogens (Jung et al., 1995; Martin et al., 1997; Oswald, 
2005). Having chemokine receptors on their apical surface, IECs can respond to 
chemokines produced by themselves or by other immune cells. The effect of IL-l is 
augmented during the infection because IL-l is synthesised and recognised by IEC 
(Oswald, 2005). In IECs, stimuli of NF-KB include microbial pathogens, pathogen 
products, and pro-inflammatory cytokines (Jobin and Sartor, 2000). 
In epithelial cells, C. jejuni has been reported to activate the transcription factor 
NF-KB 16 hours post-infection (Mellits et al., 2002). A significant dose-dependent 
activation was observed 2 hours after incubating epithelial cells with a cell-free 
boiled extract of C. jejuni. The majority of NF-KB activating component(s) were 
reported to be proteinase K partially insensitive and less than 3 kDa in molecular 
weight. The activity could not be attributed to secreted molecules as the cell-free 
filtrate did not activate NF-KB (Mellits et al., 2002). NF-KB activation was 
subsequently reported to be induced by, but not dependent on, a lipoprotein (JlpA) of 
C. jejuni (Jin et ai., 2003). Campyiobacter jejuni activation of NF-KB was also 
observed in a THP-l monocyte cell line (Jones et al., 2003). The influx of 
neutrophils through the epithelial barrier during infection brings C. jejuni in contact 
with many leukocytes (Jones et al., 2003). 
In human intestinal epithelial cells, chemical inhibition of NF-KB activation 
resulted in suppressed production of many chemokines (Hu and Hickey, 2005). Live 
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and heat-killed C. jejuni activated NF-KB and induced the production of different 
cytokines in human dendritic cells (Hu et at., 2006). Independent of flagellin, C. 
jejuni could activate NF-KB and induce the production of the dendritic cell 
chemoattractant, CCL20 (Johanesen et al., 2006). 
Composed of transmembrane proteins fibrils, the tight junctions (TJs) encircle 
the apical region of IEC to restrict diffusion along paracellular borders. Enhancement 
of TJ permeability after toxin damage by pathogens helps invasive and non-invasive 
bacteria to colonise IEC or deliver their effectors via type III secretory systems into 
IEC (Mitic and Anderson, 1998). Histopathological examination of intestinal 
biopsies from patients suffering C. jejuni acute disease revealed the infiltration of 
neurophils to the infected mucosa (Skirrow and Blaser, 2000). This may indicate the 
C. jejuni have disrupted TJs, in a similar fashion to that observed in in vitro studies 
(Bras and Ketley, 1999; MacCallum et al., 2005; Chen et al., 2006). 
Dendritic cells (DCs) play important roles in innate and adaptive immunity 
(Rossi and Yong, 2005). In the intestine DCs lie under the surface in Peyer's patches 
and form an early line of defence against invading pathogens. Upon exposure of 
DCs to bacterial inflammatory stimuli, these cells are converted from antigen-
capturing immature cells to antigen-presenting mature DCs. Moreover, DCs can aid 
the internalisation of bacterial pathogens following their uptake by M cells or 
paracellular extensions in the lumen (Rossi and Yong, 2005). A study by Hu and 
others reported that C. jejuni is internalised by DCs at an early time point following 
infection and killed within 24 hours without cytotoxicity to DCs (Hu et al., 2006). 
Various cytokines and chemokines are produced by DCs when they interact with 
pathogenic bacteria (Rossi and Y ong, 2005). The production of IL-l, IL-6, IL-8, IL-
10, IL-12, IFN-y and TNFu, has been reported in DCs infected with C.jejuni (Hu et 
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al., 2006; Johanesen et al., 2006). Intestinal epithelial recruitment of leukocytes 
plays an important role in the innate mucosal immune response to enteric pathogens 
in conjunction with DCs and T cells (Hu and Hickey, 2005). Campylobacter jejuni 
induced the production of the DCs chemokine CCL20 and the T-cell chemo-
attractant CXCLlO from the intestinal epithelial cells. Additionally, infected cells 
produced the neutrophile chemo attractants CXCl, CXCL5, and CXCL8 (Priscilla et 
at., 2006). Human monocytes produced IL-l, IL-6, IL-8 and TNFa when stimulated 
with C. jejuni (Jones et al., 2003). The transcription of GRO (growth-related 
oncogene), MCP-l (monocyte chemoattractant protein 1), MIP-l(macrophage 
inflammatory protein 1), and IP-IO (interferon-inducible protein) has been reported 
in epithelial cells exposed to C. jejuni (Hu and Hickey, 2005). 
1.12.1.4 Activation ofNF-KB via Toll-like receptor (TLR)linterleukin-1 receptor (IL-
l R) signalling. 
To date, eleven type I transmembrane toll-like receptors have been identified in 
mammals (Cario, 2005). These receptors feature three common structural motifs: a 
leucine-rich repeat ligand-binding extracellular domain, a transmembrane region, and 
a homologous cytoplasmic showing Toll/IL-l domain (Cario, 2005). 
Upon ligand binding, TLRs/IL-Rs dimerise and recruit downstream signalling 
molecules in a pathway that leads to the activation ofNF-KB (Figure 1.3) that results 
in the expression of a set of defence genes that encode inflammatory cytokines, 
chemokines and co-stimulatory molecules (Akira and Takada, 2004). TLRs have 
evolved to detect pathogen-associated molecular patterns (P AMPs) as a front line 
mechanism to induce innate immune response. In recent years the ligands to which 
each of the TLRs respond have attracted a good deal of attention. 
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TLRI detects triacylated lipoproteins, and can cooperate with TLR2 to detect 
Pam3CSK4 (Takeuchi et ai., 2002). TLR2 recognises bacterial lipoproteins, 
lipoteichoic acid (LTA) and peptidoglycan (Takeuchi et ai., 1999; Aliprantis et ai., 
1999; Underhill et al., 1999). Viral dsRNA detection is mediated by TLR3 
(Alexopoulou et al., 200 I). TLR4 senses LPS (Hoshino et ai., 1999) and 
lipoteichoic acid (Takeuchi et ai., 1999) and bacterial flagellin is detectd by TLR5 
(Hiyashi et ai., 2001). TLR6 associates with TLR2 and recognises diacylated 
mycoplasmal lipopeptide (Takeuchi et al., 1999). Human TLR7 and/or TLR8 are 
known to bind single-stranded RNA (ssRNA) products from viruses, such as human 
immunodeficiency virus (HIV)-1 and human parechovirus (Diebold et al., 2004; Heil 
et ai., 2004; Triantafilou et al., 2005). DNA containing un methylated CpO motifs 
(CpO DNA) also stimulates immune cells via TLR9 (Hemmi et al., 2000). The 
ligand for TLRI0 has yet to be identified (Cario, 2005). TLRII has been shown to be 
involved in protection from uropathogenic bacterial infection in mice (Zhang et al., 
2004). Endogenous ligands for TLR2 and/or TLR4 include heat shock proteins, 
fibrinogen, surfactant protein-A, fibronectin extra domain A, heparan sulphate, 
soluble hyaluronan and ~ - d e f e n s i n n 2 (Takeda et al., 2003; Sabroe et al., 2003). 
The downstream signalling molecules include myeloid differentiation primary 
response protein 88 (MYD88), lIL-lR-associated kinases (IRAKs), transforming 
growth factor-B-activated kinase (TAKl), TAK1-binding protein 1 (TAB 1), TAB2, 
and tumor-necrosis factor-receptor-associated factor 6 (TRAF6; Takeda et al., 2003). 
MYD88 was first identified as a gene that is induced upon IL-6 stimulation of Ml 
myeloleukemic cells. It has a COOH-terminal TolllIL-l receptor (TIR) domain and a 
NH2-terminal death domain (DD). Following pathogen-associated molecular 
patterns (PAMPs) recognition, MYD88 is recruited to the TLR complex where its 
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DD engages with with DD of IRAK-4 resulting in the phosphorylation of residues in 
the kinase-activation loop of IRAK-l. Upon activation of IRAK-l, its affinity with 
Toll-interacting protein (TOLLIP) is weakened making it accessible for further 
phosphorylation. The secondary phosphorylated IRAK-l is released from TOLLIP 
and interacts with TRAF6. TRAF6 interacts with TAB2 and this complex activates 
TAKI that mediates the activation of the IKB kinase complex and NF-KB, p38 and 
JNK (Akira and Takada, 2004). The signalling pathway activated determines the type 
of the downstream signalling for the individual TLR. This is dependent on the 
adaptor molecules that interact with different TLRs (Athman and Philippot, 2004). 
MYD88 is the adaptor molecule that is utilized by almost all identified TLRs in their 
signalling cascades (Doyle and 0' Neil, 2006). However, in the absence of this 
molecule, the activation of NF-KB by TLR3 was not affected (Alexopoulou et al., 
2003). After ligand binding to its TLR, IRAK4 is recruited to the TLR complex. The 
MyD88-IRAK4 interaction leads to the phosphorylation ofIRAK-l. The dissociation 
ofIRAK-l from MyD88-IRAK4 complex makes it available to interact with TRAF6 
(Cao et al., 1996; Suzuki et al., 2002). The precise role of IRAK-4 has not been 
clarified. It has been reported that IL-l signalling is optimized by, but not dependent 
on, IRAK-4 (Qin et al., 2004; Lye et al., 2004). In IRAKI deficient macrophage, 
LPS-induced TNFa production still occurs but at reduced levels. This may indicate 
the existence of an lRAK-l activity-mimicking molecule (Swantek et al., 2000). For 
normal response to LPS, the presence of both of lRAK 1 and IRAK2 is required 
(Zhang et al., 1999). The activation ofNF-KB by a MYD88 utilizing ligand requires 
functional TRAF6 (Cao et al., 1996). A dominant negative form of TRAF6 was 
found to inhibit NF-KB activation by IL-l (Cao et al., 1996). 
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Figure 1.3. TLR-signalling pathways leading to the activation of NF-KB. TLR signaling 
pathways originate from the cytoplasmic TIR domain . A TIR domain-contai ning adaptor, MyD88, associates 
with the cytoplasmic TIR domain of TLRs, and recruits IRAK to the receptor upon ligand binding. lRAK then 
activates TRAF6, leading to the activation of the IKB kinase (IKK) complex consisting of IKKCt, IKK/1 and 
NEMO/IKK/,. The IKK complex phosphorylates IKB, resulting in nuclear translocation of NF-KB which induces 
expression of inflammatory cytokines. TIRAP, a second TIR domain-containing adaptor, is involved in the 
MyD88-dependent signaling pathway yia TLR2 and TLR4. In TLR3- and TLR4-mediated signaling pathways, 
activation of IRF-3 and induction of IFN-/1 are observed in a MyD88-indepcndcnt manner. A third TIR domain-
containing adaptor, TRIF, is essentia l for the MyD88-independent pathway. on-typical IKKs, IKKilIKKf and 
TBKI, mediate activation of IRF-3 downstream ofTRlF. A fourth TIR domain-containing adaptor, TRAM, is 
specific to the TLR4-mediatcd MyD88-independentffRlF-dependent pathway. (Akira and Takeda, 2004; Kawai 
and Akira, 2005). 
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The IRAKI-TRAF6 complex interacts with transforming growth factor-/3 
activated kinase (TAKl) and TAKl-binding proteins (TAB 1 and TAB2). Both 
TRAF6 and TAKl are then ubiquitinated. Subsequently, TAKl and TAB2 are 
phosphorylated. This phosphorylation leads to dissociation of the TRAF6-TAKl 
protein complex from the membrane and IRAKl degradation (Wang et aI., 2001). 
Phosphorylation of the downstream IKKs is mediated by the activated T AKl. The 
IKK complex mediated phosphorylation and degradation of IKB allows the 
translocation of NF-KB to the nucleus leading to the upregulation of NF-KB-
controlled pro-inflammatory genes (Qian et ai., 2001). In mice deficient in MYD88, 
NF-KB activation and cytokine production were found to be inhibited in response to 
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TLR2, TLR7, and TLR9 ligands. However, LPS induced NF-KB activation but with 
delayed kinetics and without inflammatory cytokine production (Kawai et al., 1999). 
MAL is a molecule that shares structural similarity with MYD88. The MAL 
dominant negative form has been found to suppress NF-KB activation by LPS but not 
by IL-IR. Mice lacking MAL show an impaired response to TLR2 and TLR41igands 
but responded normally to IL-l, flagella, unmethylated DNA, dsRNA, and low 
molecular weight antiviral compounds (Fitzgerld et al., 2001). 
The activation of the transcription factor IRF3, which regulates IFN inducible 
genes, was found to occur independently of MYD88 and MAL in response to LPS, 
via TLR4 (Kawai et al., 1999). A similar observation was made with the response to 
the TLR3 ligand (Yamamoto et al., 2002). These findings suggested that there is a 
third adaptor molecule that mediates MYD88lMAL-independent signalling 
pathways. The adaptor was discovered and named TRIF (Yamamoto et al., 2002). 
TRAM, a fourth identified adaptor molecule, was reported to mediate MyD88/MAL-
independent signalling in response to TLR4 but not TLR3 ligand (Fitzgerald et ai., 
2003). In a similar way to MYD88 and MAL, NF-KB activation was mediated by the 
overexpression of TRIF. The IFN-P promoter was activated by TRIF but not by 
MYD88 or MAL (Yamamoto et al., 2002). 
To activate NF-KB, TRIF needs to associate with the receptor interacting 
protein 1 (RIP1; Meylan et al., 2004). The cytokine production in response to LPS 
was reported to be dependent on the TRIF pathway (Gohda et al., 2004). In mice 
deficient in TRIF and its related adaptor molecule TRAM, cytokine production was 
inhibited. in response to LPS but normal for TLR2, TLR7 and TLR9 ligands 
(Yamamoto et al., 2003). The expression of high levels of TLR antagonists (Zhong 
and Ghosh 2002; Fukao et al., 2002; Nakajawa et al., 2002; Wald et al. 2003; Brint 
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et al., 2004; Diehl et al., 2004; Boone et al., 2004; Chuang et al., 2004) is one 
strategy used to regulate TLR activities in IEC. This expression suppresses the 
activation of TLRs present at the cell surface. Intracellular negative regulators of 
TLRs that are expressed in most tissues include: PI3K (affects TLR-2,4,9; inhibits 
p38, JNK and NF-KB functions), TOLLIP (affects TLR-2,4; autophosphorylates 
lRAKI), SIGIRR (affects TLR-4,9; interacts with TRAF6 and lRAK), TRAILR 
(affects TLR-2,3,4; stabilizes IKBa), and TRAID3A (affects TLR-4,9; ubiquitilates 
TLRs). Other TLR antagonists that are induced by LPS and expressed by 
macrophages include SOCS 1 (affects TLR-4,9; suppresses lRAK), A20 (affects 
TLR-2,3,4,9; de-ubiquitlates TRAF6), and ST2L (affect TLR-2,4,9; sequesters 
MYD88 and MAL). Another TLR2 antagonist, which is constitutively expressed in 
breast-milk and in plasma, is the soluble form of TLR2 (LeBouder et aI., 2003). The 
soluble forms of TLR4 and MYD88 down-regulate TLR4 by blocking TLR4 
interaction with MD2 and acting as antagonist for MYD88, respectively (Iwami et al. 
2000; Janssens et al., 2002). 
Although most of immune responses to bacterial pathogens and/or their 
components are mediated through TLR2 and TLR4, it is not surprising given their 
exposure that IECs are poorly responsive to these receptor ligands (Melmed et al., 
2003; Abrue et al., 2005). lEe may not be able to discriminate among PAMPs of 
commensal and pathogenic bacteria without other pathogen-associated signs such as 
invasion or toxin production (Otte et al. 2004). In vitro prolonged exposure of IEC 
to TLR2/TLR4 ligands resulted in tolerance to these ligands (Otte et al. 2004). A 
decrease in the surface-expression of these receptors with decreased lRAK activity 
and increased TOLLIP expression are the suggested mechanisms for the observed 
tolerance (Otte et al. 2004). Receptors relocate to the basolateral membrane of the 
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cell or to cellular compartments such as the Golgi apparatus as a consequence of the 
continuous stimulation by components of commensal microflora (Hornef et al., 
2002). A study of human intestinal epithelial cell line T84 has shown that 
peptidoglycan or LPS stimulation relocates the surface expression of TLR2 (Tohno 
et al., 2005) and TLR4 (Hornef et al., 2003) to cytoplasmic compartments near the 
basolateral membrane. Of importance for the host to detect pathogens, intracellular 
TLR must retain their full signalling ability (Otte et al. 2004). It was noted that 
intracellular TLR4 was able to detect internalised bacteria and LPS (Hornef et al., 
2003). 
The precise cellular localisation of TLR5, the flagellin receptor in IEe is open 
to debate. Following TLR5 stimulation with E. coli flagellin, both basolateral and 
apical TLR5 expression were reported in HT29-19A and Caco-2 IEe lines (Gweritz 
et al., 2001; Bambou et al. 2004). Only basolateral membrane expression of TLR5 
was reported in theT84 IEC (Lyons et al., 2004). 
Since flagellin from commensal bacteria is not translocated to the basolateral 
membrane and therefore is not considered bioactive, the basolateral expression of 
TLR5 assists in the maintenance and homeostasis of the GI. Again, specific TLR 
expression and distribution are necessary for the IEe to avoid unwanted TLR 
activation while allowing them at the same time to initiate an efficient response 
against pathogen invasion (Lyons et aI., 2004). 
In the sub-epithelial compartment, intestinal myofibroblasts upregulate the 
expression of TLRs; 2, 3, 4, 6, and 7 after stimulation with LPS or LT (Otte et al., 
2003). The continued expression of TLR3 only was reported in mature crypt 
epithelial cells where the weak expression of TLR2 and TLR4 was lost as the cells 
matured and moved toward the gut lumen (Furrie et al., 2005). The continued 
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expression of TLR3 in progression to the lumen was not considered detrimental as 
TLR3 responds to dsRNA of viruses and is not a PAMP of gut bacteria (Furrie et al., 
2005). IECs constitutively express TLR9 but are unresponsive to its ligand 
(Pedersen et al., 2005). After adhesion to IEC, C. jejuni causes cellular damage, 
excessive inflammation, and CDT production. Campylobacter jejuni infection of the 
IEC results in an enhanced IL-8 production that is dependent on adhesion (Ketley, 
1997). The precise role of TLR and the exact nature of the bioactive components 
involved in this response are currently unknown. Flagellin from C. jejuni was 
reported not to activate TLR5. In CHO Kl cell line transfected with TLR5, C. jejuni 
flagellin did not activate NF-Kb. Avoidance of C.jejuni flagellin detection by TLR5 
(Andersen-Nissen et aI., 2005) is mediated by the lack of the TLR5-site specific 
residues (amino acids 89-96) that have been shown to be essential for the agonistic 
activity of S. typhimuriumfliC (Mizel et al., 2003). 
The interaction of S. typhimurium with TLRs is the most studied among the 
enteric bacterial pathogens. It has been shown that TLR2, TLR4, and TLR5 are 
important in the host defence against S. typhimurium infection. Invasion of IEC by 
S. typhimurium results in the sequestering and relocation of the bacteria to 
intracellular vacuoles in addition to localised inflammation and the lysis of infected 
cells (Lembo et al., 2003). TLR4 is important for immediate detection of S. 
typhimurium and early responses in infected macrophage and for later responses after 
invasion. Infection ofTLR4-deficient mice demonstrates the role ofTLR4 in limiting 
infection, and the induction of TNF and chemokines (Lembo et al., 2003; Weiss et 
al., 2004). In IEC, a strong inflammatory response induced by S. typhimurium 
flagellin is mediated by TLR5. Given that IEC do not express TLR5 on the apical 
membrane, the immune response to S. typhimurium flagellin suggests that a 
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translocation of flagellin to the basolateral membrane where TLR5 is expressed, is 
necessary (Gewritz et at., 2001). A study reported that S. typhimurium strains 
lacking flagellin expression induced only a weak inflammatory response indicating 
that flagellin may be the primary pathogenesis factor in S. typhimurium infection. 
The expression of capsular antigen, a virulence factor of S. Typhi, inhibits the TLR4 
and TLR5 response, allowing dissemination of the infection. Infection with S. Typhi 
does not result in IL-8 induction or neutrophil recruitment to the infected IEC 
(Sebastiani et at., 2000; Zeng et at., 2003; Raffatellu et at., 2005). 
Because of the conserved structure of Lipid A (the bioactive TLR4-
stimulating structure of LPS) among pathogenic and non-pathogenic commensal 
strains of E. coli, it is unlikely that LPS recognition by TLR4 plays a major role in 
diarrhoeagenic E. coli pathogenesis (Beckhed et at., 2003). LPS from apically 
adhered E. coli does not upregulate TLR4 in lEe. Moreover, variant 0 antigens 
among E. coli LPS do not activate TLR4 (Cario et at., 2002). TLR5-dependent 
activation of NF-KB in IEC has been reported using flagellin from several strains of 
pathogenic E. coli. Enteroaggregative Escherichia coli infect IEC to produce IL-8 
that was reported to be caused by aggregative adherence fimbriae. The involvement 
of TLR in mediating this action is not understood (Berin et al., 2002; Khan et al., 
2004; Harrington et al., 2005). TLR2 and TLR4 were reported to be activated by the 
uropathogenic E. coli fimbriae (Frendeus et al., 2001; Ogawa et al., 2002). The B 
subunit of the ETEC E. coli type II heat-labile enterotoxin activates TLR2 
(Hajishengallis et at., 2005). Independent ofTLR and MYD88, Shigellajlexneri has 
been reported to invade the IEC, activate NF-KB, and induce IL-8 production via 
NODI (Girardin et al., 2001). 
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In the hemopoietic cells (macrophages, dendritic cells, B cells, and T cells) of 
the intestinal lamina propria, TLR2 and TLR4 are expressed at low levels in a non-
inflammatory state. The macro phages are unresponsive to LPS whereas the dendritic 
cells are responsive to LPS and peptidoglycan (Rossi and Yong, 2005). 
Appropriate stimulation of TLRs on Des by their respective ligands can thus 
initiate the entire spectrum of innate and, in tum, acquired immunity. Ligand binding 
to TLRs up-regulates CDS3, co-stimulatory molecules, and CCR7, which drives DC 
migration to T cell areas of draining lymph nodes (Jarrossay et ai., 2001; Neiss and 
Reineker, 2006). These early activated Des thus play an important role in the 
activation of other DCs and the recruitment of specialising lymphocytes that support 
the adaptive immune response (Rossi and Y ong, 2005). As noted above, C. jejuni 
stimulates the production of NF-KB- regulated cytokines in Des. C-type lectin 
receptors are also expressed by DCs. These receptors sense the carbohydrate present 
on pathogens (Rossi and Y ong, 2005). 
1.12.1.5 NOD signalling 
NOD 1 and NOD2 are intracellular receptors that are generally expressed by antigen-
presenting cells (Inohara et ai., 2003) and most epithelial cells (Kim et ai., 2004; 
Hisamatsu et ai., 2003). Unlike macrophages and dendritic cells, T cells and B cells 
do not express NODI or NOD2 (Gutierrez et ai., 2002; Ogura et ai., 2001). In most 
IEC, and particularly primary cells, NOD 1 is expressed while the expression of 
NOD2 is undetectable at the protein level (Hisamatsu et ai., 2003). The expression of 
NOD2 is limited to Paneth cells, at the base of intestinal crypts (Ogura et ai., 2003). 
Baseline expression of NODI in the primary epithelial cells can be upregulated by 
I F N - ~ ~ but not by TNFa, via the interaction with IRFI at the CARD4 promoter. IFN-
~ ~ increases the baseline TNF-induced upregulation of NOD2 (Hisamatsu et ai., 
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2003). In IFN-p-deficient mice, no upregulation of NOD I or NOD2 was observed in 
response to challenge with Listeria monocytogenes (Stockinger et al., 2003). 
The synthetic peptidoglycan-derived structures iE-DAP and MDP are sensed by 
NODI (Chamillard et al., 2003) and NOD2 (Inohara et al., 2003), respectively. 
NOD2 is considered a general sensor of most bacteria because its ligand is present in 
both Gram negative and Gram positive bacteria (Inohara et al., 2004). Macrophages 
from NODI or NOD2-deficient mice were unresponsive to the ligands or these 
receptors (Chamillard et al., 2003; Pauleau et al., 2003). As they are intracellular 
receptors, NOD I or NOD2 ligands must reach the NOD-LRR (leucine rich repeat) 
domains for activation. This may be mediated through the process of phagocytosis, 
delivery of peptidoglycan into the cells through a secretion system, or via an 
intestinal peptide transporter (Viala et al., 2004; Vavricka et al., 2004). Following 
NODI or NOD2 activation by their ligands, NF-KB is activated (Figure 1.5) through 
a RICK-mediated pathway (Inohara et al., 2003). NODI and NOD2 are 
compromised of a C-terminal series of LRR, central nucleotide binding domains 
(NBs) and a cap sase-activating and recruitment domain (CARD). Overexpression of 
NODs results in the exposure of CARD, and the subsequent interaction with the 
CARD domain of a serine/thereonine kinase called RIP2 (Kobyashi et ai, 2002). The 
oligomerization of RIP2 allows it to interact with the regulatory subunit of the IKK 
complex. Such interaction leads to the phosphorylation of IKBa and the release of 
NF-KB. NF-KB was activated in epithelial cells transfected with constructs of NOD 1 
or NOD2. The activation was highly inhibited in fibroblasts expressing NODI or 
NOD2 but deficient in RICK (Kobyashi et ai, 2002). 
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Figure 1.5. NF-KB and MAPK NOD-mediated activation by peptidoglycan (PGN). 
Recognition of muramyl dipeptide(MDP) and -y-d-glutamyl-meso-diaminopimelic acid (iE-DAP) 
through leucine-rich repeat(LRR) domains activates the NOD (nucleotide-binding oligomerization 
domain) proteins NOD2 and NODI, respectively, which then recruit receptor-interacting 
serine/threonine kinase (RICK) through caspase-recruitment domain (CARD)- CARD interactions. In 
the case of NOD2, activation of RICK leads to K63 (Lys63)-linked polyubiquitylation of IKK:y, the 
scaffold of the inhibitor of NF-KB {IKB)-kinase complex (the IKK complex), which also consists of 
IKKa and IKK/3. This is followed by the phosphorylation of IKK/3, as well as the phosphorylation of 
IKB and the release of nuclear factor-KB (NF-KB) for translocation to the nucleus. CARD12 negatively 
regulates RICKmediated NF-KB activation by both NODI and NOD2, whereas CARD6 negatively 
regulates only RICK-mediated NF-KB activation by NODI. In addition to NF-KB activation, NOD! 
and NOD2 signalling gives rise to the activation of mitogen-activated protein kinases (MAPKs) such 
as JUN amino-terminal kinase (JNK), extracellular-signal regulated kinase (ERK) and p38MAPK by 
as-yet unknown mechanisms (denote'd by dashed arrows) . (Strober et al., 2006; Fritz et al., 2006) . 
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MAPK pathway activation was reported following NOD activation. The 
activation of p38 MAPK and ERK were observed in NOD2-expressing macrophages 
in response to MDP (pauleau et ai., 2003; Kobyashi et ai. , 2005). The c-Jun NH2-
terminal kinase (JNK) was activated upon NODI activation by its ligand (Girardin et 
ai., 2001), 
1.12.2 Activation ofMAPKs 
The main mammalian MAPK families are the extracellular signal-regulated 
protein kinases (ERK) , the p38 MAP kinases and the c-Jun NH2-terminal kinases 
(JNK) (Schaefe and Weber, 1999; Davis, 2000; Chang and Karin, 2001). The 
activation loop of these families has a Thr-X -Tyr motif. Phosphorylation of tyrosine 
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and threonine is essential for the activation. Upon phosphorylation, a core MKKK-
MKK-MAPK cascade is initiated in all MAPK pathway activation processes (Cobb 
and Goldsmith, 1995; Dong and Davis, 2002). 
The role of MAP kinases in the innate immune responses has been 
demonstrated using specific inhibitor studies. The activity of p38 MAPK in 
macrophages was reduced by 70% using the p38 inhibitor SB203580. Additionally, 
the disruption of MKK3, an upstream p38 activator, led to a defect in IL-12 
induction by LPS at protein and RNA levels (Lu et al., 1999). Increased stress 
resistance and survival after LPS shock were observed in knock-out mice deficient in 
MK2, the substrate for p38. The survival ofLPS shock was a result of reduced TNF-
a production by LPS (Kotlyarov et al., 1999). Macrophages from mice having 
selective ERK deficits were deficient in TNF-a LPS-induced production. ERK 
inhibitor blocked the transport of TNF-a mRNA from the nucleus to the cytoplasm 
(Eliopoulos et al., 2002). The JNK pathway can be activated by TNF, IL-l or LPS 
(Sluss et al., 1994; Davis, 2000). 
In the IEC line T84, C. jejuni activated ERK strongly but weakly activated 
p38 MAP kinase. Inhibition of ERK but not p38 suppressed the ability of C. jejuni to 
stimulate IL-8 production (MacCallum et al., 2005). A C. jejuni jlaA mutant was 
defective in stimulating these responses. However, purified flagellin from C. jejuni 
did not stimulate ERK, p38 or cytokine production, and was found to be defective in 
activating TLR5 (Priscilla et al., 2006). The activation of MAPKs by 
Campylobacter is thought to be mediated by adhesion and invasion or an interaction 
of a cell-surface receptor with a bacterial component. The cell surface lipoprotein 
JlpA expressed by C. jejuni was reported to interact with Hsp 90 and activate p38 
MAPK (Jin et al., 2003). 
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1.13 Reporter gene studies of pathogenesis 
The lack of a suitable animal model has slowed the progress towards a clear 
understanding of Campylobacter pathogenesis. An alternative is to use in vitro 
manipulation of the genes to study microbial-host interactions at the molecular level. 
The genes under control of transcriptional regulation at the end points of signalling 
pathways induced by stimulating factors maybe studied using transfection of a 
reporter gene such as luciferase under control of the response promoter (Gould and 
Subramani, 1988). Reporter constructs carry specific pieces of the promoter under 
investigation or promoter sequences with specified mutations linked to a reporter 
gene are transfected into the cells to identify pathways leading to these responses. 
Subsequently, the reporter activity is measured from the cell lysate, and is considered 
as an indicator for the promoter activity. The activities of different constructs are 
compared to each other to obtain information about the specific sequence functions 
in determining the promoter activity (Huzar et al., 2001). The measured reporter 
activity is variable and it depends on both the activity of the promoter and on the 
transfection efficiency (which depends on the plasmid DNAs and number of cells 
transfected and is determined by response to stimulating ligands). To correct for 
variation in measured reporter activity, a second reporter, such as beta-galactosidase 
should be co-transfected. This reporter gene is under the control of minimal promoter 
or a viral promoter of consititutive activity. Its expression is presumed to be 
proportional to the number oftransfected cells. The activity of the beta-galactosidase 
reporter is used to normalize the primary promoter activity for subsequent 
comparisons (Gould and Subramani, 1988). 
In experiments where the signalling pathways induced by a specific agonist are 
to be investigated, then co-transfection of interfering expression constructs or the use 
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of specific inhibitors may be included before the stimulation with the specific agonist 
(Huzar et al., 2001). The luciferase-reporter activity and p-galactosidase reporter 
activity of stimulated cells and unstimulated cells are measured, corrected and 
expressed as a multiple of the basal stimulation (Gould and Subramani, 1988). 
1.14. Current work 
This thesis has adapted the reporter gene approach to study the activation of 
the central immune response regulator NF-KB in response to C. jejuni and C. jejuni 
products. This is mainly due to the lack of a suitable animal model for C. jejuni 
infection, and the possibilities to manipulate signalling pathways leading to NF-KB 
activation. The reporter gene approach study of pathogenesis has been widely used in 
literature also to avoid issues of ethical concerns in using animal subjects. 
The transcription factor NF-KB activation by C. jejuni has been previously 
reporter. However, there is a lack in the knowledge of the pathways of activation. In 
this study, tissue culture cell lines were transfected with reporter gene (NF-KB-
dependent luciferase and NF-KB-independent p-galactosidase) along with 
receptors/adaptor molecules (e.g TLRs, NODs) to investigate the signalling pathways 
involvement of these receptors in NF-KB activation by C.jejuni. 
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CHAPTER 2 Materials and methods 
CHAPTER 2 
2.1 MATERIALS AND METHODS 
2.1.1 Bacterial strains and growth conditions 
The Campylabaeter jejuni type strain NCTC 11168, C. jejuni, NCTC 11168 
lipooligosccharide mutant waaF (Oldfield et al., 2002) and C. jejuni NCTC 11168 
capsular polysaccharide mutant kpsM (Karlyshev et al., 2000) were used in these 
studies for which the genome sequence is available (Parkhill et al., 2000). They were 
propagated on blood agar plates (Blood-agar base CM271, Oxoid, with 5% v/v 
defibrinated horse blood, TCS) under microaerobic conditions (5% O2, 10% COz, 85 
% Nz) for 24 h at 42 °C. When growing mutants the plates were supplemented with 
kanamycin at 25 ~ g / m l . .
2.1.2 Plasmid constructs 
Reporter plasmids pRc\RSVlacZ and p3EnCONALuc used to monitor the specific 
induction of NF-KB were a gift from Professor R. Hay, University of St Andrews, 
UK (Rodriguez et al., 1999). The expression plasmids pcDNA3 TLR2, pcDNA3 
TLR4, pEF-BOS MD-2 and pcDNA3 CD14 (Carl et al., 2002); and the dominant 
negative expression construct pEF-BOS DN-MYD88 (Muzio et al., 1997) were gifts 
from Professor D. Golenbock, University of Massachusetts Medical School, USA. 
The plasmid expression constructs pcDNA3 NODI, pcDNA3 DN-NODI (Girardin 
et al., 2001), pcDNA3 NOD2, pcDNA3 DN-NOD2, and pcDNA3 DN-MAL (Fritz et 
al., 2005) were gifts from Professor D. Philpott, Institute Pasteur, France. The 
pcDNA3 DN-IRAKI and pcDNA3 DN-p38 were gifts from Dr. W. Li, University of 
Southern California, USA. Plasmid constructs used in this study and their description 
are shown in table 2.1. Escherichia coli containing these constructs were grown on 
Luria Bertani agar plates (LB broth, Difco, with 1.5% w/v bacteriological agar No. 
51 
1, Oxoid) cultured over night at 37°C. They were used to inoculate 400 ml of LB 
broths and incubated with shaking 200 rpm at 37°C overnight. The extraction of 
DNA was performed using the Plasmid Maxi Prep kit according to the 
manufacturer's instructions (Qiagen). 
Table 2.1. Plasmid constructs used in this study. 
Plasmid construct Description 
pRc\RSVlacZ Reporter gene; non-specific activation measurement* 
p3EnCONALuc Reporter gene; specific KB-dependent activation measurement* 
pcDNA3 TLR2 Transmembrane receptor** 
pcDNA3 CD 14 Accessory molecule for TLR2 mediated signalling* * 
pcDNA3 TLR4 Transmembrane receptor** 
pEF-BOS MD-2 Accessory molecule for TLR4 mediated signalling** 
pEF-BOS DN-MYD88 Adaptor molecule for TLRs signalling (NR)** 
DN-lRAKI Downstream signalling molecule for MYD88 pathway (NRY 
pcDNA3 DN-MAL Adaptor molecule for TLR2 and TLR4 signalling (NR)*** 
pcDNA3 NODI Intracellular receptor; detection ofPGN*** 
pcDNA3 NOD2 Intracellular receptor; detection ofPGN *** 
pcDNA3 DN-NODI Intracellular receptor; detection ofPGN (NR)*** 
pcDNA3 DN-NOD2 Intracellular receptor; detection ofPGN (NR)*** 
pcDNA3 DN-p38 p38 MAPK signalling (NR)" 
NR= negative regulation. *: (Rodrigues et af., 1999). **: (Muzio et af., 1997; Carl et af., 2002). ***: 
(Yamamoto et af., 2002; Girardin et af, 2003). 1\: (Yeo et af., 2003). 
2.1.3 Preparation of Campylobacter boiled cell extracts 
A 24 h plate culture of C. jejuni NCTC 11168, C. jejuni NCTC 11168 LOS mutant, 
or C. jejuni NCTC 11168 KpsM mutant were used to inoculate 400 ml of Nutrient 
Broth No 2 (CM 67, Oxoid) in 1 L conical flasks and then shaken under 
microaerobic conditions (5% 02, 10% CO2, 85 % N2) for 24 h at 42°C. The bacteria 
were collected by centrifugation at 10,000 g for 15 min. The bacterial cell pellet was 
then re-suspended in 1 ml of phosphate buffered saline (PBS; BRI4a, Oxoid) and 
washed by centrifugation for a total of 3 times. The cell pellet was weighed then re-
suspended in PBS to 10% w/v. This suspension was then boiled for 10 min and 
cooled on ice. The suspension was then centrifuged at 13,000 g and the supernatant 
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collected. This extract was then filtered through a O. 2 pm filter (Minisart, Sartorius) 
to remove any residual bacteria, freeze-dried and stored at -20°C until required. 
2.1.4 Ethanol precipitation 
To precipitate proteinaceous contaminants (Oss, 1989), dried BCE was mixed with 
ice-cold ethanol, kept at - 20°C for 2 h, and then centrifuged at 15,000 g for 20 min. 
The supernatant was concentrated by evaporation under a stream of nitrogen. 
2.1.5 Enzymatic treatments 
To remove nucleic acids BCE samples were incubated at 37°C for 4 h with either 
RNAse 1 ng Jd-l or DNAse 1 Jlg Jlrl (Sigma Aldrich). Proteins were removed by 
Proteinase K (Sigma Aldrich) treatment at a final concentration of 100 Jlg mrl for 1 h 
at 55°C. All BCE samples were heated at 100°C for 10 min subsequent to 
enzymatic treatment and stored at -20°C until use. TNF-a and flagellin samples were 
used directly to prevent denaturation. 
2.1.6 Centrifugal filtration 
Three kDa and 1 kDa molecular cut-off filters (Pall) were used to remove high 
molecular weight components. BCE (3 ml) was centrifuged using these filters at 
7000 g for 3 h at room temperature. 
2.1.7 Gel filtration 
After passing through 3 kDa filters, BCE was freeze dried, re-suspended in 50 JlI 
H20, and injected into Superdex PC 3.2/30 (100 to 7000 Da separation range; 2.4 ml 
bed volume) column (Amersham Bioscience) which was run using an FPLC system 
(Pharmacia). The running (gradient 0-60% in 60 min) buffer (A) was 0.1 M 
ammonium acetate in H20 where the elution buffer (B) was H20. A total of 24 
fractions (100 JlI each! min) were collected, dried, re-suspended in sterile H20, and 
tested for bioactivity. 
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2.1.8 RP- chromatography 
The BCE active fractions obtained from gel filtration were combined and applied (50 
J.lI injection volume) to the reverse-phase JLRPC C2/C18 column (Amersham 
Bioscience) run by the FPLC system (Pharmacia) with eluent A, 0.1 % trifluoroacetic 
acid (TF A); eluent B, 70% acetonitrile containing 0.1 % TF A; gradient, 0-60% in 60 
min; flow rate 100 JLVmin. A total of 40 fractions were collected, dried, re-suspended 
in sterile H20, and tested for bioactivity. 
2.1.9 Solid phase extraction (SPE) 
The BCE fraction containing material <1000 Da was further purified usmg 
disposable reverse-phase, then normal-phase cartridges as the following: 
A reverse-phase (Sep-pak C18, Waters) cartridge was conditioned with 10 ml of 
HPLC-grade methanol (Sigma), and washed with 10 ml of H20. Then, the BCE 
fraction containing material <1000 Da suspended in 10 ml H20 was applied to the 
cartridge and allowed to enter the column by gravity. The cartridge was then washed 
with 5 ml of H20. Products of this step were concentrated, and tested for bioactivity. 
A normal-phase (CN-500 mg, Phenomenex) cartridge was conditioned with 3 ml of 
HPLC-grade acentonitrile (Pierce), the active fraction from reverse-phase separation 
was applied (10% H20 in acetonitrile) to the cartridge which was then washed with 
10% H20 in acetonitrile. The elution step was performed using 20, 30, and 40 % 
H20 in acetonitrile. Products of this step were concentrated, and tested for 
bioactivity. Additional normal-phase purification for the active fraction was 
performed as described above using a Hypercarb (porous graphitized carbon) 200 mg 
cartridge (Thermoelectric). 
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2.1.10 Normal phase high pressure liquid chromatography (NP-HPLC) 
The active fraction from the third SPE step (Hypercab purification) was loaded (in 
10% acetonitrile) on a NP-HPLC (Luna CN) column (Phenomenex). A gradient 0-
40% over 50 min was run (on PU980 pumps, Jasco) using mobile phase: A; HPLC 
grade acetonitrile and B; H20. The UV absorbance was monitored using Spectro-
Monitor 3000 (Spectra Physics, LDC) and recorded using Picolog computer software 
(Picotech). Forty fractions (l ml in volume) were collected, concentrated and tested 
for activity. This step was repeated with combined active fractions from the first 
passage. 
2.1.11 Permethylation of BeE 
For permethylation, a modification of the Ciucanu and Kerek method was used 
(Weiskopf et a!., 1997). Permethylation is thought to enhance MS sensitivity for 
carbohydrate containing samples (Weiskopf et al., 1997). Purified BCE (l mg) was 
dried down in a Teflon-capped reaction vial, to which DMSO-NaOH slurry (1 ml) 
was added. After thorough mixing, the sample was allowed to incubate at room 
temperature for 60 min. Methyl iodide (1 ml) was added to the vial, mixed 
vigorously, and then incubated at room temperature for 60 min. With the reaction 
vial placed in a small ice bath for cooling, the reaction was quenched by slow, 
dropwise addition of water (2 ml). S a m p l ~ s s were then extracted with chloroform (4 
mI), and the extracted phase was rinsed with 4 ml aliquots of water until the organic 
phase was no longer cloudy. The extract was then dried under a dry nitrogen stream, 
redissolved in 1:1 methanol-water containing 0.02 % formic acid for ESI-MS 
analysis. 
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2.1.12 Mass Spectrometry (MS) 
The active BCE fractions from the second NP-HPLC run were analysed by ESI-MS 
in positive mode using Q-ToF2 tandem mass spectrometer (Waters Co). Samples 
(10JlI) were delivered to the MS in 50% acetonitrile and 0.2% formic acid. The 
capillary voltage was 900-1200 V and the collision gas was Argon. The mass spectra 
were acquired using MaxEnt3 software (Waters Co). 
2.1.13 Treatment of BCE with glucosidases 
The initial structural characterization of BCE by MS indicated the presence of 
carbohydrate component(s). BCE was therefore treated with an alpha-exo-
glucosidase (amyloglucosidase, Sigma) or an alpha-endoglucosidase (dextranse; 
Sigma) or an endo-glucosidase (glucanase, Sigma) at concentration of 1 mg BCE: 
0.5mglml of enzyme in H20 with incubation for 24 h at 37°C. The mixture was then 
boiled for 5 min to inactivate the enzyme, centrifuged at 10,000 g for 10 min, and the 
supernatant tested for bioactivity. 
2.1.14 Gas chromatography (GC) 
The monosaccharide composition ofBCE (1 mg) was analysed by GC as their alditol 
acetate derivatives (Sawardeker et al., 1967; Papp-Szabo et al., 2005). Hydrolysis 
(in screw cap tube) of the glycosyl was performed in 4 M trifluoroacetic acid (300 
JlI) at 100°C for 4 h after which the solution was dried under stream of compressed 
air. Reduction of the sample was performed in 300 JlI of H20 with NaBD4 (Sigma) at 
room temperature for 30 min. After quenching with 500 JlI 10% HOAc in MeOH and 
evaporation to dryness, subsequent acetylation was accomplished by AC20 treatment 
with residual sodium acetate as the catalyst at 100°C for 1 h. Then, alditol acetate 
derivatives were analyzed (helium was the carrier gas; mobile phase) by GC using a 
Varian 3400 gas chromatograph equipped with a DB-17 capillary (fused silica; 
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stationary phase) column (Agilent Technologies) heated from 210°C to 240 °C 
over 30 min (2°C increment Imin). 
2.1.15 Nuclear magnetic resonance (NMR) 
HI P-NMR analysis was performed on the combined active BCE fractions from 15t 
NP-HPLC step. BCE was exchanged (3 times) with D20 (99.8%), lyophilized, and 
dissolved in D20 (99.9%). IH NMR spectra were recorded by using a 5-mm probe at 
25°C, and chemical shifts were measured relative to internal acetone (2.25). Spectra 
were recorded on DRX500 (500MHz) spectrometer (Bruker) using BrukerWinNMR 
software. 
2.1.16 Preparation of flagellin extracts 
Campylobacter jejuni were cultured in Nutrient Broth No.2 (Oxoid) as described in 
section 2.1.1, harvested by centrifugation at 10,000 g for 10 min and re-suspended in 
1 ml of PBS. Escherichia coli were cultured in Nutrient Broth No. 2 but under 
atmospheric conditions. Cells suspensions were passed through narrow bore tubing a 
total of 20 times to shear flagella. The flagella were isolated in the supernatant 
following centrifugation at 10,000 g for 10 minutes at 20°C. The supernatant was 
then re-centrifuged at 50,000 g for 60 min at 4 °c and the resulting flagella pellet re-
suspended in a 5 ml volume of PBS. Flagella preparations were monitored by sodium 
dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Enteropathogenic 
E. coli E2348/69 was used as source of flagellin to stimulate an innate immune 
response (Zhou et al., 2003). 
To precipitate Lipid-A (Schromm et al., 2000), boiled cell extract (BCE) was 
treated with acetate buffer (O.IM pH 4.4; at 100°C for Ih) and centrifuged (10,000 g 
at 4 °c for 10 min) after cooling. The supernatant was desalted using a Sephadex-l0 
57 
(Amersham Biosciences) column with H20 as the eluting buffer. The precipitated 
pellet was washed 3 times with H20. 
To inactivate LPS (Paik et ai., 2003), a fraction of BCE was incubated with 
Polymyxin B (10 J.lglml; Sigma) before the induction assay. To hydrolyze 
lipopeptide (Shibata et ai., 2000) that may be present in BCE, a BCE fraction was 
treated with lipopeptide lipase (8 J.lglml; Sigma) before the induction assay. 
2.1.17 Cell culture and transfection 
HELA 57A cervical epithelial cells (Rodriguez et ai., 1999), HCA-7 colonic 
epithelial cells (Kirkland, 1985), Caco-2 colonic epithelial cells (Jung et ai., 1995) 
and HEK293 kidney derived cells (Graham et ai., 1977) were grown in monolayer 
cultures of approximately 5 x 106 in Dulbecco's Modified Eagle's Medium (D-
MEM) supplemented with penicillin at 100 /lg mrl, streptomycin at 100 /lg mrl and 
foetal calf serum (FCS) at 10% (v/v) (Invitrogen Ltd). Cell viability was monitored 
by performing microscopic examination of 0.4% Trypan Blue stained cells. To 
provide selection for the transcriptional markers present in the HeLa 57 A cell line, 
such cultures were supplemented with G418 at 0.5 /lg mrl (Invitrogen). All cell lines 
were grown under 5% CO2 conditions at 37°C. The calcium phosphate procedure 
(Jordan and Wurm, 2004) was used to trans feet plasmid DNAs into Caco-2, HEK293 
and HCA-7 cells. Cultured cells were seeded in D-MEM supplemented with 10% 
FCS and allowed to grow until 80% confluence. Three hours before transfection the 
growth medium was replaced fresh. Transfection mixes (150 J.ll of2X HBS {HEPES 
50 mmol, KCI 10 mmol, glucose 12 mmo!, NaCl 280 mmol, and Na2HP04 1.5 
mmol; final pH 7.05}, 37 J.lI of 2M CaCh, and H20 to final volume of 300 J.lI) 
containing plasmid DNAs at total mass 4 /lg (where the balance in all experiments 
was made up to the target DNA mass with pcDNA3 empty vector), were incubated 
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for 40 min at room temperature, remixed and added drop-wise onto the cells (300 
J.lVwell) that were incubated at 5% CO2 for 8 h at 37°C. Cells were then washed 
with pre-warmed PBS, supplemented with growth media and incubated 36 h as 
before. 
HEK293 cells were transfected with; the reporter genes plasmid DNAs (500 ng of 
NF-KB dependent luciferase, and 250 ng NF-KB-independent l1-galactosidase gene) 
plus; A- TLR2 (300 ng)-CD14 (200 ng), or A+DN-MYD88 (600 ng), or B-TLR4 
(300 ng)-MD2 (200 ng) or B+ DN-MYD88 (600 ng), or 600 ng ofDN-MYD88 or 50 
ng ofDN-NODl, or 50 ng of NODI, or 1 ng of NOD2, or 1 ng ofDN-NOD2, or 
A+NODl, or A+DN-NODl, or B+NOD2, or B+DN-NOD2. The DN-p38 plasmid 
DNA (200 ng; Yeo et al., 2003), or DN-IRAKI (50 ng), or DN-MAL (100 ng; 
Yamamoto et al., 2003) was transfected in HEK-293 cells along with the reporter 
genes plasmid DNA. Hela 57A cells were transfected with MD-2 or TLR2-CD14. 
The plasmid DNA concentrations (Table 2.2) used were selected to minimize basal 
NF-KB activation. 
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Table 2.2. Plasmid constructs and transfection concentration used in this study. 
Plasmid construct Transfected concentration (ng) 
NF-KB dependent luciferase 250 
NF-KB-independent {3-galactosidase gene 250 
TLR2 and CD 14 300,200 
TLR2, CD14 and DNMYD88 300,200, 600 
TLR4andMD2 300,200 
TLR4, MD2 and DNMYD88 300,200, 600 
DNMYD88 600 
DN-NODI 50 
NODI 50 
DN-NOD2 I 
NOD2 I 
TLR2, CDI4 and NODI 300,200,50 
TLR2, CDI4 and DN-NODI 300,200,50 
TLR4, MD2 and NOD2 300,200, I 
TLR4, MD2 and DN-NOD2 300,200, I 
DN-p38 200 
DN-IRAKI 50 
DN-MAL 100 
2.1.18 Induction with BeE and live C. jejlllli 
For induction with BCE, cultured cells were starved of serum for 16 h and inductions 
carried out by adding BCE or by adding tumour necrosis factor-a (TNF-a; EU 
Programme EV AlMRC Centralized Facility for AIDS Reagents, NIBSC, UK; Grant 
numbers QLK2-CT-1999-00609 and GP828102) to a final concentration of 50 ng mr 
, 
I, The TLR2 agonist N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-Cys-
[S]-Serl-[S]-Lys (4) trihydrochloride (Pam3SK4) was used at 100 ng mrl and 
purchased from EMC microcollections, Ttibingen, Germany, Ultrapure grade E. coli 
KI2 LPS (Invivogen) was used to stimulate TLR4 at 10 p,g mrl, The synthetic 
peptidoglycan derivative GlcNAc-M urN Ac-L-Ala-),-D-Glu-meso-diamino-pimelic 
acid (M-triDAP) was a gift from Dr Dominique Mengin-Lecreulx Institute Pasteur, 
and used to stimulate NODI at 10 jlg mrl. The muramyldipeptide MurNAc-L-Ala-
D-isoGln was purchased from Invivogen and used at 10 jlg mrl to stimulate NOD2. 
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For induction with live bacteria the eukaryotic cells were removed from 
antibiotic-containing medium and the serum reduced to 1 % v/v for 16 h prior to the 
addition of C. jejuni at the multiplicity of infections indicated or by adding TNF-a to 
a final concentration of 50 ng mrl. Campylobacter jejuni were cultured in Nutrient 
Broth No.2 as described above but harvested by centrifugation at 10000 g for 5 min 
at 22°C. The bacterial cell pellet was re-suspended in D-MEM plus 1% v/v FCS and 
incubated at 42°C for Ih shaking at 140 rpm under microaerobic conditions (5% 02, 
10% COz, and 85 % N2). Viable counts were performed on these cultures using 
blood-agar plates to determine the true inocula applied to cultured host cells, to 
monitor the viability of the bacteria in the presence of tissue culture cells and to 
ensure the absence of contaminating bacteria. Heat killed bacteria were prepared as 
above but were heated for Ih at 75°C and then cooled to 22 °c prior to addition to 
eukaryotic cells. 
2.1.19 Polarised colonic epithelial cells 
Caco-2 and HCA-7 cells were cultured on semi-permeable polycarbonate filter 
inserts of 0.4 p,m pore size in Transwell units (Coming-Costar). Transepithelial 
electrical resistance (TEER) was measured on a daily basis (by Prof. Ian Connerton) 
using a voltmeter (World Precision Instruments). Confluent mono layers reached 
TEER values between 800 and 1,500 Ocmz (from 25 days after seeding). 
2.1.20 Reporter cell assays 
HELA 57 A cells are stably transfected with an NF-KB-dependant promoter driving 
luc transcription, and an independent Rous Sarcoma Virus promoter driving lacZ 
expression (Rodriguez et al., 1999). Other cell lines were transiently transfected with 
reporter plasmids pRc\RSVlacZ and p3EnhCONALuc to perform these functions. 
After the specified induction time (6 h for BCE and heat-killed bacteria, or 16 h for 
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live bacteria), cultured cells were washed with PBS and lysed by incubating them 
with 250 J.lVwell of IX lysis buffer (Promega) for 10 min at room temperature. The 
cells were then harvested using cell scraper (Nunc) centrifuged at 10,000 g for 1 min 
and the supernatants were stored at -70°C. Replicate luciferase and /3-galactosidase 
reporter assays were performed. Luciferase activity (40 J.lI of luciferin added to cell 
lysate supernatant containing 10 J.lg of protein concentration) was measured using a 
Turner Bioluminometer as recommended by the manufacturer (Promega Ltd). To 
measure /3-galactosidase activity, 400 J.lI of lacZ buffer (60 mmol Na2HP04.7H20, 40 
mrnol Na2HP04.H20, 10 mmol KCI, 1 mmol MgS04; and 1.35 J.lI beta-2-
mercaptoethanol; pH 6.95) were added to 100 J.lI of cells lyaste supernatant in 
eppdendorf tube. Then, 100 III of O-nitrophenyl-/3-D-galactopyranoside (4 mg/l ml 
H20) were added to the tube and the mixture incubated at 37°C until yellow colour 
development. The reaction was stopped by adding 250 J.lI of 1M Na2C03 and the 
activity measured (after centrifugation at 10,000 g for 5 min) at absorbance of 420 
nm using the Cecil spectrophotometer (Cecil Instruments). 
To determine the degree of NF-KB induction, all luciferase activity values were 
normalised against internal /3-galactosidase activities in order to provide a 
constitutive control of basal expression levels, and further expressed as a multiple of 
the mock-induced control (fold-induction). 
Fold of induction= SV /MV 
SV= stimulated cell luciferase activity value/ stimulated cell /3-galactosidase value, 
where MV= mock treated cell luciferase value/ mock treated cell /3-galactosidase 
value. Experimental data represent the means and standard deviations of three 
independent determinations. The data were analysed using either t-tests or ANOV A, 
where p<0.05 was considered significant. 
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2.1.21 Cytokine analysis 
Cultured cells were prepared and induced as described above. After 6 h incubation 
the external media was removed and stored at -20°C until examined using a Coulter-
Alter Flow Cytometer in conjunction with a BD cytometric bead array human 
inflammation kit according to manufacturer's instructions (BD Biosciences). IL-8 
was specifically measured (by Prof. Ian Connerton) using a sandwich ELISA, by 
capture with a murine anti-human IL-8 and detected using biotinylated goat anti-
human IL-8 using streptavidin-coupled horseradish-peroxidase according to the 
manufacturer's instructions (R&D Systems). 
2.1.22 Determination ofTLR and Nod expression in tissue culture cells 
Eukaryotic cell-lines were cultured as detailed above and harvested at 80% 
confluence using a cell scraper. RNAs were extracted from cells using the Qiagen 
RNeasy kit as per the manufacturer's instructions (Qiagen). RNA was quantified 
using a NanoDrop spectrophotometer (NanoDrop Technologies) and 0.5 Jlg was used 
to generate cDNA using Oligo( dT} primers with Superscript III reverse transcriptase 
(Invitrogen). The primers used to PCR-amplify TLRs, NODs, and TOLLIP are given 
in Table 2.2 using Taq DNA polymerase (Qbiogene) typically for 30 cycles at 90°C 
for 30 s, 60°C for 30 s and 72°C for 1 min. PCR products (191 to 622 bp) were 
examined on 4% polyacrylamide gels electrophoresed in TBE (100 mM Tris-Borate, 
1mM EDTA) and stained with ethidium bromide (Sigma Aldrich) following 
electrophoresis. 
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Table 2.3. peR primers used in this study. 
Gene Forward (5'·3') Reverse (5'-3') Product (bp) Reference 
TLRI CTATACACCAAGTTGTCAGC GTCTCCAACTCAGTAAGGTG 220 Young et al., 2004 
TLR2 GTACCTGTGGGGCTCATTGT CTGCCCTTGCAGATACCATT 191 Young et al., 2004 
TLR3 ATTGGGTCTGGGAACATTTCTCTTC GTGAGATTTAAACATTCCTCTTCGC 319 Saikh et al., 2003 
TLR4 CTGCAATGGATCAAGGACCA CCACCACCATGATGAGAGCA 622 Saikh et al., 2003 
TLR5 CTAGCTCCTAATCCTGATG CCATGTGAAGTCTTTGCTGC 438 Young et aI., 2004 
TLR6 AGGTGCCTCCATTATCCTCA GAATCCATTTGGGAAAGCAG 211 Young et al., 2004 
TLR7 AGTGTCTAAAGAACCTGG CTTGGCCTTACAGAAATG 542 Saikh et al. 2003 
TLR8 GCCAGCGAGTCTCACTGAACT GCCAGGGCAGCCAACATA 558 Young et al., 2004 
TLR9 TTCCCTGTAGCTGCTGTCC ACAGCCAGTTGCAGTTCACC 207 Young el al., 2004 
TLRIO GGCCAGAAACTGTGGTCAAT CTGCATCCAGGGAGATCAGT 199 Young el al., 2004 
NODI TCCAAAGCCAAACAGAAACTC CAGCATCCAGATGAACGTG 180 Kim el al., 2004 
NOD2 GAAGTACATCCGCACCGAG GACACCATCCATGAGAAGACAG 174 Kim et af., 2004 
TOLLIP TGGAATAAGGTCATCCACTG AGAAGGCTCTCTCATCGAA 78 Melmed el al., 2003 
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CHAPTER 3 Activation of NF-KB by Canzpylohacter ;e;lIni 
CHAPTER 3 
3.1 Introduction 
The inducible transcription factor NF-KB is ubiquitously expressed in 
different tissues where it regulates the cellular immune responses to inflammatory 
stimuli such as foodbome pathogens. Campylobacter jejuni causes enteritis by 
mechanisms that are not clearly understood (Ketley, 1997, Mellits et al., 2002, Hu 
et al., 2006). However, the ability of C. jejuni to activate NF-KB is thought to be 
responsible for the pathological and clinical symptoms during the infection 
(Mellits et al., 2002; Hu et al., 2006; MacCallum et al., 2006). In vitro studies 
indicated that when C. jejuni is incubated with epithelial cell lines NF-KB is 
induced resulting in the production of pro-inflammatory cytokines and 
chemokines (Mellits et aI., 2002; Jin et ai, 2003; Jones et al., 2003; Hu and 
Hickey, 2005; Hu and Hickey, 2006; Priscilla et al., 2006; MacCallum et al., 
2006). Interleukin-8 (IL-8) is a potent immune cell chemo-attractant and activator 
that is thought to be important for host immune response to C. jejuni in vivo. 
The activation of NF-KB and the subsequent production of the pro-
inflammatory molecules by live enteric bacterial pathogens and their products 
have been reported (Jobin and Sartor, 2000; Akara and Takeda, 2004; Strober, 
2006). It has been previously demonstrated that C. jejuni and heat-stable cell free 
extract (BCE) of C. jejuni induce NF-KB and IL-8 production in HeLa 57 A cells 
stably transfected for NF-KB-dependant (luc) and independent (LacZ) reporter 
genes (Mellits et al., 2002). This observation was extended by transfecting 
HEK293, Caco-2 and HCA-7 cells with the corresponding reporter plasmids and 
treating these cells with live C. jejuni 11168 or heat-killed bacteria or BCE. 
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Additionally, the effect of specific mutations in C. jejuni or pre-treatments of C. 
jejuni boiled cell extract (BCE) on NF-Kl3 activation has been investigated. 
3.2 Results 
3.2.1 Live C. jejulli, or heat-killed C. jejulli, or BeE can activate NF-KB and 
induce IL-8 production in tissue culture cell lines. 
HeLa 57 A, HEK293, Caco-2 and HCA-7 cells stably or transiently 
transfected with the reporter plasmids pKB-Iuc and pRSV-Iac were treated for 6 h 
with C. jejuni 11168 (m.oj of 100) or alternatively for 6 h with either heat-killed 
bacteria (at an equivalent m.oj.) or BCE. Activation ofNF-KB together with the 
secretion of the pro-inflammatory cytokine IL-8 were observed in the cell lines 
following the various treatments (Table 3.1). 
Table 3.1. NF-KB and IL-8 induction levels by C. jeju1I; in the tested cells. The positive 
control was TNF-<l (50 nglmr l). Data represent the means of three independent measurements ± 
standard deviation. 
Cell line Live bacteria Heat-killed BCE NFl TNF-<l NFl BCE IFI (initial 
NFl bacteria NFl pg mrl) 
Hela 57 A 130±27 90±15 275±25 225±20 48 (50) 
HEK293 5.2±0.8 2.1±0.2 14.5±27 2.1±15 66 (80) 
Caco-2 2.5±0.2 2±0.2 5.4±1.2 12±3.3 4 (50) 
HCA-7 9.3±3 6±2 26±4 16±2 460 (40) 
Nfl: NF-KB fold ofmductlOn.IFI: IL-8 fold ofmductlon (data provided by Prof. Ian Connerton). HeLa 57A 
cells stably expressing the reporter genes are more responsive. 
All cells induced NF-KB and secreted IL-8 in response to live/or heat 
killed C. jejuni or C. jejuni BCE. However, it is evident that there are inherent 
differences in the sensitivities of these cells to C. jejuni products based on the IL-
8 response levels. Most notably the HCA-7 and Caco-2 cell lines are both derived 
from human colon carcinomas, and are capable of polarisation and tight junction 
formation in culture but HCA-7 cells secrete relatively high levels of IL-8 in 
response to a 6 h C. jejuni BCE treatment compared to Caco-2 cells, which show 
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a significantly weaker response from similar pre-induction levels of IL-8 (Table 
3.1). Treatment of the colonic epithelial cells (Caco-2 or HCA-7) with C. jejuni 
NCTC 11168 (m.oj. 100) did not result in cell death over a 30 h time course, 
since trypan blue staining of parallel infections showed no significant differences 
between the viability of mock infected cells and those infected with bacteria. 
Viable counts of C. jejuni present in the tissue culture medium of these cells 
revealed that the bacteria were not adversely affected by either the incubation 
conditions or the cellular response, as the counts remained static over the 30 h 
time course. 
3.2.2 Campylobacter jejulli and BCE induce polarised colonic epithelial cells 
to produce IL-S. 
IL-8 is an important chemokine that is regulated by NF-KB, and has been 
reported to increase NF-KB activation. It is produced mainly by macrophages, and 
IEC to attract neutrophils to the site of infection. Production of IL-8 from the 
basolateral gut epithelial cell will initiate signalling to underlying cells types. 
Polarised cell monolayers (TEER >800 ncm2) of HCA-7 or Caco-2 
exposed to either live cells (m.oj 100) or BCE for 6 h on their apical face also 
show differences in IL-8 production measurable from their basolateral side 
(Figure 3.1). Campylobacter jejuni treatment of HCA-7 polarised cells produced 
a six-fold increase in IL-8 in the basolateral chamber after 16 h compared to a 
mock treated control (corresponding to 360±40 pg mr' and 190±30 pg mr' oflL-8 
respectively in the basolateral and apical chambers), whereas Caco-2 cells 
produced a two-fold increase in IL-8 over a mock treated control (corresponding 
to 160±30 pg mr' and 90±30 pg mr' of IL-8 respectively in the basolateral and 
apical chambers). At 16 h post-infection the tight junctions of these monolayers 
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remained largely intact as judged by modest falls in the TEER of 50-100 ncm2, 
around 5% of the total. Although, 12 h later the TEER values began to fall wi th 
bacteria present in the basolateral chamber. BCE treatments of HCA-7 or Caco-2 
resulted in temporary falls in TEER va lues up to 100 ncm2 that showed recovery 
24 h later. BCE treatment of HCA-7 polarised cells produced a twelve-fold 
increase in IL-8 in the basolateral chamber after 6 h compared to a mock treated 
contro l (colTesponding to nO±60 pg mrl and 480±40 pg mrl oflL-8 respectively 
in the basolateral and ap ical chambers). In contrast at 6 h post BCE treatment 
polarised CACO-2 cells produced a three-fold increase in IL-8 over a mock 
treated contro l (corresponding to 180±40 pg mrl and 80±20 pg mrl IL-8 
respectively in the basolateral and apical chambers). 
Figure 3.1. lL-8 induction levels by C. j ejlllli. Live C. j ejuni induced IL-8 in the apical (HCA-
7 A-api , CACO-2A-api) and basolateral (HCA-7 A-bas, CACO-2A-bas) chambers. Induction leve ls 
by BCE in the apical (HCA-7B-api , CACO-2B-api) and basolateral (HCA-7B-bas, and CACO-
2B-bas) chambers. 
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3.2.3 NF -KB activation by BeE is independent of peptide, nucleic acids, 
capsular polysaccharide, and lipid containing components. 
Subsequent to the finding above, BeE was prepared from C. jejuni 
mutants affected in LOS or CPS production, treated with proteinase K (PK), 
DNAse, RNAse, lipopeptide lipase, sodium acetate buffer (to precipitate lipid A), 
or pre-incubated with polymyxin B ( binds to LPS) before the induction assay on 
the He La 57 A cell line. Since proteinaceous structures (e.g. flagellin), epG DNA. 
RNA. LPS, CPS, and lipoproteins have been reported to induce host immune 
responses (Akira and Takeda, 2004), the treatments above were performed to 
investigate the possibility of these structures contributing to NF-KB activation as 
components of BeE, and gain insight into what factors might be responsible for 
the inflammatory responses characteristic of C. jejuni caused enteritis. Moreover, 
the lipid-A component of Gram-negative lipopoly/lipooligosaccharides are known 
to activate NF-KB through a signaling pathway dependent on the accessory 
protein MD-2. This signaling pathway is not complete in the HeLa 57 A cell line 
due to the absence of MD-2 (Re and Strominger, 2002; Nishimura and Naito, 
2005). The possibility of yet to be identified signaling molecules or structural 
modifications of the hydrophilic part of lipid A or polysaccharides liberated upon 
boiling may activate NF-KB prompted an investigation of the bioactive 
components present in BeE. Figure 3.2a shows NF-KB activation levels by BeE 
treated with PK, or DNAse, or RNAse. It also shows the activation levels by 
flagellin prepared (and treated with PK) from C. jejuni. The levels of activation of 
NF-KB by precipitated crude BeE (the pellet presumably contains lipid A), the 
supernatant, BeE treated with lipopeptide lipase, BeE from a C. jejuni waaF 
mutant, and from a C. jejuni kpsM mutant are shown in figure 3.2b. 
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The data presented in figure 3.2 indicate that the bioactive component(s) in BCE 
are not tlagellin, DNA, RNA, lipopolysaccharide, CPS, or lipoprotein. Prev iously, 
the bioactive component in BCE was reported to be a prote inase K res istant 
molecule less than 3 kDa (Mellits et al., 2002). Here in thi s study, the result of the 
extended treatments on BCE has not been reported for C. jejuni or other 
food borne bacterial pathogens. 
Figure 3.2a. Induction-fold of NF-KB in HeLa 57 A cells incubated with C. j ejlllli BCE a n ~ ~
Ilagcllin with or without enzymatic treatment; E. coli flagellin (50 ng/mr l), E. coli fl agc llin 
trea ted wi th proteinase K(PK; at 100 llg/mr1), C. j ejulli fl age llin (50 ng/mr1), C. j ejl/lli tl age ll in 
treated with proteinase K(PK; at I 00 ~ l g / m r l ) , , C. jejl/lli boiled-ce ll extract (BCE), BCE treated 
with DNAse (I pg/mr l), or BCE treated with RNAse ( I ng/mrl) . TNF-a was used as positive 
contro l of acti vation and PK activity at 50 ng/mrl. The data are recorded as the means of 3 
independent determinations. 
E. COI/flag.llln ' ~ ~____ __ 
E. coil flagellln+PK ~ ~
C. j4JJun l flageil in ~ ~
C. }o}u.,II ••• "'n.PK ~ ~B C E ~ ~________________ -
B C : , C R E : ~ . . ! ~ - - - - - - - - - - - - - I I I
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Figure 3.2b . Induction-fold of NF-KB in HeLa 57A cells incubated with C. jej/l/l; BeE 
(prepared from wild-type, mutants, or subjected to pre-treatments); wt- C. j ejl/lli boiled ce ll 
extract (BeE I), kpsM-C. jejuni boiled-ce ll extract (BCE2), waaF- C. j ejull i boiled-cell cxtract 
(BCE3) , supernatant of BCE I a fter lipid-A rcmova l (BeE) a), precipitated lipid-A from BCE) 
(BCE lb), BCE) treated with lipopeptide lipase (BCElc), BeE pre-incubated with polymyxin B 
(BCEpb), polymyx in B (pb). TNF-a was the control activation (50 ng/mr 1). The data are recorded 
as the means of three independent determinations . 
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3.3 Discussion 
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Campylobacter is cUITently the most reported cause of foodborne mediated 
enteritis worldwide (Brown et al., 2004). Having a range of environmental 
reservoirs and the abi lity to survive outside the host organisms (Ketley, 1997; 
Butzler, 2004), campylobacters can still be detected in processed retail foods 
(Bongkot, 1997; Kramer et al., 2000; Wyte et al., 2000). This along with 
unhygienic practices during food preparation by households may contribute to the 
high incidences of infection by thi s bacterium (Altekruse et al., 1995; Griffith el 
al., 1998; Jay et al., 1999). 
The infection prognoses of C. j ejuni can be self-limiting. The disease is 
characterized by watery or bloody diarrhoea accompanied by abdominal cramps, 
or chronic condition affecting the peripheral nerves (Smith, 1995; Ketley, 1997). 
In intestinal epithelial cells (lEes), where the interactions between bacterial 
food borne pathogens and the host take place, the innate immune responses, which 
are mainly responsible for the disease pathology, are mainly controlled by the 
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transcription factor NF-KB (Jobin and Sartor, 2000). The production of cytokines, 
chemokines, inflammatory enzymes, and immunoregulatory molecules are 
regulated by the heterodimer composed of the RelA (p65) and NF-KB 1 (p50) 
subunits whose activation proceeds via the IKB dependent pathway (Jobin and 
Sartor, 2000). 
To activate NF-KB, the inflammatory stimuli (e.g. a pathogen or its 
components) need to be recognized as pathogen associated molecular patterns 
(PAMPs) by extracellular and/or intracellular receptors. These receptors differ in 
the ligands they recognize and in the adaptor molecules they use to transfer the 
stimulating signals to NF-KB. The virulence factors (e.g. flagella, COT, LOS, 
CPS, peptidoglycan, lipoproteins, and aMP) and mechanisms (e.g. motility, 
chemotaxis, adhesion, invasion, translocation, iron acquisition, and intracellular 
survival) may contribute to the pathogenesis of Campylobacter and the induction 
of the host immune responses. In in vitro studies, the activation of NF-KB by live 
bacteria, flagella, nucleic acids, LPS/LOS, PGN, CPS, and lipoproteins have been 
reported. Apart from the nucleic acids, these structures are bound to Gram-
negative bacteria' cell-surfaces and are thought to be extracted with minimal 
changes by repeated centrifugations followed by boiling in a saline buffer (Mellits 
et al., 2002). 
Live C. jejuni or its cell-free boiled extract (BCE) have been reported to 
activate NF-KB in epithelial cells (HeLa 57A and HCA-7) via an IKB-dependent 
pathway, and induce the production ofTNF-u and IL-8 (Mellits et al., 2002). The 
activation by BCE, which was dose-dependent and immediate, may imply that C. 
jejuni can cause inflammatory responses independent of its adherence to or 
invasion of the host cell (Mellits et al., 2002). In this study, the activation of NF-
KB and IL-8 production were observed in HeLa 57 A, HEK293, HCA-7, and 
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Caco-2 cell lines. The higher levels of activation in all cell lines by BCE may 
suggest that the bioactive component is liberated by heat to be more readily 
available for recognition by cellular receptor(s). Additionally, the NF-KB 
activation by BCE occurred independently of the major components of C. jejuni 
cell surface and its nucleic acids. The host immune responses to these components 
in IECs are regulated by means that accommodate the commensal bacteria and 
detect the presence of pathogens. At the apical membrane of IEC, which is 
continuously exposed to the gut flora, the adherence of bacterial pathogens 
coupled with their ability to invade and reach the basolateral membrane is thought 
to be responsible for immune stimulation and a precursor to systemic infection. 
IL-8, a potent chemokine produced at the basolateral surface and controlled by 
NF-KB, attracts the neutrophils to the site to limit the infection. Here, during co-
incubation of polarized of HCA-7 and CACO-2 cell lines with C. jejuni or BCE, 
IL-8 was produced at higher levels in basolateral chambers by both cell lines 
compared to the apical chambers. This may reflect that C. jejuni interaction with 
host cells does not have to involve invasion and intracellular survival to cause 
inflammatory response in vivo. Although inflammatory responses may be 
insufficient to characterise Campylobacter enteritis, they will contribute to the 
disease symptoms. Moreover, inappropriate pro-inflammatory responses to 
bacterial components in the absence of live bacteria may contribute to temporary 
bouts of discomfort. IL-8 has been reported to be produced by a variety of cell 
lines exhibiting differences in the induction levels in response to C. jejuni. The 
differences in production levels have been reported to be due to the contamination 
of cell lines by another cell line, or the requirement of a cell-to-cell cross talk for 
immune response in the gut mucosa (MacCallum et at., 2006). 
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The data presented in this chapter report NF-KB activation by live C.jejuni 
in different cell lines, and provided initial structural details about the NF-KB 
activating component in BCE. In chapter 4, different fractionation techniques, 
mass spectrometry, gas chromatography, and nuclear magnetic resonance were 
applied to identify the bioactive component in BCE. The signalling pathways 
leading to NF-KB activation by C.jejuni are investigated in chapter 5. 
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CHAPTER 4 Structural characterisation of NF -KB 
activating components in Call1pylobacter jejlllli BCE 
CHAPTER 4 
4.1 Introduction 
One of the measures taken to mInImIZe the risk for contracting a 
foodbome disease is sufficient heat-treatment. However, the reported activation 
of NF-KB by BeE from C. jejuni may invalidate this measure. Unlike other 
methods for extracting bacterial immune-response provoking components, 
boiling-mediated liberation of the bioactive component(s) from C. jejuni will not 
introduce any further components that could add to the response. Using the HeLa 
57 A cell line as a model for studying NF-KB activation by BeE, Mellits et al. 
(2002) reported that BeE is heat-stable and treatment of BeE with proteinase K 
did not suppress its activation of NF-KB. Moreover, the cell line does not express 
the full complement of receptors known to lead to NF-KB activation (Re and 
Strominger, 2002; Nishimura and Naito, 2005). This along with the results 
presented in chapter 3, which indicate that BeE is not affected by various 
treatments, may imply that BeE of C. jejuni represents a novel component 
responsible for NF-KB activation. 
The aim of this chapter is to characterize the structure of the NF-KB 
activating component(s) in C. jejuni BeE. This was carried out using several 
different purification steps and the product analysed using mass spectrometry, gas 
chromatography, enzymatic treatments and by NMR. 
4.2. Results 
4.2.1 NF-KB is activated mainly by a fraction less than 1000 Da 
The majority of the components capable of BeE activation of NF-KB were 
reported to be less than 3000 Da (Mellits et al., 2002). Molecular size-based 
fractionation was the first step in purifying BeE for further structural 
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characterization methods. This was performed uSing a size-exclusion co lumn 
(SEC) and 1000 Da molecular cut-off filters. The separation of BCE on a SEC 
gave 4 active fractions that were eluted from a column fractionating between 100 
to 7000 Da. The broad peak of activity could be due to eluting efficiency rather 
than structural difference. However, since BCE preparation involves a boiling 
step that may break the physiological structure of a parent molecule, the observed 
size may not reflect the true molecular weight of th activating component sizes. 
NF-KB activation by BCE applied to the SEC and I K filter are shown in figure 
4.1. 
Figure 4.1. Induction-fold of NF-KB in H eLa 57 A cells incubated with C. j ejlllli BeE 
fractionated by a size-exclusion column and a 1 kDa filter ; C.jejulli boi led-ce ll extract (BCE), 
fractions of BCE obtained from separation on the size-exclusion column (numbered F I to F23), 
BCE I kDa fraction (BCE I kDa), and the BCE retained fraction on the I kDa filter (BCErct). TNF-
a was the contro l activation (50 nglml'l). 
1 
BCEret c:::::::::J 
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F20 I ~ = = = = = : : : J J
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F1S \ ~ ~==:::1 
F1to 17 
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~ ~ I I~ = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = ~ ~
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4.2.2 The NF-KB activating component in BeE does not adsorb to the 
reverse-phase column under hydrophobic conditions. 
NF-KB can be activated by water-soluble and water-insoluble bacterial-derived 
components (Yoshibiko et al., 2005). Thus, knowing the polarity of the active 
component in BCE will indicate if the active component belongs to specific 
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polarity-categorized ligands. The resultant active fractions from the SEC column 
were combi ned and applied to a reverse-phase co lumn fo llowing the operational 
conditions recommended by the manufacturer for characterising unknown 
samples. As shown in figure 4.2, the result indicates that the NF-KB activating 
component did not adsorb to the column and was e luted immediately in the void 
vo lume. Thus, the active component is a hydrophilic structure. An advantage of 
using an RP-column here would be to filter-out hydrophobic contaminants that are 
often present in biological samples as high-molecular weight structures. 
Figure 4.2. Induction-fold of NF-KB in He La 57A cells incubated with C. j ejulli IleE 
fractionated by reverse-phase HPLC column : C. j ejulli boi led-cell extract (BCE), combined 
BeE active fractions from the size exclusion column run on the reverse-phase column (F I to F40). 
TNF-a was the control acti vation (50 ng/ml"l). 
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F 4 to 40 ~ ~F3 1 -------
F2 ~ ~
I 
F1 ~ ~
BeE I 
TNF ~ . . - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ~ ~
I ~ ~- - - - - - - - - - - - - - - - - - - ' - - - - - - - - - r - - - - - - - - - - - - - - - - - - - - ~ ~
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4.2.3 Solid Phase Extraction (SPE) purification of BeE indicates that the 
active component is optimally eluted using a specific solvent composition. 
Subsequent to the finding above, BCE-l kDa from wi ld-type C. j ejuni was purified 
using SPE disposable (CI8, CN, and POC) co lumns before further fractionation 
on the normal-phase- HPLC column. SPE (reviewed in Hennion, 1999) is a 
simple chromatographic process that provides pre-HPLC purification for higher 
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sample volumes in a convenient time frame. In SPE, the sorbent is the stationary 
phase whi le the mobile-phase is the solvent of the sample. BCE-l kDa was 
purified by the RP-SPE column (C 18; traps hydrophobic contaminants), by the 
NP-SPE column (CN; traps polar components), then by another P-SPE column 
(PGC). During the purification steps using the NP-SPE column, the NF-KB 
activating component was optimally-eluted using a 70/30 acetonitrile-water 
mixture, and this behaviour IS typically observed when separating 
oligosaccharides. Recorded NF-KB act ivation fold-induction of BCE puri fled by 
SPE columns are presented in figure 4.3. 
Figure 4.3. Induction-fold of NF-KB in HeLa 57A cells incubated with C. j ejl/Ili BeE 
fractionated by solid-phase extraction columns: C. jejulli boiled-ce ll ex tract « I kDa fraction of 
BeE), < I kDa fraction of BeE, BeE puri ficd by the reverse-phase C I column (BCE I), BCE 
purified by normal-phase CN column and eluted with; 20% H20 in acetonitrile (BCE2), BCE 
eluted with 30% H20 in acetonitri le (BCE2a), BCE eluted with 40% H20 in acetonitrile (BCE2b). 
BeE purified with the second normal-phase porous-graphtized carbon (hybercarb) column 
(BCE3), BCE eluted with; 20% H20 in acetonitrile (B E3), BCE eluted wi th 30% H20 in 
acetonitrile (BCE3a), BCE eluted with 40% H20 in acetonitrile (BCE3b). The purifica tion order 
was; less than I kDa fract ion of BCE> C 18 column> N column (20, 30, and 40% elutions fro the 
same column» Hypercarb column (20, 30, and 40% elutions from the same column). TNF-a was 
the control activation (50 ng/mrl) . 
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The retention of an oligosaccharide on a normal-phase SPE or HPLC column is 
controlled by the concentration of the organic modifier in the mobile phase. At 
high acetonitrile concentration, the bonding formation between the hydroxyl 
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groups of the oligosaccharide with the column's stationary phase is increased, 
whereas higher water content and less acetonitrile weaken the bond formation and 
permits the oligosaccharide elution from the column (Lo-Guidice and Lhermitte, 
1996; Hennion, 1999). 
4.2.4 Normal-phase IIPLC of BeE gave active fractions that have very low 
UV -absorbance. 
To further fractionate BCE for MS and NMR studies, purified BCE-1 kDa by SPE 
was applied to a NP-HPLC column. This cyanopropyl-bonded silica column is 
recommended for fractionating polar samples. The first NP-HPLC run resulted in 
broad-range NF-KB activating fractions (Figure 4.4a) where the second NP-HPLC 
run (on the active fraction from the first NP-HPLC) gave two NF-KB active 
fractions (Figure 4.4b). This could be due to the column efficiency regarding its 
sample-loading limit. Of interest during NP-HPLC fractionation was the 
demonstration of UV absorbance at 195nm which may indicate the presence of 
carbohydrate in the sample. Attempts to record UV absorbance at higher wave-
lengths were not successful. NF-KB activation levels by BCE fractions from the 
15t and 2nd NP-HPLC purifications and their UV absorbance are shown in figure 
4.4a, 4.4b, 4.4c and 4.4d, respectively. 
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Figure. 4.4a. Induction-fold of NF-KB in HeLa 57 A ce ll s incubated with C. j ejlllli BCE 
fractionated by normal-phase HPLC column () SI run): C.jejulli boiled-cell ex tract from 5-litres 
culture (BCE: < I kDa fracti on of BCE purified by SPE), fractions (F I to 40) obtained by purifying 
BCE by NP-HPLC. TNF-a was the contro l acti vati on (50 ng/mr l ). 
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Figure 4.4b. Induction-fold of NF-KB in HeLa 57A cells incubated with C. jejllll; BCE 
fractionated by normal-phase HPLC column (2"d run) : C. jejuni boiled-cell ex tract (BCE; 
combined ac ti ve fractions from the 1st NP-H PLC puri fi cation) , frac tions (F I to 40) of BCE frol11 
2nd NP-HPLC purificati on. TNF-a was the con tro l ac ti vati on (50 ng/mr l) . 
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Figure 4.4c. 
UV absorbance during the 1st NP-HPLC run 
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4.2.5 Mass spectrometric analysis of purified neE indicates that the NF-KB 
activating component is a 5-hexose residue oligosaccharide. 
Mass spectrometry (MS) employing various ionization (Aebersold and Mann, 
2003) methods (electron ionisation, fast atom bombardment, electrospray 
ionisation, and matrix-assisted laser desorption ionisation) has been widely used 
in protein profiling, metabolic analysis, and structural characterization of 
bacterial-derived components such as LPS (Risberg et al., 1999), peptidoglycan 
(Xu et al., 1997), lipopeptide (Hashimoto et al., 2004), and carbohydrate (Harvey, 
1999). A mass spectrometer separates and detects ionised forms of the analyte on 
the basis of their mass to charge ratio. Therefore, MS is a valuable technique for 
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molecular-weight determination (Aebersold and Mann, 2003). Boiled-cell extract 
(BeE) from C. jejuni wild-type, C. jejuni waaF mutant and C. jejuni kpsM mutant 
were analyzed by MS using the electrospray method for ionisation (Table 4.1 and 
Figure 4.5). 
Table 4.1. Electrospray mass spectrometry analysis of the combined BeE active fractions 
obtained from the 2nd NP-HPLC purification. The analysis was performed in positive mode, 
negative mode and MS/MS positive mode for ion 851 mlz. The proposed moiety is based on matching 
the ions ofBCE to that oftheoretical5-hexose residue oligosaccharide. Interpretation of the analysis 
results was performed using the Glycofragment online tool*. 
Ion Ion type Moiety 
(+mode) 
851 [M+Na]H 5-hexose residue 
689 [M+Na]H 4-hexose residue 
527 [M+Na]H 3-hexose residue 
365 [M+Na+H20]H 2-hexose residue 
203 [M+Na+H20]H I-hexose residue 
185 [M+Na]H I-hexose residue 
Ion (-mode) 
827 [M-H] 5-hexose residue 
665 [M-H] 4-hexose residue 
503 [M-H] 3-hexose residue 
341 [M-H]+H20 2-hexose residue 
322 [M-H]-H20 2-hexose residue 
179 [M-H]+H20 I-hexose residue 
161 [M-H] I-hexose residue 
MS/MS 
(851) 
851 [M+NalH 5-hexose residue 
689 [M+Na]H 85I-16i(1 hex) 
671 rM+Na lH-1120 851-1800 hex+H2O) 
585 2.5 X + Na+ 
527 [M+NalH 851-324 (2 hexoseS) 
509 [M+NalH 851-342 (2 hexoses+HzO) 
407 U.l X + Na+, 2.4 A + Na+ 
393 1.5 X +Na+ 
365 [M+Na+H201H 851-486 (3 hexoses) 
347 rM+NalH-H20 851-504 (3 hexoses+H2O) 
265 2.5 A + H+ 
225 0,2 X + 2H+ 2.4 A +2 H+ , 
185 rM+Na]H 85\-666 (4 hexoses+ H2O) 
*: hup://www.dkftz.de/spec/g\ycosciences.de/too\s/glycofragmentslfragment.php4 
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Figure 4.5. Mass spectra of BeE of wt-C. j ejuni (a-d), C.jejuni waaF-mutant (a l -dl ), C.jejuni 
kpsM mutant (a2-d2), nega ti ve-mode MS spectra of wt- BeE (a3-d3). Figures show whole spectra 
and focused region mlz spectra. MS/MS of ion 85 1 from BeE mass spectrum of wt-BeE (a4) 
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(c); focused region (300 to 600 mlz) spectru m 
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(a2); whole spectrum 
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4.2.6 Fragmentation pattern in mass spectrometry analysis of BeE is 
consistent with that of an oligosaccharide. 
A glycosidic bond can be formed between the hemiacetal group of one 
monosaccharide and the alcohol group of another monosaccharide. The type of 
linkage (e.g. a-l-4 or ~ - 1 - 3 ) ) is determined by which alcohol group of the 
monosaccharide participates in the bond-formation reaction with the carbon atom 
(a lways numbered 1) of the hemiacetal group. The possibility of a glycosidic-
bond mixture (e.g. 1-4» 1-6) is fac ilitated by the avai labi li ty of more than one 
alcohol-group in a monosaccharide which can participate in di fferent bond 
formations. Due to these various linkage possibilities and anonnic configurations, 
oligosaccharides have greater complex structural possibilities than either amino 
acids or nucleotides. However, despite the plethora of possible structures the 
fragmentation pattelll produced upon mass spectrometry of a sample can provide 
useful structural details about the component. Based on the proposed 
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fragmentation pattern of oligosaccharides (Domon and Costello, 1988), the 
oxonium ions (Bn-type ions) result from the direct cleavage of the glycosidic 
bonds and contain the non-reducing tenninus of the 01 igosaccharides. Y n-type 
ions result from the transfer of a proton from the non-reducing part of the 
oligosaccharide to the reducing-terminus. The glycosidic bond cleavage ions on 
the reducing terminal side of the glycosidic oxygen are assigned Cn and Zn-type 
ions. 
Figure 4.6. Fragmentation patterns of oligosaccharidcs during mass spectrometry analysis 
(Domon and Costello, 1988). Yn and 8 n ion types (A ; glycos idic bonds cleavage), Zn and Cn ion 
types (8; glycos idic bonds cleavage), and n.mX and n.mA ion types (C; cross-ring c leavage). Figure 
adapted from (Tang et al., 2005). 
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Due to the facile nature of the glycosidic bond, double or multiple Bn Yn ions can 
occur in the cleavage of one molecule (Domon and Costello, 1988). The nature 
and the monosaccharide sequence in an oligosaccharide can be deduced from the 
mass differences (con'esponding to the monosaccharide residue masses) between 
the observed Bn and Yn ions. Cross-ring fragmentation ions (nl11X and nl11A) result 
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from the cleavage of carbon-carbon or carbon-oxygen bonds in the 
monosaccharide rings (Domon and Costello, 1998). The type of linkage in the 
oligosaccharide can be deduced by observing which cross-ring ions are present 
and absent (Lemoine et al., 1993; Mulroney et al., 1995). The fragmentation 
pattern of BeE generates numerous ions as can be observed in the BCE MS 
spectra (Figure 4.5). Of the observed ions, only those matched in the database 
search are listed in table 4.1. For underivatized oligosaccharide, attempts to get 
information on the linkage types have been reported (Y oon and Laine, 1992; 
Yamagaki et al., 1998). However, the samples analyzed in these reports were 
pure low molecular weight compounds and were not applied to unknown samples. 
The fragmentation pattern resulting in 02 An ion (by the loss of 60 amu from 
M+Na) is indicative of 1-4-linkage where the formation of 02 An (-60 amu), 03 An (-
90 amu), and 04An (-120 amu) are indicative of 1-6-linkage (Reinhold et al., 
1995). The fragment ions observed for BCE indicate the presence of a mixture of 
1-4 and 1-6-type linkages. The 1-3-linkage type is not indicated by a specific 
fragment ion formation (Reinhold et al., 1995). Relative-intensity of MS ions 
provides limited information on the linkage type because of the need for a wide-
range of standards that would resemble the unknown sample (Yamagaki et al. 
1998). Fragmentation ions ofBCE are shown in table 4.2. 
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Table 4.2. Fragmentation pattern of BeE as interpreted by Glycofragment tool. Many of the ions 
observed in BeE show fragmentation pattern consistent with that of oligosaccharide (glycosidic bond 
and cross-ring cleavage). 
Mass· Fragmentation ions Mass** Mass* Fragmentation ions 
38 o,S An + Na+ 319 1.5 A,.,+ Na+ 
53 1,2 Xn + Na+, 2,3 An + Na+ 328 Zn - H20 + Na+, Bn - H20 + Na+ 
67 4,S An+ Na+ 335 3,4 An + Na+, 0,1 A,., + Na+ 
83 1,3 Xn + Na+, 0,4 An + Na+ 346 Yn - H20 + Na+, Cn - H20 + Na+ 
97 3,S An+ Na+ 347 Zn + Na+, Bn + Na+ 
113 1,4 Xn + Na+, 0,3 An + Na+ 113 365 Yn + Na+, Cn + Na+ 
127 2,S An + Na+ 127 377 3,4 Xn + Na+, 0,1 Xn + Na+ 
143 0,2 An + Na+ 143 393 1,5 Xn + Na+ 
157 I,S An + Na+ 157 407 0,2 Xn + Na+, 2.4 An + Na+ 
166 Zn - H20 + Na+, 8 n • H20 + Na+ 166 421 l,S An + Na+ 
173 0,1 An + Na+ 173 423 l.S Xn+ Na+, 
184 Yn - H20 + Na+, Cn - H20 + Na+ 184 437 1,4 Xn + Na+, 0,3 Xn + Na+, 
185 Zn + Na+, Bn + Na+ 185 451 2,5 A,., + Na+ 
203 Yn + Na+, Cn + Na+ 203 453 3,5 Xn + Na+ 
215 0,1 Xn + Na+, 3,4 Xn + Na+ 215 467 2,4 Xn + Na+, 0,2 A,.,+ Na+ 
231 1,5 Xn + Na+ 231 481 1,5 A,., + Na+ 
245 0,2 X4n + Na+, 2,4 An + Na+ 244 490 Z. - H20 + Na+, Bn - H20 + Na+ 
259 3,S An + Na+ 259 497 0,1 A,., + Na+, 3.4 A,., + Na+ 
261 2,S Xn + Na+ 261 508 Yn - H20 + Na+, Cn• H20 + Na+ 
275 0,3 Xn + Na+, 1,4 Xn + Na+, 0,3 A,., + 275 509 Z. + Na+, Bn + Na+ 
Na+ 
289 2,S An+ Na+ 289 527 Yn + Na+, Cn + Na+ 
291 3,5 Xn + Na+ 291 539 3,4 Xn + Na+, 0,1 Xn + Na+ 
305 2,4 Xn + Na+, 0,2 An + Na+ 307 555 1,5 Xn + Na+ 
Mass* Fragmentation ions Mass·· 
569 0,2 Xn + Na+, 2,4 A,., + Na+ 569 
583 3,5 A,., + Na+ 583 
585 2,5 Xn + Na+ 585 
599 1,4 Xn + Na+, 0,3 Xn + Na+, 0,3 A,., + 599 
Na+, 1,4 A,., + Na+ 
613 2,5 A,., + Na+ 611 
615 3,5 Xn + Na+ 613 
629 2,4 Xn+ Na+, 0,2 An + Na+ 629 
643 1,5 A,., + Na+ 643 
653 Zn - H20 + Na+, Bn' H20 + Na+ 653 
659 0,1 A.n + Na+, 3,4 A,., + Na+ 659 
671 Yn - H20 + Na+, Cn• H20 + Na+, 671 
Zn + Na+ ,Bn + Na+ 
689 Yn + Na+, Cn + Na+ 689 
701 0,1 Xn+ Na+ 701 
717 1,5 Xn + Na+ 717 
731 0,2 Xn + Na+ 731 
747 2,5 Xn+ Na+ 747 
761 0,3 Xn+ Na+, 1,4 A,., + Na+ 761 
777 3,5 Xn + Na+ 777 
791 0,4 Xn + Na+, 2,4 Xn + Na+, 1,3 A,., + 791 
Na+ 
807 4,5 Xn + Na+ 809 
821 2,3 Xn + Na+, 1,2 An + Na+, 3,4 A,.,+ 823 
Na+ 
835 0,5 Xn + Na+ 835 
.: All theoretical ions for a sodiated 5-hexose residue oligosaccharide .•• : BCE ions. 
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Mass·* 
317 
328 
335 
346 
347 
365 
377 
394 
407 
421 
423 
437 
451 
453 
467 
481 
490 
498 
508 
509 
527 
539 
555 
4.2.7 Mass spectrometric analysis of permethylated BeE indicates that the 
active component is a linear oligosaccharide. 
In methylated oligosaccharides, the free hydroxyl groups are completely 
methylated. In this method, the glycosidic linkages are not broken because of their 
insensitivity to the basic conditions required for alkylation (Ciucanu and Kerek, 
1984). Mass spectrometry of methylated oligosaccharide benefits from better 
sensitivity, and can provide information about the linkage type (Visuex et al., 
1999). 
In the mass spectrum of a methylated oligosaccharide three ion-products can be 
observed (Reinhold et al., 1995). They are non-reducing, reducing, and internal 
ions (noted; Me (Hex)n-H, H(Hex)nOMe, and H(Hex)n-H, respectively). By 
adding or subtracting the symbol's masses, one can determine the ions masses, 
where 'n' indicates the number of residues in the ion fragment, Hand 0 are the 
usual elemental symbols, the masses of Me (methyl group) and methylated-
hexose (Hex) are 15 and 204 Da, respectively. In a linear methylated 
oligosaccharide, the three fragment ions will be present, where the absence of the 
reducing ion H(Hex)nOMe and the observation of H(Hex)-OMe(l4 Da) would 
indicate a branching at the reducing-terminus (Reinhold et aI., 1995). 
In the MS spectrum of permethylated BCE, the three fragment ions can be 
observed in their sodiated forms; Me(Hex)n-H.Na, H(Hex)nOMe.Na, and 
H(Hex)n.Na. Table 4.3 shows ion types observed in the mass spectra of 
permetheylated BCE. Figure 4.7 shows mass spectra ofpermethylated BCE. 
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Table 4.3. Ion types of permethylated BCE. Masses and ion types observed in BeE that 
con-espond to that observed in MS analysis of per methy lated oligosaccharide arc li sted. 
Interpretation is based on that recommended by Reinhold (Rei nhold el at., 1995) 
Mass Ion type Comment 
1075 H(Hex)50Me 5-hexose res idue 
1058 Me(Hex)5-H 
1044 H(Hex)5-H 
87 1,667 , 463, and 259 Losses of 204 from 1075 
854, 650, 446, and 242 Losses of 204 from 1058 
840, 636, 432, and 228 Losses of 204 from 1044 
Figure 4.7_ Mass spectra of permetheylated BCE (a-d). Whole spectrum (a), focu sed region (b 
to d) 
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4.2.8 Gas-chromatography analysis indicates that glucose is the sole 
component in fractionated BeE. 
Gas chromatography (GC) is a sensitive method for analysing the monosaccharide 
contents of oligo/poly-saccharides. The derivatization of a monosaccharide 
facilitates its volatilization that is a requirement for GC analysis. The common C 
method to analyze the carbohydrate content of a sample uses the alditol-acetate 
derivatization step (Steinberg and Fox, 1999). The coupling of GC with MS can 
provide structural details about the oligosaccharide sample under study (Hansson 
et 01., 1989). However, in this study, this was not attempted because the harsh 
derivatization process of BCE modifies the structure of the NF-KB-activating 
component. Hence, corresponding structural-activity to data from GC-MS was not 
possible. In figure 4.8b, glucose was observed as the only monosaccharide present 
in purified BCE. The glucose-peak was identified by comparing its retention time 
(rt) to that of a series of standards (figure 4.8a). 
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Figure 4.8. Gas-chromatography (GC) analysis of fractionated BeE. GC of external 
monosaccharide standards (A; from left to right: rhamnose (rt; 4.39 min) , arabinose (rt; 6.26 min), 
xylose (rt; 8 min), allose (6.69), m a ~ o s e e (rt; 10.53 min), galactose (rt; 11.34 min) and glucose (rt; 
12.37 min). GC of BCE (B) where the internal standard was allose (rt; 9.64 min) . 
(A) (B) 
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4.2.9 NF-KB activation by BCE is inhibited by treatment of BCE with alpha-
glucosidases. 
To investigate whether the NF-KB activating structure in BeE is sensitive to 
glucosidase-hydrolysing enzymes (GHE) , BeE was incubated with the exo-
alpha-GHE (Sun and Henson, 1990) amyloglucosidase (has hydrolysing activity 
on 1-4, 1-3, and 1-6 linkages), endo-alpha-GHE (Wheatley and Moo-Young, 
1977) dextranase (acts on endo-1-6 linkage), or endo-beta- GHE (Malet et al., 
1993) beta-glucanase; (acts on beta-endo-1-3/1-4 linkages). The NF-KB 
activation levels by BeE treated with these enzymes are shown in the figure 4.9. 
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The results of the enzymes treatment indicate that the bioactive-structure in BCE 
is an alpha-type linked oligosaccharide. However, because these enzymes are not 
specific to one linkage-type, it is not possible to determine the exact alpha linkage 
type by enzymatic digestion alone. Although it requires higher sample quantity, 
the linkage types present in a methylated oligosaccharide subjected to a series of 
glucohydrolase digestions can be deteml ined by GC of the derivatized methylated 
sample (Zaia, 2003). However, performing a bioassay for structure-activity 
determination was not possible using derivatized BCE. 
Figure 4.9 . NF-KB-dependent gene expression in HeLa 57 A cells treated for 6 h wi th one of the 
follo wing: C. jejuni boiled-cell extract (BCE), BCE treated with amyloglucos ida e (B E I), BCE 
treated with dextranase (BCE2), BCE treated with beta-glucana e (B E3). TNF-a was the control 
ac ti va tion (50 ng/mr i ) . The data are recorded as the means of three independent detennination . 
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4.2.10 NF-KB is not activated by BCE applied to the aminopropyl column or 
by permethylated BCE. 
Aminopropyl columns can be used for separation of polar compounds (Bennion, 
1999). However, in this study, NF-teB was not activated by BCE once app lied to 
this column (Figure 4.10). The active component in BCE could not be detected in 
the pass-through, wash, or elute of this column. This could be explained by the 
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glycosylamine format ion between the reducing-terminus of the oligosaccharide 
and the amino group of the column's stationary phase (Robinson et al. 2007). 
Permethylation of BeE replaces the hydroxyl groups of the oligosaccharide with 
methyl groups. T his makes BeE less polar and can be retained by a reverse-phase 
co lumn under hydrophobic conditions. NF-Kl3 was not activated by permethylated 
BeE (Figure 4.10) implies the importance of its polarity for the activation. 
Figure 4.10. NF-KB-dependent gene expression in HeLa 57 A cells treated for 6 h with one of the 
fo llowing: C. jejuni boiled-cell extract (BCE), the pass-through of BCE app lied to aminopropyl 
column (BCE I), the wash of BCE applied to aminopropyl column (BCE2), the elute of BCE 
applied to aminopropyl co lumn (BCE3), permethylated BCE (BCE4). T F-a was the control 
activation (50 nghnrl). 
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4.2.11 Alpha-linked glucan reporter-chemical hifts are present in the 
spectrum of BeE analysed by nuclear magnetic resonance (NMR) 
NMR is a non-destructive technique that has been used for carbohydrate structural 
determination (Duus et al., 2000). Data from IH NMR, which show the anomeric 
proton resonances (chemical sh ift range; 4.40 to 5.5 ppm) and the ring resonances 
(chemical shi fts range; 3 to 4.2 ppm), can provide useful structural details when 
combined with data from other techniques such as MS, GC, and GC-MS. 
Requiring purified samples, the application of NMR to BeE in this study was 
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limited to IH NMR because of the quantity of sample needed. Additionally, the 
highly polar nature of carbohydrate means the purification steps before NMR is of 
limited performance. This would result in polar but not active component being 
co-eluted during the purification. The 1 H NMR spectrum of purified BCE is 
shown in figure 4.11. Interpretation of the chemical shifts (Table 4.4) was 
performed using online CASPER computer software. 
Table 4.4. Interpretation ofBCE NMR chemical shifts. The online CASPER tool was used to 
interpret the NMR data. Chemical shifts of alpha-glucose simulated by Casper software, BCE, 
found in database and reported in literature are listed. 
H Casper I ppm BCE DatabaseT Literature) 
minimax L T B 
1 5.23 4.93- 4.8115.569 5.39,4.98 5.38,4.98 5.38,4.99 
5.32 
2 3.54 3.36- 3.36/3.68 3.66,3.63,3.61 3.66,3.62 3.66,3.62.3,64 
3.68 
3 3.72 3.58- 3.58/3.85 3.96,3.71,4.0 3.97,3.72 3.98,3.72,4.03 
3.85 
4 3.42 3.46- 3.36/3.64 3.66,3.44,3.65 3.64,3.44 3.66,3.44 
3.64 
5 3.84 3.56- 3.56/4.13 3.88,3.79,3.89 3.85,3.73 3.85,3.73,3.88 
4.13 
6,6' 3.84,3.76 3.78- 3.78/3.98 3.87,3.86 3.9,3.8, 3.8,3.9 
3.98 
1: Casper sImulated (http:/www.casper.organ.su.se/casper.html) chemIcal ShIftS 
for alpha-d-glucose 2: Minimum/maximum reported chemical shifts for alpha-d-
glucose found in database: http://www.dkfz.de/spec/glycosciences.de/sweetdb/ 
3- Reported chemical shifts for linear (L), terminal (T), and branched (B) alpha-
glucan (Zhang et al., 1991; Dinadayala et al., 2004; Bittencourt et al., 2006). 
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Figure 4.11. 1H proton NMR spectrum ofBCE. The combined active fractions from the 1st NP-
HPLC purification of BCE (from wild-type C. jejuni) were analyzed by MR. The chemical shift 
of acetone (2.25 ppm) was used as internal reference. The other chemical shifts found in 1 to 3 
ppm range might be that of co-eluting components. BCE analysis show chemical shits that fall 
in the range of anomeric chemical shifts (4.40-5.50 ppm) and the ring chemical 
shifts (3- 4.2 ppm) 
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Campylobacter is one of the most reported causative agents of foodbome diseases 
worldwide where most of Campylobacteriosis cases are largely caused by C. 
jejuni in developed countries with active surveillance. During infection, C. jejuni 
interacts with the host by pqorly understood mechanisms (Ketley, 1997). These 
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interactions ultimately result in the up-regulation of the inflammatory- response 
genes that are generally controlled by the transcription factor NF-KB. Upon 
cellular stimulation by live C. jejuni or its extracted component(s), NF-KB 
translocates from the cytoplasm to the nucleus where it binds to DNA turning on 
the target genes that induce pro inflammatory responses that are characteristic of 
the disease symptoms (Mellits et al., 2002). NF-KB can be activated by many 
enteric pathogens (Santos et al., 2003; La Feria et al., 2004; Sansonetti, 2006) and 
their derived components (Akira et al., 2006), although they differ in their 
physiochemical properties. Whether the reported activation of NF-KB by isolated 
bacterial components reflects the live pathogen interaction with the host's immune 
system is not known. This is because the methods (Darveau et al., 1983; Muhlradt 
et al., 1997; Travasoss et al., 2004) utilized for the isolation of the components 
involve the use of chemicals that may inevitably cause structural modifications. 
Additionally, differences of interaction in vivo and in vitro (Philpott et al., 2000; 
Hopkins and Sriskandan, 2005) would confound experimental findings as detailed 
knowledge about the signalling pathways in both systems is not fully understood 
and may not be similar. However, the lack of suitable animal models for studying 
C. jejuni pathogenesis (Walker et al., 1986; Ketley, 1997) makes in vitro 
investigation the only plausible route to obtain information about how C. jejuni 
may cause disease. 
In a dose-dependent manner, BeE from C. jejuni has been reported to activate 
NF-KB maximally 6 hours after stimulation of the HeLa 57A cell line (Mellits et 
al., 2002). Given the insensitivity of BeE to boiling and proteinase K digestion, 
one may rule out a proteinaceous structure as the activating component in BeE. 
Additionally, a lipid-moiety containing structure does not participate in the 
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activation since BeE is also resistant to lipopeptide lipase treatment. Unlike 
BeE, cell-filtrate did not activate NF-KB indicating the bioactive structure is 
liberated or modified during BeE preparation that involves a boiling step (Mellits 
et al., 2002). 
The cell wall of C. jejuni, from which BCE components derive, like other Gram-
negative bacteria, mainly contains LPS, PGN, membrane proteins, and 
lipoproteins The lipid components of LPS (Dixon and Darveau, 2005) and 
lipoproteins (Okusawa et al., 2004) are the most important for NF-KB activation 
by these two structures. Peptidoglycan NF-KB activation is induced by the beta 1-
4 linked NAG-NAM moiety of PGN (Chamaillard et al., 2003). The bioassays 
used to evaluate NF-KB activation by these structures have been performed in cell 
lines that express cellular receptors needed for the signalling pathways leading to 
the activation. 
The cell line HeLa 57 A was used in this study to determine NF-KB activation by 
BeE during different purification steps. This cell line does not express TLR2 
(lipoprotein and PGN receptor), MD2 (necessary for LPS signalling pathway), 
and NOD2 (recognizes the minimal activating moiety of PGN). NODI, which 
also recognizes PGN, is expressed in this cell line. However, the stimulatory 
component of NODI has been reported to be found in the culture supernatant but 
not in cell extracts from different bacteria (Hasegawa et al., 2006). Culture 
supernatant and LOS of C.jejuni did not activate NF-KB (Mellits et al., 2002). 
BeE prepared from C. jejuni LOS and capsule polysaccharide mutants or BeE 
. subjected to treatment that precipitates lipid-A (if any) are able activate NF-KB. 
Generally capsular polysaccharide is thought to be a weak immune-stimulant 
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(Henderson et al., 1996). Given the infonnation above, the active component in 
BCE are not LOS, PGN, CPS, or lipo-proteins. 
As supported by evidence from structural analysis (MS, GC, and NMR) and 
inactivation by alpha-glucohydrolases, NF-KB is activated by a short-alpha linked 
oligosaccharide in BCE. Activation of NF-KB by similar structures has not been 
reported for Campylobacter or any other Gram-negative bacteria. 
Recently, NF-KB activation and production of pro-inflammatory cytokines by 
alpha-linked glucan has been reported for other organisms such as 
Pseudallescheria boydii (Bittencourt et al., 2006), Tinospora cordifolia (Nair et 
al., 2006) and Streptococcus mutans (Choi et al., 2005; Okamoto et al., 2007). 
However, maerophages have been used in these reports. Many receptors are 
expressed by macrophages (Taylor et al., 2005) that may lead to NF-KB activation 
in a different manner than possible in the HELA 57 A cell line. 
A cell-surface expressed alpha 1-4 linked glucan has been recently detected in C. 
jejuni (Papp-Szabo et al., 2005). In the C. jejuni CPS mutant (kpsM), sugar 
linkage analysis showed that this glucan is made up of 25-glucose residues that 
have infrequent branching points. Glucose was found as the sole sugar present in 
the identified gluean. IH NMR spectra showed chemical shifts of 5.42,3.64,3.98, 
and 3.66 for HI, H2, H3, H4 resonances, respectively. In C. jejuni, the genetic 
basis for alpha-glucan synthesis has not been detennined (Papp-Szabo et ai., 
2005). Substituted with phosphoglycerol, phosphoethanolamine, and succinyl 
residues, osmoregulated periplasmic glucans (OPGs) are synthesized by members 
of the Enterobacteriaceae (Bohin, 2000). Made of glucose only, linear and 
branched substituted OPGs of 5-13 residues have been reported in Gram-negative 
bacteria (Page et al., 2001). The role of OPGs mostly ~ - l i n k e d d glucan in C. jejuni 
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pathogenesis is yet to be determined. OPGs can exist as mixture of 
substitutedlunsubstituted a / ~ - g l u c a n s s and are thought to be important for 
interaction with the host's cells in addition to their osmoprotectant function. In E. 
coli, synthesis of OPGs is regulated by the mdoGH operon (Bohin, 2000). 
Different types of chromatography columns have been used for fractionating 
carbohydrate containing samples (Davies and Hounsell, 1996). However, there is 
no single system that is capable of purifying all possible carbohydrate isomers 
utilizing volatile buffers. The performance of size-exclusion column (SEC) 
chromatography is limited because separation of the carbohydrate mixture is not 
based on the possible linkage types (Deery et at., 2001). Since carbohydrates are 
of polar nature, separation using a reverse-phase chromatographic method is 
limited to only removing hydrophobic contaminants. Unless non-volatile ion-
pairing agents are used, carbohydrate will elute in the void volume when applied 
to a RP-HPLC column (Davies and Hounsell, 1996). 
Oligosaccharides lack UV absorbing groups such as nitriles and double bonds 
making their detection only available below 21 Onm. At such low wavelength, NH 
and C=O UV absorbance is poor, and solvents usually cause observed drifting in 
baseline absorbance (Paulus and Klockow, 1996). Detection of carbohydrate 
during an HPLC separation using reflective index (RI) values is limited because 
the sensitivity of the detector to the mobile-phase composition changes (Davies 
and Hounsell, 1996). 
Derivatization and chromophoric labelling of oligo saccharides will increase their 
detection during HPLC purification. However, in this study, chemical labelling of 
BCE interfered with the bioassay for NF-KB activation and was avoided. This 
made identifying the active fractions only possible after performing the cell 
107 
culture based bioassays. Detennination of the proposed structure of the NF-KB 
activating component was only possible by combining infonnation obtained from 
different experiments. The use of MS, GC, enzymatic inactivation, and NMR for 
the structural characterization of BCE were limited by the inability of MS to 
differentiate carbohydrate isomers, the hydrolysing nature of GC derivatization 
step, the non-one-linkage type specific action of glucohydrolases, and the sample 
quantity and purity requirements for NMR analysis, respectively. 
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CHAPTER 5 The role ofTLR and NOD receptors in NF-KB 
activation by Campvlobacter ;e;uni 
CHAPTERS 
5.1 Introduction 
The host's immune responses during the course of foodbome infection are mainly 
regulated by NF-KB (Gewirtz et ai., 2002). Depending on the immune system 
status of the patient, campylobacteriosis can be a self-limiting infection, or 
accompanied by systematic and chronic complications (Coker et ai., 2002). In 
intestinal epithelial cells, where the first interaction with the host's immune 
system takes place, the signalling cascade by pathogens or their products 
proceeds generally via an IKB-dependent pathway resulting in NF-KB activation 
and up-regUlation of the inflammatory response genes (Schottelius and Baldwin, 
1999; Jobin et aI., 2000). This pathway utilizes trans-membrane receptors (e.g. 
TLRs) and/or cytoplasmic receptors (e.g NODs) via adaptor molecules (e.g 
MYD88, lRAKs, and MAL for TLRs and RIP2 for NODs) leading eventually to 
the translocation ofNF-KB from the cytoplasm to the nucleus where it binds target 
gene DNA sequences (Akira and Takada, 2004; Strober et ai., 2005). Signalling 
via other pathways such as MAPK has been reported to mediate NF-KB regulation 
of the immune responses (Zhang and Dong, 2005). 
How these receptors/adaptor molecules contribute to NF-KB activation by C. 
jejuni would be of significant help in understanding the pathogenesis of C. jejuni. 
In this chapter, the roles of these molecules in NF-KB activation are investigated 
by means of adding (transfection of wild type genes), or masking (transfection of 
dominant negative alleles) of the receptor/adaptor in question. 
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5.2 Results 
5.2.1 Campylobacter jejulli activates NF-KB through TLRlMYD88 
independent and dependent pathways 
5.2.1.1 TLRlMYD88 independent pathway 
Lipopolysaccharide, lipoproteins/peptidoglycan, flagella, and CpG DNA are 
major PAMPs that are recognized by TLR4, TLR2, TLR5, and TLR9. The 
expression of TLRs in tissue culture cell lines has been reported to vary among 
laboratories (Nishimura and Naito, 2005). Therefore, reverse-transcriptase PCR 
was used to verify the expression ofTLRl-lO mRNAs in HeLa 57A, HEK-293, 
HCA-7, and Caco-2, the cell lines used in this study (Table 5.1). 
Table 5.1. Expression pattern* of TLRs and NODs receptors in cell lines used in the study. 
Product Caco-2 HeLa 57A HCA-7 HEK293 Ligands 
TLRI triacylated lipoproteins 
TLR2 lipoproteins 
TLR3 + + dsRNA 
TLR4 + lipopolysaccharide 
TLR5 + + + flagellin 
TLR6 diacylated lipoprotein 
TLR7 + ssRNA 
TLR8 ssRNA 
TLR9 unmethylated CpG DNA 
TLRIO 
NODI + + + + iE-DAP 
NOD2 + Muramyl dipeptide 
TOLLIP + + + Inhibitor ofTLRs 
*: Data provided courtesy of the technical assistance of Mrs. E. Dillon. 
The HeLa 57 A cell line that is stably transfected for the reporter plasmids and 
produces robust responses to NF-KB activators (Rodriguez et al., 1999), was 
shown to express mRNAs to TLRs 3, 4, 5 and 7, but does not express MD-2, an 
accessory molecule necessary for TLR4 signalling (Re and Strominger, 2002; 
Nishimura and Naito, 2005). However, Caco-2 cells cultured under these 
conditions produced no detectable TLR expression and the alternative colonic cell 
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line HCA-7 exhibited only TLR3 expression. HEK293 cells exhibited mRNA 
expression of TLR5 and no other TLR. The influence of the TLR inhibitor protein 
TOLLIP was considered as it has been reported to suppress PAMP recognition. 
TOLLIP was found to be expressed in Caco-2, HeLa 57A and HCA-7 cells (Table 
5.1), and would therefore have to overcome if these cells were to respond to C. 
jejuni via their TLRs. Overall, the cell lines did not express a common TLR that 
could account for recognition of a discreet C. jejuni pro-inflammatory product or 
known NF-KB activator. It is possible that C. jejuni products may be recognized 
by alternative yet to be identified TLRs depending on the cell context but the 
possibility exists that C.jejuni can activate NF-KB independent ofTLRs. 
The data presented in chapter 3 indicated that C. jejuni flagellin present in BCE 
does not activate NF-KB through TLR5 present in either HEK293 or HELA 57A 
cells since HELA 57 A cells were not responsive to purified C. jejuni flagellin but 
that they could respond to flageUin of E. coli (Zhou et at., 2003). These data are 
consistent with recent reports that C. jejuni flagellin along with other a. and E 
proteobacterial flagellins can evade innate immune recognition by TLR5 (Watson, 
& Galan, 2005; Andersen-Nissen et al., 2005). The negative response to flagellin 
is also consistent with the observation that the majority of the C. jejuni BCE 
activity is proteinase K insensitive. 
We further disrupted the classical TLR responsive pathway by the expression of a 
dominant negative form of the adaptor molecule MYD88. HEK293 cells were co-
transfected with the reporter plasmids and either a plasmid bearing a dominant 
negative form of MYD88 or empty vector as a control. The transfected cells were 
treated with live C. jejuni 11168 (m.o.i. 100) for 6 h or alternatively heat killed C. 
jejuni or BeE for 6 h (Figure 5.1). A significant difference was detected between 
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the dominant negative MYD88-expressing cells and the control cells for 
treatments with live C. jejuni (P=O.O 19) and BeE (P=O.035) that was not evident 
in the TNF-a control, which activates NF-KB independent of MYD88. However, 
we note that HEK293 cells retain their ability to respond to C. jejuni and its 
products, and are able activate NF-Kl3 in the presence of transfected dominant 
negative MYD88. 
Figure 5.1. Induction-fold of NF-KB in HEK293-DNMYD88 cells by C. jejulli. HEK293 cells 
were transfected with reporter plasmids DNA (lCB-Iuc and RSV-IacZ) and DN-MYD88. 
Transfected cells were treated with either live (for 16 h) or heat-killed C.jejuni 11168 or C.jejuni 
boiled cell extract (BCE) for 6 h. Significant differences between the DN-MYd88-expressing cells 
and the control cells for live C. jejuni" (P=O.OI9) and BCE·· (P=O.035) corresponds with the 
asterisks as indicated. The data are recorded as the means of 3 independent determinations. 
live C.Jejuni .... * 
live c . j e j u ' ' l i + D I ~ m y l D 8 8 I ' ' ' * 
BCE 
--- ** 
heat killed 
heat killed+DNmyD88 
TNF"IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII---
TNF+DNmyID88 .. 11111111111111111111111111111111 •• ----
o 5 10 15 20 25 30 35 40 45 50 
Activation of NF-KB (fold-induction) 
5.2.1.2 Activation of NF-KB by C. jejuni and BeE is augmented through 
TLR2 
We further sought to establish if C. jejuni 11168 and its heat-stable products could 
activate NF-KB through TLRs 2 and 4 if present. We therefore specifically 
expressed these receptors in HEK293 cells that are naive for TLRs 2 and 4 and do 
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not respond to the microbial ligands associated with these receptors. Co-
transfection of HEK293 cells with plasmid DNAs directing the expression of 
human TLRs and the accessory proteins MD-2 and CD-14 confer the ability to 
respond to previously unrecognised microbial products. Figure 5.2a shows that 
transient expression of functional TLR2 results in a nine-fold increase in the NF-
KB-dependent reporter gene activity in the presence of live C. jejuni (m.oj. 100) 
compared to HEK293 cells transfected with MD-2, CD14 and empty vector 
control plasmid DNAs. Heat-killed C. jejuni and C. jejuni BCE also exhibited 
similar trends with respective four- and three-fold increases in NF-KB-dependent 
reporter gene activity when transfected with the TLR2 expression plasmid. By 
way of controls, HEK293 cells were transfected with TLR2 and shown to gain the 
ability to respond to the synthetic TLR2 ligand Pam3CSK4, but not pure E. coli 
LPS that is dependent on activation of NF-KB through TLR4. Conversely 
expression of TLR4 in HEK293 cells results in sensitivity to E. coli LPS but does 
not result in sensitivity to Pam3CSK4. However, TLR4 expression in HEK293 
cells did not result in any significant increase in their NF-KB-dependent response 
to C. jejuni or BCE (Figure 5.2a). To demonstrate the increase in activity was 
dependent on the TLR2IMYD88 pathway, HEK293 cells were co-transfected with 
TLR2-CDI4 and a dominant negative MYD88-expressing plasmid. Expression of 
dominant negative MYD88 prevented NF-KB induction via Pam3CSK4 with 
TLR2 and reduced the response to live C. jejuni, heat-killed C. jejuni and BCE to 
either similar or lower levels than those observed in the absence of TLR2 (Figure 
5.2a). 
TLR2-CDI4 or TLR4-MD-2 were further introduced into CACO-2 cells to 
examine if these colonic epithelial cells could also demonstrate an enhanced NF-
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KB response to C. jejuni via TLRs. Figure 5.2b shows CACO-2 cells transfected 
with TLR2 show a significant increase in their response to C. jejuni (m.oj. 100), 
and that the increased response may be abrogated by co-expression of dominant 
negative MYD88. However, TLR4 expression in CACO-2 cells did not enhance 
their response to live C. jejuni or BCE to complete a similar trend to that observed 
with HEK293 cells. 
Figure 5.2. Induction-fold ofNF-KB in HEK293/Caco2-TLR2/4 cells by C.jejulli. HEK293 (a) 
and Caco-2 (b) cells were transfected with the reporter plasmids DNA, plasmid DNA of TLR4 and 
MD-2 or TLR2 and CD14, and DN-MYD88 as indicated. Transfected cel\s were treated for 6 h 
with one of the following: ultrapure E. coli LPS (TLR4 agonist; at 10 Ilg/mrl); PAM3SK4 (TLR2 
agonist; at 100 ng/mn; heat-killed C. jejuni, or C. jejuni boiled cel\ extract (BCE). Incubation 
with live C. jejuni was at m.o.i of 100 for 16 h. The activation control TNF-a was added at 50 
ng/mrl. The data are recorded as the means of 3 independent determinations. 
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(b): Caco-2 cells 
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5.2.2 Campylohacter jejulli exhibits synergy between TLR2 and NODI to 
activate NF -KB 
Consistent with reports that NOD 1 is expressed in many tissues (Girardin and 
Philpott, 2004), we found NODI expression in all the cell lines examined 
including intestinal epithelial cells. NOD 1 has been shown to respond to a Gram-
negative peptidogycan product M-triDAP, and is a candidate mechanism by 
which C. jejuni could activate NF-KB in the absence of TLRlMYD88 pathways. 
HEK293 cells were transfected with a plasmid expressing a dominant negative 
form of NODI and NF-KB was induced in these cells with either live C. jejuni 
(m.o.i. 100) or BCE. Figure 5.3 shows that no significant falls in NF-KB activity 
were recorded in response to either live C. jejuni or BCE upon expression of 
dominant negative NOD 1. However, when dominant negative NOD 1 was 
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expressed with the TLR2-CD14 constructs required to sensitise HEK293 cells to 
TLR2 ligands and enhance the activation of NF-KB, the comparative activation 
levels exhibited significant reductions for live C. jejuni (P=O.047) and BCE 
(P=O.021). It appears that although C. jejuni does not appear to require NOD 1 
within the 6 h period of this experiment to activate NF-KB, the presence of 
functional NODI appears to act synergistically to enhance the NF-KB response to 
BeE through the TLR2IMYD88 pathway. 
Figure 5.3. Synergized induction of NF-KB in HEK293-TLR2-NODl cells by C. jejuni. 
HEK293 cells were transfected with the reporter plasmid DNA, TLR2-CD14 and with NODI or 
DN-NODI as indicated. Transfected cells were treated for 6 h with one of the following; NODI 
agonist M-triDAP (10 Jlg/mr l ), live C. jejuni 11168; C. jejuni boiled-cell extract (BCE). The 
activation control was TNF-a (50 ng/mr l ). Significant differences between TLR2-expressing cells 
and those co-expressing DN-NODl are indicated with asterisks for live C. jejuni" (P=0.047) and 
BCE" (P=O.021). The data are recorded as the mean of 3 independent determinations. 
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5.2.3 TLR2 only senses the oligosaccharide present in BeE 
Since BeE activates NF-KB independent of TLR2, but the levels of activation 
increase upon transfection of the cell line with this receptor, the effect of BeE 
treatment with amyloglucosidase on this increase was investigated to know 
whether the sen ing is due to the alpha-oligosaccharide in BCE or another 
component. In HEK-293 cell line transfected with TLR2-CD 14, the activation of 
NF-KB by BeE treated with amyloglucosidase was significantly reduced (Figure 
5.4). This is consistent with the recent reporting that TLR2 is the receptor 
mediating an immune response to alpha-glucan (Bittencourt et ai., 2006). 
Figure 5.4. Induction-fold of NF-KB in HEK293-TLR2 cells by C. jejulli BCE pre-treated 
with amyloglucosidase. C. jejuni BCE treated with amyloglucosidase (BCE+AM) minimally 
induced F-KB- dependent gene express ion in HEK293 ce l1 s transfected with the reporter plasmid 
DNA and TLR2-CD 14. The transfected cel1s were incubated for 6 h with one of the fol1owin g: C. 
jejL/lli boiled cel l extract (BeE), BCE treated with amyloglucosidase, TLR2 agonist PAM3SK4 
(100 nglmr\ and TLR2-independent activation control TNF-a (50 nglmr'). The data are recorded 
as the means of three independent determinations. 
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BCE+AM ~ ~
BCE I ~ ~__________________________________________ ~ r - - - ~ ~
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5.2.4 Expression of TLR2 or MD-2 in HE LA 57 A has no increasing effect on 
NF-KB activation by BeE 
HELA 57A cells were transfected with TLR2-CD14 or MD-2 to see the effect on 
NF-KB activation levels. Although TLR2 increases the activation in HEK293 
cells this increase was not observed in HeLa 57 A. Additionally, the transfection 
of the TLR4 accessory protein (MD-2) did not result in BCE sensing by this 
receptor (Figure 5.5). In transfected HeLa57 A, TLR2 or TLR4 did not sense their 
ligands. This maybe due to low transfection efficiency, very low expression of 
MYD88, and high levels of TOLLIP present in this cells line (Nishimura and 
Naito 2005). 
Figure 5.5. Induction-fold of NF-KB in He La 57A-TLR2ITLR4 cells by C.jejlllli BeE. NF-
KB-dependent gene expression by BCE is not increased by transfecting HeLa 57 A cells with TLR2 
or M D-2. HeLa 57 A stably trasnfected with the reporter plasmid DNA were transiently transfected 
will, empty pIa mid D A, or TLR2-CDI4, or MD-2. Transfected cells were incubated for 6 h 
with one of the following: BeE, TLR2 agonist PAM3SK4 (100 ng/mr l ) , TLR4 agonist LPS (10 
~ g g m r \ \ The data are recorded as the means of three independent determinations. Transfection 
with empty plasmid D A (TNF-A, LPS-A, PAM3SK4-A, BeE-A), TLR2-CDI4 (TNF-B, 
PAM3 K4-B, BeE-B) MD-2 (T F-e, BeE-C, LPS-C) 
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5.2.5 Campylobaeter jejulli can activate NF-KB via NOD2 
400 
OD2 was only found to be expressed in the HCA-7 cell line of those examined 
(Table 5.1). We therefore elected to transfect HEK293 cells with a plasmid 
expres ing NOD2 to examine its effect on NF-KB induction levels. Figure 5.6 
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shows NOD2 expressIOn conferred sensitivity to the NOD2 agonist MDP. 
However, consistent with previous reports the introduction of NOD2 resulted in 
an increase in the background levels ofNF-KB-driven luciferase activity, making 
comparison between cells transfected with NOD2 encoding plasmids and those 
with reporter plasmids/empty vector controls difficult to interpret (Ogura et ai., 
2001). Co-transfection of a dominant-negative form of NOD2 also resulted in a 
similar increase in non-induced NF-KB-driven luciferase levels but these could not 
be induced by MDP. Therefore to assess if the introduction ofNOD2 affected the 
ability of live C. jejuni (m.oj. 100) or BCE to activate NF-KB, we compared the 
induction factors in the presence and absence of DN-NOD2. Using this criterion 
the expression ofNOD2 increases the activation ofNF-KB to live C.jejuni, in that 
the co-expression ofDN-NOD2 significantly reduces the response to live C.jejuni 
(P=0.04). The reduction in the activation of NF-KB by BCE in the presence of 
DN-NOD2 was not significant. 
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Figure 5.6. Induction-fold of NF -KB in HEK293-NOD2 cells by C. jejuni. HEK293 cells were transfected 
with the reporter plasmids DNA, along with NOD2 or DN-NOD2 as indicated. Transfected cells were treated 
for 6 h with one of the following: NOD-2 agonist MDP (100 Ilg/mrl); live C.jejuni 11168, C.jejuni boiled-
cell extract (BeE). The activation control was TNF-a (50 ng/mrl). Significant differences between the 
NOD2-expressing cells and those co-expressing DN-NOD2 (P=0.04) for live C. jejuni are indicated by the 
asterisk. The data are recorded as the means of 3 independent determinations. 
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5.2.6 NF -KB activation by BeE is severely inhibited by DN-lRAKl but not by 
DN-MAL or DN-p38 
lRAKI is a downstream molecule of the MYD88-dependent TLR signalling 
pathway. It acts to transfer signalling from MYD88 to TRAF6 leading to NF-KB 
activation (Alexopoulou and Kontoyainnis, 2005). Although BeE can activate 
NF-KB in cells transfected with DN-MYD88, the activation is suppressed (Figure 
5.7) by disrupting the signalling pathway in cells transfected with DN-lRAKI 
(P=<O.OOI). What molecule participates of NF-KB activation in the absence of 
MYD88 and may interact with lRAKI is not known. 
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Figure 5.7. Induction-fold of NF-KB in HEK293-DNp38IDNlRAKIIDNMAL cells by C. 
jejllfli. F-KB-dependent gene expression in HEK293 cell s transfected with reporter plasmid DNA 
(BCE- l , TNF-l ), a long with DN-p38 (BCE-2, TNF-2), DN-lRAKI (BCE-3, TNF-3), DN-MAL 
(BCE-4, T FA). Transfected cells were incubated for 6 h with C. j ejuni boiled-ce ll extract (BCE) 
or contro l activation TNF-a (50 ng/mr l ). The data are recorded as the means of three independent 
determinations. 
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MAL (also known as TlRAP) is an adaptor molecule reportedly important for 
MYD88-dependent TLR2/TLR4 signalling (Takada and Akira, 2004). However, 
HEK-293 cells transfected with DN-MAL did not show impaired response to 
BCE (P=0. 14) (Figure 5.7). Signalling cross-talks between p38 and NF-KB have 
been reported to regulate inflammatory responses (Olson et at., 2006). Therefore, 
the effect of DN-p38 on NF-KB activation was investigated in HEK-293 cells. 
Cells transfected with DN-p38 showed a decrease in NF-KB activation levels in 
response to stimulation with BeE (P=0.0015) (figure 5.7) . 
5.3 Discussion 
The mechanisms used by C. jejuni to cause disease in humans are not fully 
understood. However, the ability of this pathogen to activate NF-KB and other 
immune response regulators has been reported (Mellits et ai., 2002; McCallcum et 
al. , 2005). To cause an enteric illness, a pathogen must first overcome the first 
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responses of the host's innate immune defence. The highly acidic environment of 
the stomach, the constant physical movement in the gut, and production of anti-
microbial peptides in the intestine are examples of these defence responses 
(Muller et at., 2005). The reduction of stomach acidity (Waterman and Small, 
1998), defective flagella (Yao et at., 1994), and antimicrobial peptides production 
(Bevins et at., 1999) are considered risk factors for contracting infection, minimal 
invasion, and limiting the disease progress, respectively. The flagella-mediated 
motility of C. jejuni may be an important factor for successful interaction with the 
host's intestinal cell (Grant et at., 1993) and ultimately NF-KB activation by the 
live bacteria. However, since BCE activates NF-KB, the contribution of heat-
treatment of foods (Mellits et at., 2002) contaminated with C. jejuni or anti-
microbial-killed (Zilbauer et at., 2005) bacteria in liberating the bioactive 
components needs to be considered. 
The disruption of the IECs tight junction and the subsequent infiltration of 
professional phagocytes by C. jejuni have been reported (Chen et at., 2006). This 
is aided by the finding that C. jejuni induces the production of IL-8 that attracts 
neutrophils to the site of infection. Depending of the host's immune system 
status, this may limit the infection or being the early defences are overcome by C. 
jejuni resulting in more complications. 
To activate NF-KB in IECs, C. jejuni or its products must be recognized by 
cellular receptor(s) that initiates the signalling cascade leading to NF-KB 
activation. In attempt to illustrate C. jejuni in vivo interactions with the host, C. 
jejuni and its BCE activation of NF-KB were investigated in different cell lines 
varying in the pattern expression of the receptors under study. 
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To date 11 transmembrane receptors (TLRs) and 2 cytoplasmic receptors (NODs) 
have been identified (Akira and Takada, 2004; Strober et at., 2006). Regarding the 
sensing of foodbome bacterial pathogens, TLR2, TLR4, TLR5, and TLR9 are 
well characterized to recognize specific ligand(s). Bacterial ligands delivered into 
the host cell by invasion, phagocytosis, or injection are recognized by NOD 1 or 
NOD2 (Strober et at., 2006). 
Because flagella are sensitive to boiling and proteinase K treatment, TLR5 was 
not investigated in this study. As BeE treated with DNAase still activates NF-KB, 
TLR9 was also not included in this study. The results obtained here indicate the 
livelheat-killed C. jejuni or BeE can activate NF-KB independent of TLR2 and 
TLR4. The activation was also independent of NOD 1 and NOD2. These findings 
have not been previously reported for C. jejuni. 
MYD88, the central adaptor used by most TLRs, was found have a role but not 
necessary for observed NF-KB activation. However, disruption of the signalling 
molecule IRAK1, a downstream molecule ofMYD88, severely suppressed NF-KB 
indicating that signalling by C. jejuni is initiated by an IL-llToll like receptor 
which is not TLR2/TLR4 and yet to be identified. It might be possible that C. 
jejuni does not activate NF-KB by an IL-llToll like-independent receptor. The 
other adaptor molecule is MAL, which is reported to be important for MYD88-
TLR2ITLR4 -dependent signalling was found not to be necessary for the 
activation. Studies about MYD88-independent TLR signalling have reported the 
importance of the TRIF adaptor in this pathway for TLR3 and TLR4 (Akira and 
Takada, 2004). Because BeE was found not to be sensed by TLR4, and TLR3 
recognizes viral dsRNA, the role of this pathway in NF-KB activation by C.jejuni 
was not investigated. 
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NODs, the cytoplasmic receptors that sense peptidoglycan fragments, are not 
necessary for NF-KB activation by C. jejuni. The activation occurs in HELA 57 A 
cells, where NOD2 is not expressed. Additionally, the presence of NODI, which 
mainly senses a secreted peptidoglycan fragment (Hasegawa et at., 2006), may 
not be functional as its commercial ligand does not activate NF-KB in these cells. 
Previously, C. jejuni culture supernatant was reported not to induce NF-KB 
activation (Mellits et al., 2002). 
Since structural characterization of BCE showed that the proposed NF-KB 
activating component is an alpha-linked oligosaccharide, the sensing of BCE 
treated with amyloglucosidase by TLR2 was investigated. As recently reported, 
TLR2 sensing of alpha-glue an was lost upon treatment with this enzyme 
(Bitteneourt et at., 2006). 
Although GC analysis showed glucose as the sole component in BCE, one must 
take into consideration that not all carbohydrates can be analysed by GC as 
alditol-acetate derivatives. Additionally, the observed inactivation of BCE by 
amyloglucosidase might not exactly reflect the component's nature since this 
enzyme exhibits low foreign activity (1 %) toward other sugars. 
The MAPK p38 was reported to partially regulate the production of inflammatory 
eytokines by C. jejuni (Watson and Galan, 2005; McCallum et at., 2005). In this 
study, HEK-293 cells transfeeted with DN-p38 showed decreased levels ofNF-KB 
activation by BCE. The role of p38 in regulating NF-KB function is thought to 
occur in the nucleus independently of its translocation or binding to specific DNA 
target sequences, and it is a consequence of phosphorylating the transcriptionally 
active subunit ofNF-KB, RelA (Olson et at., 2006). 
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In lEes, the expression of TLRs is highly regulated to discriminate among normal 
gut microflora and pathogens. This is mediated by very low levels of receptor 
expression, site of expression and high levels of TLR negative-regulating 
molecules (Abreu et at., 2005). The results obtained here may suggest that C. 
jejuni interacts with the host's IECs through yet-to be understood 
mechanismlreceptor(s). However, it is clear that the unknown receptor utilizes the 
adaptor molecules (MYD88, lRAKI) that mediate the classical NF-KB activation 
by IL-IITolllike receptors family. 
Campylobacter has been reported to cause enteritis at low infectious doses 
(Robinson, 1981). One risk factor for contracting the infection is the consumption 
of foods such as raw milk (Peterson, 2003). The subsequent disease onset after 
contaminated milk ingestion indicates that Campylobacter has strategies to avoid 
the host initial defence responses. Enteric pathogenic bacteria have evolved 
mechanisms for overcoming these defences. The mechanisms include evasion of 
PAMPs detection at the mucosal surface, resistance to anti-bacterial peptides, 
invading and crossing the epithelial cells, escaping the phagocyte responses, and 
interfering with humoral immune responses (Homef et al., 2002). Since TLR2, 
TLR4, and TLR5 were found not necessary forNF-KB activation by C.jejnui, the 
P AMPs detection evading mechanism is expected to be important for C. jejuni 
pathogenesis. In IECs, which are characterised by their unresponsiveness to TLRs 
signal, NOD 1 has been reported to be the general sensor for enteroinvasive E. coli 
and S. flexneri that mediates NF-KB activation (Strober et al., 2006). Unlike these 
pathogens, C. jejuni activation of NF-KB was found independent of NODI. The 
production of antimicrobial peptides (Zilbauer et al., 2005), regulated by NOD2 in 
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lEes (Hisamatsu et at., 2003; Strober et at., 2006) may indicate a role for NOD2 
in limiting C. jejuni infection. 
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CHAPTER 6 Discussion 
CHAPTER 6 
6. Discussion 
Campylobacter species, a genus with a range of reservoirs and the ability 
to survIve m the environment, are the major cause of food-borne bacterial 
gastroenteritis worldwide. Principally caused by C. jejuni, the incidence of 
campylobacteriosis has followed an increasing pattern since the 1990s. Given that 
campylobacters are found in foods in retail stores, educational campaigns for 
consumers are thought to be an important factor to minimise the risk of 
contracting infections. It has been reported that most of the food-borne infections 
that occur in private households can be reduced if the consumers follow basic 
steps in handling and processing of food items. To better design 
control/prevention measures for Campylobacter enteritis, understanding how this 
pathogen causes disease is important. This can be partially investigated by 
studying the pathogen interaction with the host's cells at the molecular levels. 
Live C. jejuni (NCTC 11168) can activate the transcription factor NF-KB 
m epithelial cells but this response requires around 16 h before a sustained 
induction of the transcription factor takes place (Mellits et al., 2002). In contrast a 
boiled cell extract could activate NF-KB dependent gene transcription within two 
hours but that this response was transient peaking at 6 h and demonstrating the re-
synthesis ofIKBn after 90 min (Mellits et al., 2002). Consistent with these data we 
. 
show here that BCE and heat-killed bacteria can activate NF-KB-dependent 
reporter genes transfected into a range of cell types at 6 h (HE LA 57A, HEK-293, 
CACO-2 and HCA-7), and that the result of this activation is correlated with the 
elaboration of the cytokine IL-8. The presentation of live C. jejuni leading to the 
invasion of tissue cultured cells has the potential to stimulate internal receptors 
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differentially to cell surface receptors. This demonstrated for the first time that C. 
jejuni can elicit a pro-inflammatory response through the surface receptor TLR2 
in a MYD88 dependent manner, and that this response can be increased by the 
presence of the internal receptor NODI. However, in the absence of TLR2 or 
when a dominant negative form of MYD88 is co-expressed in cultured cells, C. 
jejuni and BeE can still activate NF-KB leading to IL-8 production. How this 
MYD88 independent activity occurs is not known at this time but the general 
consequence is that all the cell lines studied here, and likely a wider array of cell 
types, will inherently produce a pro-inflammatory response when challenged by 
C. jejuni or its products. This basal response may be enhanced in certain cell types 
through the expression of established receptors leading to robust activation ofNF-
KB. Campylobacter enterocolitis is predominantly an inflammatory disease and 
the ability of the bacteria to activate NF-KB in a range of cell types likely 
contributes to the disease process. 
The responses of intestinal epithelial cells need to be tightly controlled because 
they are continually exposed to bacteria and bacterial products. However, these 
cells must retain the ability to respond to pathogen associated damage (Abreu et 
al., 2005). The activation of NF -KB by C. jejuni in intestinal epithelial cells leads 
to the secretion of a series important cytokines and chemokines (IL-8, growth 
related oncogene n or GRan, GROy, macrophage inflammatory protein 1, 
monocyte chemoatractant protein 1 and IFNy-inducible protein 10) that contribute 
to the induction of inflammatory and adaptive immune responses (Hickey et al., 
1999; Mellits et al., 2002; Bakhiet et al., 2004; Watson & Galan, 2005; Hu & 
Hickey, 2005). It is the activation of the innate immune system by C. jejuni to 
produce pro-inflammatory cytokines that leads to localised inflammation and to 
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the development of symptoms associated with the disease. Cells responsible for 
mobilising adaptive immunity also respond to C. jejuni. Human monocytes have 
been reported to respond to C. jejuni by induction of IL-l, IL-6, IL-8, and TNF-u 
via NF-KB (Jones et at., 2003; Hickey et at., 2005), and similarly C.jejuni induces 
immature dendritic cells to produce I L - l ~ , , IL-6, IL-8, IL-lO, IL-12, IFNy, and 
TNF-a (Hu et at., 2006). Dendritic cells are of key importance to the intestinal 
immune system as they not only release cytokines but upon antigen capture 
mature to become the major antigen presentation cells capable of initiating 
proliferation in naive T -cells to induce a primary immune response and enable 
immunological memory. In addition to the expression of many TLRs, dendritic 
cells express C-type carbohydrate-recognizing receptor (Rossi and Young, 2005). 
The importance of this C-type receptor in sensing C. jejuni- derived carbohydrate 
is not currently known. 
In addition to the proposed alpha-glucan in BCE, TLR2 recognises a wide variety 
of ligands that include bacterial lipopeptides/lipoproteins, lipoteichoic acid, 
lipoarabinomannan as well as trypanosome glycosylphosphatidylinositol-
anchored protein and yeast zymosan (Takeda et aI., 2003). Lipoproteins and 
lipopeptides are candidate ligands for the TLR2 dependent activation ofNF-KB by 
C. jejuni and BCE. Genome sequences of C. jejuni encode a number of putative 
lipoproteins that include the C. jejuni surface lipoprotein JlpA, which has been 
reported to interact with cellular heat shock protein Hsp90 to activate NF-KB (Jin 
et at. 2003). The expression ofTLR2 increases the ability ofHEK293 and CACO-
2 cells to respond to BCE in a similar way to live C. jejuni. BCE contains a heat-
stable TLR2 agonist that is insensitive to proteinase K digestion. It is possible that 
residual lipopeptides could survive these processes and therefore are candidates 
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for the activation of NF-KB via TLR2. However, treatment of purified lkDa 
fraction of BCE with amyloglucosidase abolished NF-KB activation even in the 
presence of TLR2 indicating that this receptor only sensed an oligosaccharide 
structure in BCE. In contrast the expression of TLR4 in HEK293 cells did not 
result in enhanced activation of NF-K13 by C. jejuni or BCE. The natural agonist 
of TLR4 is bacterial lipopolysaccharide (LPS), however, C. jejuni synthesises 
lipooligosaccharide (LOS) as a component of its cell surface. LOS differs from 
LPS common to other Gram-negative species in that the O-chain polysaccharide 
is absent leaving core polysaccharide attached to lipidA. There is considerable 
variation in the LOS structures of C. jejuni and structural variants arise within 
cultures of the same strain due to phase variation in the reading frames of LOS 
biosynthetic genes (reviewed by Karlyshev et al., 2005). The core polysaccharide 
structure of C. jejuni NCTC 11168 has been determined and exhibits structural 
variants, most notably in the terminal structures that are analogous to human 
gangliosides GMla and GM2 and subject to phase variation (Oldfield et al., 2002; 
Michael et al., 2002). The lipid-A backbone of C. jejuni NCTC 11168 also shows 
variation with combinations of the disaccharides 2,3-diamino-2,3,-dideoxy-D-
glucose and D-glucosamine exhibiting different patterns of 
pyrophosphorylethanolamine attachment. All this structure variation could mean 
that only selective LOS types have the possibility of acting as agonists of TLR4 or 
possibly they could contribute to TLR2 dependent activation. Regardless of these 
possibilities the expression of TLR4 with MD2 and CD14 in HEK293 cells did 
not significantly increase activation of NF-KB by C. jejuni NCTC 11168 or BCE, 
and signalling by this pathway appears limited compared to the strong pro-
inflammatory responses recorded for the alternative pathways investigated here. 
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NOD I and NOD2 are internal cellular sensors of muropeptides derived from the 
breakdown of bacterial peptidoglycan. NOD I responds to the naturally occurring 
product GlcNAc-MurNAc-L-Ala-y-D-Glu-meso-diamino-pimelic acid formed 
upon the breakdown of peptidoglycan from Gram-negative bacteria (Girardin et 
aI., 2003), whereas the minimal structure to which NOD2 will respond is the 
muramyl dipeptide MurNAc-L-Ala-D-isoGln that is a common component of 
Gram-negative and Gram-positive bacteria (Inohara et al., 2003; Girardin et al., 
2003). C. jejuni is clearly a source of these molecules or related structures, which 
could be delivered as breakdown products in BCE or through invasion by live 
bacteria. However, NODI has only been conclusively shown to affect NF-KB 
activation in cells co-expressing TLR2-CD-I4. This effect appears to be a feature 
of the response to C. jejuni because the NODI agonist M-triDAP did not show 
any significant increase in the activation of NF-KB following co-expression of 
TLR2. The expression of NOD2 in HEK293 cells leads to an increase in the 
background levels of the luciferase reporter ofNF-KB but clearly further sensitises 
the cells to C. jejuni. 
The presentation of heat killed or dead bacteria to cultured cells may lead to 
internalisation but these particles will not be replaced unlike the situation with a 
growing bacterial culture. Consistent with this view heat-killed C. jejuni produce 
a transient activation ofNF-KB compared to the delayed but sustained stimulation 
by live bacteria (Mellits et al., 2002) C. jejuni BCE represents a soluble diffusible 
activator that may be rapidly recognised by cell surface receptors and has the 
possibility of being transported within the cell to stimulate internal receptors. 
Stimulation by BCE is by nature transient but represents a stable material that 
gives rise to a strong reproducible response that can be easily quantified to test the 
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effects of chemical or enzyme treatments on BCE, or alternatively changes in the 
responses of host cells to manipulation of the signal transduction pathways 
available to them. Response to BCE was not confined to sub-confluent tissue 
culture cells but was also evident when applied to polarised monolayers of colonic 
epithelial cells (Caco-2 and HCA-7) by the production of IL-S. Application of 
BCE to the apical face of polarised mono layers resulted in a greater accumulation 
of IL-S in the physiologically relevant basolateral chamber. The application of 
live C. jejuni to the apical face of polarised Caco-2 and HCA-7 mono layers 
induced a slower accumulation of IL-S over 16 h but with a similar result in that 
the IL-8 levels recorded in the basolateral chambers were greater than those of the 
apical chamber. Viable counts of C. jejuni applied at an m.o.i. of 100 in D-MEM 
to cell cultures under these conditions remain static, likely due to the bacteria 
being in stationary phase, as it is evident from microscopic examination that a 
proportion of the extracellular bacteria continue to divide. At 16 h the effective 
dose of live and dead bacteria will be greater than the initial input m.o.i. of 100. 
However, despite the increase in microbial load at this time the tight junctions of 
these mono layers remain largely intact as judged by modest falls in the TEER of 
around 5%. Although, 12 hours later against a greater microbial load the TEER 
values were observed to fall implying the loss of tight junctions to provide access 
to the basolateral chamber for C. jejuni via a paracellular route, as reported by 
previous authors (Bras & Ketley, 1999; MacCallum et al., 2005). 
All the cell types investigated responded to treatment with C. jejuni or BCE by 
induction of NF-KB but the levels of IL-8 elaborated by the cells were markedly 
different. Of particular note the HCA-7 and Caco-2 cell lines are similarly derived 
from human colon carcinomas and capable of forming polarised monolayers in 
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culture as discussed above, but HCA-7 cells secrete almost 100-fold the quantity 
of IL-8 in response to BCE treatment compared to Caco-2 cells. Polarised cells 
also show a five-fold difference in the basolaterallevels of IL-8 between the two 
cell lines. A possible explanation for this difference could be in the expression of 
TLR3 or NOD2, which were detectable by RT-PCR from HCA-7 cells but absent 
in Caco-2 cells. Treatment with nuc1eases that would remove the dsRNA ligand 
for TLR3 did not reduce the ability of BCE to activate NF-KB. However, we 
demonstrate that NOD2 expression in HEK293 cells results in a general up-
regulation of the NF-KB reporter response, and that inhibition of NOD2 function 
by co-expression ofDN-NOD2 results in a reduction in the ability oflive C. jejuni 
to activate NF-KB. The presence of NOD2 in HCA-7 could at least in part 
account for the ability of C. jejuni to induce increased levels of IL-S. This with 
another reported function of NOD2, that is regulating antimicrobial peptides in 
IECs, suggests that NOD2 assists in early recognition and limiting C. jejnui 
infection. However, it is not certain this explanation could extend to BCE, where 
co-expression with DN-NOD2 did not produce a significant fall in the activation 
of NF-KB. NOD2 has been reported to be expressed at low levels in colonic 
epithelial cells but to be up-regulated by pro-inflammatory cytokines, TNF-a and 
IFNy (Rosenstiel et al., 2003). Indeed the NOD2 gene promoter contains a KB 
response element that will ensure a response to internalised pathogens following 
initial surface receptor stimulation even if NOD2 levels are initially low 
(Gutierrez et al., 2002). It is possible that the rapid and robust response to 
diffusible BCE will lead to increased NOD2 expression that may in part overcome 
the dominant negative phenotype of the plasmid borne DN-NOD2 allele. 
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That heat inactivated C. jejuni can activate NF-KB has been reported for human 
monocyte derived THP-l and dendritic cells (Jones et al., 2003; Hu et al., 2006), 
although a recent report has suggested that heat inactivated C. jejuni 81-176 does 
not activate NF-KB in intestinal derived T84 cells (Johanesen & Dwinell, 2006). 
In these experiments the chemokine CCL20 (synonymous with macrophage 
inflammatory protein 3a) was monitored over a 24 h period where the infection 
model was reported to consist of a 2 h incubation of C. jejuni or dead bacteria 
with the T84 cells before treatment with gentamycin and removal of the bacteria. 
Continued stimulus could only be possible through internalised bacteria. Our data 
clearly demonstrate for that stimulation through the internal receptor NODI is 
only evident when the cells co-express and respond to TLR2, and that this 
response requires MYD88 and the accessory protein CD-14. However, the 
expression of NOD2 does lead to an enhanced activation of NF-KB that is not 
reliant on the co-expression of TLR2. It would seem that NOD2 is likely 
responsible for the NF-KB activation by internalised bacteria but the response may 
be weak if the combination of C. jejuni 81-176 and T84 cells do not exhibit the 
basal response to heat-stable products we note here in several cell lines and 
previously with other C. jejuni strains (Mellits et al., 2002). However, it has been 
recently reported that with the notable exception of the anti-inflammatory 
cytokine IL-I 0, cytokine production in dendritic cells did not show any significant 
differences between live and heat-killed C. jejuni 81-76 (Hu et al. 2006). Taken 
together these latter findings would suggest that the signals required for dendritic 
cell trafficking and response to C. jejuni are not confined to live cells, and that 
invasion can contribute to cytokine induction but is certainly not a prerequisite. 
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To summarise we have demonstrated that C. jejuni and its heat-stable products 
can activate NF-KB in a range of cell types that are independent of the expression 
of Toll-like receptors, and the internal receptors NODI and NOD2. However, the 
presence ofTLR2 with accessory protein CD-I4 will further sensitise cells to C. 
jejuni and its heat-stable products in a MYD88 dependent manner to enhance the 
activation of NF-KB, and that the activation conferred by TLR2 shows synergy 
with NOD 1. The expression of NOD2 also increases the sensitivity of cells to C. 
jejuni. The response of humans to the food borne pathogen C. jejuni is likely to 
have several facets that include recognition of several P AMPs by a variety of 
surface and internal receptors that stimulate pathways that converge on the 
transcription factor NF-K8 to elicit a potent pro-inflammatory response that is the 
hallmark of the pathogen. 
Because BCE of C. jejuni is a serious concern for food safety structural 
characterization was limited to understand the nature of the NF-KB activating 
component in BCE. The structures of other C. jejuni derived products, which are 
thought not to contribute to NF-KB activation have been reported previously 
(Michael et ai., 2002; Karlyshev et ai., 2005). The understanding that BCE is 
heat, proteinase K, and lipopeptide lipase resistant, was the initial consideration 
towards the development of purification methods. Size-exclusion chromatography 
based separation is usually the first choice for estimating the molecular weight for 
the component of interest. Followed by SPE and the suitable phase of HPLC, the 
structure under study can be identified by MS, GC (if sample is derivatizable), 
MS-GC, and/or NMR. However, the combination of structural characterization 
with tracking of the bioactive components can limit methods of purification and 
make structural details about the molecules difficult to obtain or indeed confound 
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any conclusion. In this study, the use of strong buffers or chemicals that would 
require the sample to be desalted before MSINMR was avoided to eliminate 
affecting the bioassay results or loss of sample during desalting. Therefore, the 
purification methods development were limited by the suitability of available 
buffer systems. 
The activation of the calcium-dependent transcription factor NF-AT 
(reviewed by Macian, 2005) and its contribution to innate immune responses have 
not been clearly demonstrated (Goodridge et at., 2007). Zymosan, a yeast-derived 
product mostly composed o f ~ - g l u c a n , , was reported to activate NF-AT and induce 
the production of early growth response 2 and early growth response 3 
transcription factors, cycIooxygenase 2, IL-2, IL-lO and IL-12 p70 by Dectin-l 
expressing stimulated dendritic cells (Goodridge et at., 2007). 
The nature of the NF-KB-activating structure in BeE was found to be an 
alpha-glucan (5-glucose residue). Only until recently, the activation ofNF-KB by 
alpha-glucan has been reported (Bittencourt et at., 2005). Given that beta-glucan 
is of beneficial health effect, that is by shifting of pro- inflammatory responses to 
anti-inflammatory responses through the regulation of the interleukin-l receptor 
antagonist gene (Luhm et at., 2006), what makes alpha-glucan induce 
inflammatory responses is not known. This is assuming that NF-KB activation as 
observed in cell line bioassays reflects the host's inflammatory responses to 
infection. How alpha-glucan can be recognised by trans-membrane or cytoplasmic 
receptors is not understood. However, for BeE it seems that the hydroxyl groups 
in the structure playa role in its recognition by the host's receptors because 
replacing these groups with methyl groups inhibits BeE ability to activate NF-KB. 
If BeE is recognized by an IL-llToIl like receptor, then its hydrophilic active 
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component must interact with the extracellular domain (ED) of the receptor. The 
ED, which has a conserved LRR motif, varies in structure for different TLRs to 
enable binding to wide range of P AMPs (Strober et al., 2006). After binding, the 
signal is initiated at the conserved 160 amino acids-motif (TIR domain) that is 
found at the cytolosic domain ofTLRs. Binding ofBCE to ED could be facilitated 
by a hydroxyl (of BCE) -hydroxyl (of amino acids in ED) interaction. 
Recognition of P AMPs by NODs is also mediated by their LRR motif (Strober et 
al., 2006). Although alpha-glue an has been recently described for C. jejuni, its 
synthesis and contribution to the interaction with host cells are not known. The 
OPGs, mostly beta-linked but reported to contain alpha-linked glucan, could be a 
possible source for the bioactive component in C. jejuni. 
The knowledge obtained here has highlighted the possible interactions of C. jejuni 
products with the host, and will assist in developing better prevention/control 
methods of Campylobacter mediated infections. Additional investigations to 
identify the cellular receptors used by C. jejuni in the host's IECs to induce 
inflammatory responses and characterization of the bioactive structure(s) 
responsible for the responses in IECs are needed. 
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